CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 DECEMBER 2021
|
(in thousands of HRK) |
Note |
2021 |
2020 |
|
|
Revenues |
8 |
4,631,519 |
4,503,217 |
|
|
Cost of goods sold |
11 |
(2,953,381) |
(2,843,802) |
|
|
Gross profit |
1,678,138 |
1,659,415 |
||
|
Other income |
9 |
34,983 |
23,247 |
|
|
General and administrative expenses |
11 |
(346,110) |
(335,920) |
|
|
Selling and distribution costs |
11 |
(619,421) |
(592,555) |
|
|
Marketing expenses |
11 |
(373,762) |
(377,440) |
|
|
Other expenses |
10 |
(8,529) |
(44,401) |
|
|
Operating profit |
365,299 |
332,346 |
||
|
Financial income |
13 |
1,782 |
542 |
|
|
Financial expenses |
14 |
(7,801) |
(18,878) |
|
|
Profit before tax |
359,280 |
314,010 |
||
|
Income tax |
15 |
(41,458) |
(57,876) |
|
|
Profit for the year |
317,822 |
256,134 |
||
|
Other comprehensive income: |
||||
|
Items that will not be reclassified to profit or loss account |
||||
|
Actuarial loss net of deferred tax |
(969) |
(2,602) |
||
|
Items that can be subsequently reclassified to profit and loss account |
||||
|
Exchange differences on translation of foreign operations |
365 |
8,628 |
||
|
Total other comprehensive income |
(604) |
6,026 |
||
|
Total comprehensive income |
317,218 |
262,160 |
||
|
Profit attributable to: |
||||
|
Equity holders of the parent |
309,221 |
248,934 |
||
|
Non-controlling interests |
8,601 |
7,200 |
||
|
Total comprehensive income attributable to: |
||||
|
Equity holders of the parent |
308,754 |
254,473 |
||
|
Non-controlling interests |
|
8,464 |
7,687 |
|
|
Earnings per share (in HRK): |
||||
|
- Basic |
16 |
44.1 |
35.6 |
|
|
- Diluted |
16 |
43.4 |
35.4 |
|
The accompanying accounting policies and notes form an integral part of these consolidated financial statements.
CONSOLIDATED STATEMENT OF FINANCIAL POSITION
AS AT 31 DECEMBER 2021
|
(in thousands of HRK) |
Note |
31 December 2021 |
31 December 2020 |
|
|
ASSETS |
||||
|
Non-current assets |
||||
|
Goodwill |
17 |
28,103 |
26,819 |
|
|
Intangible assets |
18 |
249,235 |
253,155 |
|
|
Property, plant and equipment |
19 |
2,206,453 |
2,222,277 |
|
|
Right-of-use assets |
20 |
93,234 |
100,318 |
|
|
Investment property |
21 |
115,406 |
117,086 |
|
|
Non-current financial assets |
23 |
43,209 |
43,291 |
|
|
Deferred tax assets |
15 |
150,101 |
141,411 |
|
|
Total non-current assets |
2,885,741 |
2,904,357 |
||
|
Current assets |
|
|
||
|
Inventories |
24 |
933,710 |
980,437 |
|
|
Trade and other receivables |
25 |
1,026,086 |
972,996 |
|
|
Financial assets at fair value through |
26 |
- |
106 |
|
|
Income tax receivable |
6,426 |
2,023 |
||
|
Cash and cash equivalents |
27 |
33,306 |
51,856 |
|
|
Non-current assets held for sale |
28 |
23,683 |
28,873 |
|
|
Total current assets |
2,023,211 |
2,036,291 |
||
|
Total assets |
4,908,952 |
4,940,648 |
||
|
|
|
|||
|
EQUITY AND LIABILITIES |
||||
|
Shareholders' equity |
||||
|
Issued capital |
29 |
1,566,401 |
1,566,401 |
|
|
Share premium |
29 |
191,489 |
187,215 |
|
|
Treasury shares |
29 |
(39,387) |
(47,568) |
|
|
Reserves |
30 |
1,090,288 |
951,174 |
|
|
Retained earnings |
31 |
822,186 |
714,828 |
|
|
Attributable to equity holders of the parent |
3,630,977 |
3,372,050 |
||
|
Non-controlling interests |
32 |
63,289 |
54,932 |
|
|
Total shareholders' equity |
3,694,266 |
3,426,982 |
||
|
Non-current liabilities |
||||
|
Borrowings |
34 |
139,740 |
301,194 |
|
|
Lease liabilities |
20 |
62,769 |
68,642 |
|
|
Non-current provisions for employee benefits |
35 |
52,825 |
52,023 |
|
|
Other non-current provisions |
35 |
34,265 |
26,451 |
|
|
Other non-current liabilities |
36 |
18,445 |
19,129 |
|
|
Deferred tax liability |
15 |
37,984 |
39,034 |
|
|
Total non-current liabilities |
346,028 |
506,473 |
||
|
Current liabilities |
||||
|
Trade and other payables |
37 |
531,316 |
554,910 |
|
|
Income tax payable |
2,419 |
4,747 |
||
|
Financial liabilities at
fair value through |
33 |
35 |
66 |
|
|
Borrowings |
34 |
258,884 |
381,977 |
|
|
Lease liabilities |
20 |
32,403 |
33,322 |
|
|
Current provisions for employee benefits |
35 |
42,221 |
32,030 |
|
|
Other current provisions |
35 |
1,380 |
141 |
|
|
Total current liabilities |
868,658 |
1,007,193 |
||
|
Total liabilities |
1,214,686 |
1,513,666 |
||
|
Total equity and liabilities |
4,908,952 |
4,940,648 |
The accompanying accounting policies and notes form an integral part of these consolidated financial statements.
CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDER'S EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2021
|
(in thousands of HRK) |
Issued capital |
Share premium |
Treasury shares |
Treasury shares reserves |
Legal reserves |
Reinvested profit reserve |
Statutory reserves |
Other reserves |
Retained earnings |
Total |
Non-controlling interests |
Total |
|
As at 1 January 2020 |
1,566,401 |
179,803 |
(47,568) |
147,604 |
66,358 |
189,738 |
64,046 |
385,834 |
620,878 |
3,173,094 |
46,334 |
3,219,428 |
|
Comprehensive income |
||||||||||||
|
Profit for the year |
- |
- |
- |
- |
- |
- |
- |
- |
248,934 |
248,934 |
7,200 |
256,134 |
|
Foreign exchange differences |
- |
- |
- |
- |
- |
- |
- |
8,141 |
- |
8,141 |
487 |
8,628 |
|
Actuarial losses (net of deferred tax) |
- |
- |
- |
- |
- |
- |
- |
(2,602) |
- |
(2,602) |
- |
(2,602) |
|
Other comprehensive income |
- |
- |
- |
- |
- |
- |
- |
5,539 |
- |
5,539 |
487 |
6,026 |
|
Total comprehensive income |
- |
- |
- |
- |
- |
- |
- |
5,539 |
248,934 |
254,473 |
7,687 |
262,160 |
|
Transactions with owners and transfers recognised directly in equity |
||||||||||||
|
Allocation from retained earnings |
- |
- |
- |
- |
10,238 |
- |
3,505 |
78,312 |
(92,055) |
- |
- |
- |
|
Liquidation of a subsidiary |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
911 |
911 |
|
Exercise of options |
- |
(3,708) |
- |
- |
- |
- |
- |
- |
- |
(3,708) |
- |
(3,708) |
|
Fair value of share-based payment transactions |
- |
11,120 |
- |
- |
- |
- |
- |
- |
- |
11,120 |
- |
11,120 |
|
Dividend declared |
- |
- |
- |
- |
- |
- |
- |
- |
(62,929) |
(62,929) |
- |
(62,929) |
|
Total transactions with owners recognised directly in equity |
- |
7,412 |
- |
- |
10,238 |
- |
3,505 |
78,312 |
(154,984) |
(55,517) |
911 |
(54,606) |
|
As at 31 December 2020 |
1,566,401 |
187,215 |
(47,568) |
147,604 |
76,596 |
189,738 |
67,551 |
469,685 |
714,828 |
3,372,050 |
54,932 |
3,426,982 |
|
Comprehensive income |
||||||||||||
|
Profit for the year |
- |
- |
- |
- |
- |
- |
- |
- |
309,221 |
309,221 |
8,601 |
317,822 |
|
Foreign exchange differences |
- |
- |
- |
- |
- |
- |
- |
502 |
- |
502 |
(137) |
365 |
|
Actuarial losses (net of deferred tax) |
- |
- |
- |
- |
- |
- |
- |
(969) |
- |
(969) |
- |
(969) |
|
Other comprehensive income |
- |
- |
- |
- |
- |
- |
- |
(467) |
- |
(467) |
(137) |
(604) |
|
Total comprehensive income |
- |
- |
- |
- |
- |
- |
- |
(467) |
309,221 |
308,754 |
8,464 |
317,218 |
|
Transactions with owners and transfers recognised directly in equity |
||||||||||||
|
Allocation from retained earnings (note 30) |
- |
- |
- |
- |
9,712 |
- |
2,621 |
127,215 |
(139,548) |
- |
- |
- |
|
Exercise of options |
- |
(1,986) |
8,181 |
- |
- |
- |
- |
- |
812 |
7,007 |
- |
7,007 |
|
Fair value of share-based payment transactions (note 39) |
- |
6,260 |
- |
- |
- |
- |
- |
- |
- |
6,260 |
- |
6,260 |
|
Dividend declared |
- |
- |
- |
- |
- |
- |
- |
- |
(63,127) |
(63,127) |
- |
(63,127) |
|
Additional acquisition of minority interests (note 30) |
- |
- |
- |
- |
- |
- |
- |
33 |
- |
33 |
(107) |
(74) |
|
Total transactions with owners recognised directly in equity |
- |
4,274 |
8,181 |
- |
9,712 |
- |
2,621 |
127,248 |
(201,863) |
(49,827) |
(107) |
(49,934) |
|
As at 31 December 2021 |
1,566,401 |
191,489 |
(39,387) |
147,604 |
86,308 |
189,738 |
70,172 |
596,466 |
822,186 |
3,630,977 |
63,289 |
3,694,266 |
The accompanying accounting policies and notes form an integral part of these consolidated financial statements.
CONSOLIDATED STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 31 DECEMBER 2021
|
(in thousands of HRK) |
Note |
2021 |
2020 |
|
|
Profit before tax |
359,280 |
314,010 |
||
|
Depreciation and amortization |
11 |
218,166 |
218,225 |
|
|
Impairment on property, plant and equipment |
10 |
766 |
132 |
|
|
Impairment/(reversal of impairment) of intangible assets |
10 |
7,674 |
(4,000) |
|
|
Impairment/(reversal of impairment) of trade and other receivables |
533 |
(5,246) |
||
|
(Gain)/loss from sale and disposal of non-current assets |
(396) |
323 |
||
|
Remeasurement of financial assets and liabilities at FVTPL |
75 |
(321) |
||
|
Share-based payment transactions |
6,260 |
11,120 |
||
|
Gain on disposal of assets held for sale |
(5,272) |
(1,320) |
||
|
Increase in provisions |
20,046 |
4,375 |
||
|
Interest income |
13 |
(613) |
(211) |
|
|
Dividend income and similar |
(12) |
- |
||
|
Interest expense |
14 |
7,784 |
14,771 |
|
|
Foreign exchange differences |
(950) |
11,708 |
||
|
Total adjustments |
254,061 |
249,556 |
||
|
Changes in working capital: |
||||
|
Decrease/(Increase) in inventories |
46,727 |
(32,177) |
||
|
(Increase) in receivables |
(53,649) |
(18,740) |
||
|
(Decrease) in payables |
(23,058) |
(53,450) |
||
|
Cash generated from operations |
583,361 |
459,199 |
||
|
Income taxes paid |
(58,224) |
(59,953) |
||
|
Interest paid |
(8,077) |
(14,792) |
||
|
Net cash from operating activities |
517,060 |
384,454 |
||
|
Cash flows from investing activities |
||||
|
Purchase of property, plant, equipment and intangibles |
(170,264) |
(192,417) |
||
|
Proceeds from sale of assets held for sale |
28 |
11,532 |
2,091 |
|
|
Proceeds from sale of property, plant, equipment and intangibles |
1,669 |
3,200 |
||
|
Loans given |
(3) |
(39) |
||
|
Proceeds from loans given |
20 |
71 |
||
|
Interest received |
613 |
189 |
||
|
Dividends received |
12 |
- |
||
|
Net cash from investing activities |
(156,421) |
(186,905) |
||
|
Cash flows from financing activities |
||||
|
Dividend paid |
(62,782) |
(62,546) |
||
|
Additional acquisition of minority interests |
(74) |
- |
||
|
Sale of treasury shares |
7,983 |
- |
||
|
Proceeds from borrowings |
226,847 |
389,411 |
||
|
Repayment of borrowings |
(512,326) |
(491,496) |
||
|
Repayment of leases |
(38,837) |
(36,651) |
||
|
Net cash from financing activities |
(379,189) |
(201,282) |
||
|
Net (decrease) of cash and cash equivalents |
(18,550) |
(3,733) |
||
|
Cash and cash equivalents at beginning of year |
51,856 |
55,589 |
||
|
Cash and cash equivalents at the end of year |
27 |
33,306 |
51,856 |
|
The accompanying accounting policies and notes form an integral part of these consolidated financial statements.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 1 – GENERAL INFORMATION
History and incorporation
Podravka prehrambena industrija d.d., Koprivnica (“the Company”) is incorporated in the Republic of Croatia. The principal activities of the Group comprise production of a wide range of food products as well as production and distribution of drugs, pharmaceutical products, cosmetics, auxiliary medical preparations and other chemicals. The Group consists of the parent company Podravka d.d. and its subsidiaries as stated in note 22. Podravka d.d. was established as a joint stock company under the entity registration number 010006549 and personal identification number 18928523252.
The Group is headquartered in Koprivnica, Croatia, Ante Starčevića 32.
The main location of the Company’s operations is Koprivnica, the Republic of Croatia.
The Company’s shares were listed on the official market of the Zagreb Stock Exchange until 27 December 2018, since when they have been listed on the Prime Market of the Zagreb Stock Exchange. The shareholder structure is shown in note 29.
Podravka d.d. is the ultimate parent company of the Group.
During 2021, there were no changes in the Company’s name or other identification of the reported entity.
General Assembly
The General Assembly of the Company consists of the shareholders of Podravka d.d.
|
Supervisory Board: |
||
|
Members of the Supervisory Board in 2021: |
||
|
President |
Želimir Vukina |
(01.07.2019 - 30.06.2023) |
|
Deputy President |
Luka Burilović |
(08.09.2018 - 07.09.2022) |
|
Member |
Marina Dabić |
(01.07.2019 - 30.06.2023) |
|
Member |
Tomislav Kitonić |
(01.07.2019 - 30.06.2023) |
|
Member |
Ksenija Horvat |
(01.07.2019 - 30.06.2023) |
|
Member |
Ivana Matovina |
(30.06.2017 - 29.06.2021) |
|
Member |
Petar Miladin |
(08.09.2018 - 09.09.2022) |
|
Member |
Dajana Milodanović |
(08.09.2018 - 07.09.2022) |
|
Member |
Krunoslav Vitelj |
(08.09.2018 - 07.09.2022) |
|
Member |
Ivan Ostojić |
(30.06.2021 - 30.06.2022) |
|
Management Board: |
||
|
President |
Martina Dalić |
(04.02.2021 - 23.02.2027) |
|
President |
Marin Pucar |
(24.02.2017 - 06.01.2021) |
|
Member |
Davor Doko |
(01.05.2017 - 23.02.2027) |
|
Member |
Marko Đerek |
(19.07.2017 - 23.02.2022) |
|
Member |
Hrvoje Kolarić |
(24.02.2017 - 23.02.2022) |
|
Member |
Ljiljana Šapina |
(24.02.2017 - 23.02.2027) |
|
Member |
Milan Tadić |
(24.02.2022 - 23.02.2027) |
More detailed information is presented in note 43.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 2 – BASIS OF PREPARATION
(i) Statement of compliance
The consolidated financial statements have been prepared in accordance with International Financial Reporting Standards as adopted by the European Union (“EU IFRS”).
Financial statements are presented for the Group. The financial statements of the Group comprise the consolidated financial statements of the Company and its subsidiaries. The separate financial statements of the Company, which the Company is also required to prepare in accordance with EU IFRS, are published separately and issued simultaneously with these consolidated financial statements. The consolidated financial statements are available on the Company’s website.
Changes in accounting policies are explained in note 5.
These financial statements were authorised for issue by the Management Board on April 4, 2022.
(ii) Basis of measurement
The consolidated financial statements of the Group have been prepared on the historical cost basis, except where stated otherwise (see note 6).
(iii) Functional and presentation currency
These financial statements are prepared in the Croatian kuna (“HRK”), which is also the functional currency, rounded to the nearest thousand.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
The principal accounting policies adopted in the preparation of these consolidated financial statements are set out below. These policies have been consistently applied to all the years presented.
3.1 Basis of consolidation
The consolidated financial statements of the Group incorporate the financial statements of Podravka d.d. (“the Company”) and entities controlled by Podravka d.d. (its subsidiaries) as at and for the year ended 31 December 2021. Control is achieved if the Company has the power to govern the financial and operating policies of an entity so as to obtain benefits from its activities.
(i) Subsidiaries
Subsidiaries are all entities over which the Company has the power to govern the financial and operating policies generally accompanying a shareholding of more than one half of the voting rights. The existence and effect of potential voting rights that are currently exercisable or convertible are considered when assessing whether the Company controls another entity. Subsidiaries are fully consolidated from the date on which control is transferred to the Company and are de-consolidated from the date that control ceases.
(ii) Business combinations
The Group uses the acquisition method of accounting to account for business combinations. The consideration transferred for the acquisition of a subsidiary is the fair values of the assets transferred, the liabilities incurred and the equity interests issued by the Group. The consideration transferred includes the fair value of any asset or liability resulting from a contingent consideration arrangement. Acquisition related costs are expensed in the statement of comprehensive income as incurred. Identifiable assets acquired and liabilities and contingent liabilities assumed in a business combination are measured initially at their fair values at the acquisition date. On an acquisition-by-acquisition basis, the Group recognises any non-controlling interest in the acquiree either at fair value or at the non-controlling interest’s proportionate share of the acquiree’s net assets.
The excess of consideration transferred, the amount of any non-controlling interest in the acquiree and acquisition-date fair value of any previous equity interest in the acquiree over the fair value of the Group’s share of the identifiable net assets acquired is recorded as goodwill. If this is less than the fair value of the net assets of the subsidiary acquired, the difference is recognised directly in the statement of comprehensive income.
(iii) Non-controlling interests
Non-controlling interests are initially measured by their proportionate share of recognised net assets of the acquiree at the acquisition date. Changes in the Group’s share in the subsidiary that do not result in loss of control are accounted for as transactions with owners.
(iv) Loss of control over subsidiaries
When the Group loses control of a subsidiary, the subsidiary’s assets and liabilities and all related non-controlling interests and other equity items are derecognised. Gains or losses are recognized in the income statement. Retained share in the former subsidiary is measured at fair value when control is lost.
(v) Transactions eliminated on consolidation i
Intra-group balances and transactions, and any unrealised gains arising from intra-group transactions, are eliminated in preparing the consolidated financial statements. Unrealised gains arising from transactions with associates and jointly controlled entities are eliminated to the extent of the Group’s interest in the enterprise. Unrealised gains arising from transactions with associates are eliminated against the investment in the associate. Unrealised losses are eliminated in the same way as unrealised gains, but only to the extent that there is no evidence of impairment.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
3.2 Goodwill
Goodwill arising on an acquisition of a business is carried at cost as established at the date of acquisition of the business, less accumulated impairment loss, if any.
For the purposes of impairment testing, goodwill is allocated to each of the Group's cash-generating units (or groups of cash-generating units) that is expected to benefit from the synergies of the combination.
A cash-generating unit to which goodwill has been allocated is tested for impairment annually, or more frequently when there is indication that the unit may be impaired. If the recoverable amount of the cash-generating unit is less than its carrying amount, the impairment loss is allocated first to reduce the carrying amount of any goodwill allocated to the unit and then to the other assets of the unit pro rata based on the carrying amount of each asset in the unit. Any impairment loss for goodwill is recognised directly in the consolidated statement of comprehensive income. An impairment loss recognised for goodwill is not reversed in subsequent periods.
On disposal of the relevant cash-generating unit, the attributable amount of goodwill is included in the determination of the profit or loss on disposal.
3.3 Non-current assets held for sale
Non-current assets and disposal groups (which may include both non-current and current assets and liabilities directly associated with those assets) are classified in the statement of financial position as ‘held for sale’ if it is highly probable that their carrying amount will be recovered principally through a sale transaction within twelve months after the reporting date rather than through continuing use. Non-current assets classified as held for sale in the current period’s consolidated statement of financial position are not reclassified in the comparative consolidated statement of financial position.
Held-for-sale property, plant and equipment or disposal groups as a whole are generally measured at the lower of their carrying amounts and fair values less costs to sell or distribute. Held-for-sale property, plant and equipment are not depreciated.
3.4 Revenue recognition
The Group recognises revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Group expect to be entitled in exchange for those goods or services. Revenue is recognised, net of value-added tax, volume rebates, trade discounts, returns, listing fees and various promotional and marketing activities that are an integral part of contracts with customers. This core principle is delivered in a five-step model framework.
The Group considers whether there are other promises in the contract that are separate performance obligations to which a portion of the transaction price needs to be allocated.
In determining the transaction price, the Group considers the effects of variable consideration, the existence of significant financing components, noncash consideration and consideration payable to the customer.
Group’s sales contracts generally comprise of only one performance obligation. As such, the Group do not disclose information about the allocation of the transaction price.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
3.4 Revenue recognition (continued)
(i) Revenue from sale of products and merchandise – wholesale
The Group manufactures and sells its own products and goods of third parties (for which the Group is a distributor) in the wholesale market. Revenue is recognised when the Group transfers the promised goods or services to the wholesaler.
Products are sold with volume discounts and customers have a right to return products in the wholesale market in case of defects. Sales are recorded based on the price specified in the sales contracts, net of estimated volume rebates and trade discounts and returns. The volume discounts are assessed based on contracts with customers. No element of financing is deemed present in the sales.
(ii) Revenue from sale of products and merchandise – retail
Sales of products and goods sold in retail stores are recognised when the Group sells a product to the customer. Retail sales are usually in cash or by credit card. The Group does not operate any customer loyalty programmes.
(iii) Revenue from services
Sales of services, such as private label production, are recognised in the accounting period in which the services are rendered, by reference to stage of completion, on the basis of the actual service provided as a proportion of the total services to be provided.
(iv) Finance income
Finance income comprises interest income on funds invested, changes in the fair value of financial assets at fair value through profit or loss and foreign currency gains. Interest income is recognised as it accrues, using the effective interest method. Dividend income is recognised when the right to receive payment is established.
3.5 Leases
Lease is a contract or part of the contract that conveys the right to control the use of an asset (identified asset) for a period of time in exchange for consideration. The Podravka Group leases certain property (including long-term lease of agricultural land), plant and equipment.
The Group adopted IFRS 16 using the modified retrospective method of adoption, with the date of initial application of 1 January 2019. The Company applied the standard only to contracts that were previously identified as leases applying IAS 17 and IFRIC 4 at the date of initial application.
The Group also elected to use the recognition exemptions for lease contracts that, at the commencement date, have a lease term of 12 months or less and do not contain a purchase option (short-term leases), and lease contracts for which the underlying asset is of low value in the amount up to HRK 35 thousand (low-value assets). Assessment of asset of a low value starts from the assessment of new assets, regardless of the age of that asset at the time of assessment. If a lessee subleases an asset the head lease does not qualify as a lease of a low value asset. In short-term leases and leases of a low value asset, lease payments associated with these leases are recognized as an expense on a straight-line basis over the lease term.
At the commencement date of the lease the Podravka Group recognizes right-of-use assets at cost. The cost of right-of-use assets comprises of amount of the initial measurement of the lease liability, all lease payments plus all direct costs and less any lease incentives received. The asset is activated when it is put into use.
The Podravka Group at the commencement date also recognizes lease liabilities at the present value of the minimum future lease payments (discounted value). Interest rate implicit in the lease contract is used for discounting or if that rate cannot be readily determined, the incremental borrowing rate at the commencement date is used.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
3.5 Leases (continued)
Variable lease payments that do not depend on the index or rate are not included in lease liabilities but are recognized in the income statement in the period in which they are incurred.
Subsequently, right-of-use asset company as a lessee measures at cost less any accumulated depreciation and any accumulated impairment losses and adjusts for any remeasurement of the lease liability.
Asset is amortized from the commencement date of the lease until the end of the useful life of the asset.
Lease liabilities are measured at the effective interest rate method and re-measured to include changes due to reassessments (changes in fixed payments, lease terms, discount rates and other similar changes).
Lease term includes the non-cancellable period during which the lessee is entitled to use the asset that is the subject of the lease and begins on the date on which the lessee makes the determined assets available to the lessee. Lease term includes periods covered by an option to extend the lease if the lessee is reasonably certain to exercise that option and periods covered by an option to terminate the lease if the lessee is reasonably certain not to exercise that option.
In the statement of financial position, right-of-use assets is reported as a separate line under long term assets, lease liabilities are disclosed as a separate item within long-term and short-term liabilities.
The statement of comprehensive income includes the cost of depreciation of the right-of-use assets and interest expenses on lease liabilities (see note 20).
Leases where the significant portion of risks and rewards of ownership are not retained by the Group are classified as operating leases. Payments made under operating leases are charged to the statement of comprehensive income on a straight-line basis over the period of the lease.
Sale and leaseback
Sale and leaseback transactions include the sale of some assets and return/lease of the same.
If the transfer of an asset by the lessee is a sale, the Group as a seller-lessee shall measure the right-of-use asset arising from the leaseback at the proportion of the previous carrying amount of the asset that relates to the right of use retained by the seller-lessee. In this case the Group as a seller-lessee shall recognize only the amount of any gain or loss that relates to the rights transferred to the buyer-lessor.
If the fair value of the consideration for the sale of an asset does not equal the fair value of the asset, or if the payments for the lease are not at market rates, the Group shall make the adjustments to measure the sale proceeds at fair value. Any below-market terms shall be accounted for as a prepayment of lease payments and any above-market terms shall be accounted for as additional financing provided by the buyer-lessor to the seller-lessee. All potential adjustments are measured on the basis of the more readily determinable of the difference between the fair value of the consideration for the sale and the fair value of the asset and the difference between the present value of the contractual payments for the lease and the present value of payments for the lease at market rates.
If the transfer of an asset is not a sale, the Group as a lessee shall continue to recognize the transferred asset and shall recognize a financial liability equal to the transfer proceeds.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
3.6 Foreign currency transactions
(i) Transactions and balances in foreign currencies
Transactions in foreign currencies are translated into the functional currency at the foreign exchange rate ruling at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies at the reporting date are retranslated into the functional currency at the foreign exchange rate ruling at that date. Foreign exchange gains and losses resulting from the settlement of such transactions and from the translation of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss.
Non-monetary assets and items that are measured in terms of historical cost of a foreign currency are not retranslated.
Non-monetary assets and liabilities denominated in foreign currencies, which are stated at historical cost, are translated into functional currency at foreign exchange rates ruling at the date of transaction.
(ii) Group companies
Items included in the financial statements of each of the Group’s entities are measured using the currency of the primary economic environment in which the entity operates (“the functional currency”). The consolidated financial statements are presented in Croatian kuna (“HRK”), which is also the Company’s functional currency.
Income and expense items and cash flows of foreign operations are translated into the Company’s and Group’s presentation currency at rates approximating the foreign exchange rates ruling at the dates of transactions and their assets and liabilities are translated at the exchange rates ruling at the year end. All resulting exchange differences are recognised in a separate component of equity. The applicable foreign exchange rates for relevant currencies are included within currency risk disclosures.
(iii) Net investment in Group companies
Exchange differences arising from the translation of the net investment in foreign operations are taken to equity. When a foreign operation is sold, such exchange differences are released in profit or loss as part of the gain or loss on sale of foreign operations.
3.7 Borrowings and borrowing costs
Borrowings are recognised initially at fair value, net of transaction costs incurred. Borrowings are subsequently stated at amortised cost; any difference between the proceeds (net of transaction costs) and the redemption value is recognised in the consolidated statement of comprehensive income over the period of the borrowings using the effective interest method.
Borrowing costs directly attributable to the acquisition, construction or production of qualifying assets, which are assets that necessarily take a substantial period of time to get ready for their intended use or sale, are added to the cost of those assets, until such time as the assets are substantially ready for their intended use or sale.
Investment income earned on the temporary investment of specific borrowings pending their expenditure on qualifying assets is deducted from the borrowing costs eligible for capitalisation.
Borrowings are classified as current liabilities unless the Group has an unconditional right to defer settlement of the liability for at least 12 months after the reporting date.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
3.8 Government grants
3.9 Dividends
Dividend distribution to the Company’s shareholders is recognised as a liability in the financial statements in the period in which the dividends are approved by the General Assembly of the Company’s shareholders.
3.10 Segment reporting
A segment is a distinguishable component of the Group that is engaged either in providing related products or services (business segment), or in providing products or services within a particular economic environment (geographical segment), which is subject to risks and rewards that are different from those of other segments.
At the consolidated level, the Group internally monitors and reports the following segments:
- BP Culinary
- BP Baby food, sweets and snacks
- BP Podravka Food
- BP Žito and Lagris
Žito and related companies
Other companies
- BP Meat products, meat solutions and savoury spreads
- BP Fish
- Pharmaceuticals
- Other sales
The Group identifies operating segments on the basis of internal reports about components of the Group that are regularly reviewed by the chief operating decision maker (which was identified as being the Management Board of the Company) in order to allocate resources to the segments and to assess their performance. Details on the operating segments are disclosed in note 8 to the consolidated financial statements. Comparative information is presented using the comparability principle.
3.11 Taxation
(i) Income tax
Income tax expense comprises current and deferred tax. Tax expense is recognised in the statement of comprehensive income except to the extent that it relates to items recognised in other comprehensive income or directly in equity, in which case it is recognised in the statement of other comprehensive income or in equity.
Income tax for the current year is calculated on the basis of the tax laws enacted at the balance sheet date in countries where the Company and its subsidiaries operate and earn taxable profit.
Current tax is the expected tax payable on the taxable income for the year, using tax rates enacted or substantively enacted at the reporting date, and any adjustment to tax payable in respect of previous years.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
3.11 Taxation (continued)
(ii) Deferred tax assets and liabilities
Deferred tax is recognised using the balance sheet method, providing for temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for taxation purposes. Deferred tax is not recognised for the following temporary differences: the initial recognition of goodwill, the initial recognition of assets or liabilities in a transaction that is not a business combination and that affects neither accounting nor taxable profit and differences that relate to investments in subsidiaries and joint ventures when it is probable that no significant change is expected in the foreseeable future. Deferred tax is measured at the tax rates that are expected to be applied to the temporary differences when they reverse, based on the laws that have been enacted or substantively enacted by the reporting date.
A deferred tax asset is recognised to the extent that it is probable that future taxable profits will be available against which temporary difference can be utilised. Deferred tax assets are reduced to the extent that it is no longer probable that the related tax benefit will be realised.
Deferred tax asset recognised on the basis of tax losses carried forward is recognised in accordance with tax legislation of the country where the company operates for the period envisaged by the law and is discharged at the expiry of this period if it is not used until then.
Deferred tax assets and liabilities are offset if there is a legally enforceable right to offset current tax liabilities and assets, and they relate to taxes levied by the same tax authority on the same taxable entity, or on different tax entities, but they intend to settle current tax liabilities and assets on a net basis or their tax assets and liabilities will be realised simultaneously.
(iii) Investment tax credits
Investment tax credits are incentives arising from government incentive schemes which enable the Group to reduce its income tax liability or liabilities arising from other specified taxes in future periods, and are linked to the construction or acquisition of certain assets and/or performance of certain activities and/or fulfilment of certain specific conditions prescribed in the relevant regulation for investment incentives by the relevant authorities. Tax investment credits are initially recognized as a deferred tax asset and an income tax benefit in the amount equal to the lower of the maximum authorized credit and the estimated amount of credit that the Group expected it will be able to utilize until the incentive expires. Deferred tax assets recognized as a result of investment tax credits is utilized during the period of the incentive, i.e. until the expiration of the credits (if so specified) in accordance with and subject to the availability of tax obligations in future years against which the credits can be offset.
(iv) Tax exposure
In determining the amount of current and deferred tax, the Group takes into account the impact of uncertain tax positions and whether additional taxes and interest may be due. This assessment relies on estimates and assumptions and may involve a series of judgements about future events. New information may become available that causes the Group to change its judgement regarding the adequacy of existing tax liabilities; such changes to tax liabilities will impact tax expense in the period that such a determination is made.
(v) Value added tax (VAT)
The Tax Authorities require the settlement of VAT on a net basis. VAT related to sales and purchases is recognised and disclosed in the consolidated statement of financial position on a net basis. Where a provision has been made for impairment of receivables, impairment loss is recorded for the gross amount receivable, including VAT.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
3.12 Property, plant and equipment
Property, plant and equipment are included in the consolidated statement of financial position at cost less accumulated depreciation and accumulated impairment losses, if any. Cost includes expenditure that is directly attributable to the acquisition of the items.
Subsequent expenditure is included in the asset’s carrying amount or recognised as a separate asset, as appropriate, only when it is probable that future economic benefits associated with the item will flow to the Group and the cost of the item can be measured reliably. The carrying amount of the replaced part is derecognised. All other repairs and maintenance are charged to the consolidated statement of comprehensive income during the financial period in which they are incurred.
Land and assets under construction are not depreciated. Depreciation of other items of property, plant and equipment is calculated using the straight-line method to allocate their cost to their residual values over their estimated useful lives, as follows:
|
Buildings |
10 to 50 years |
|
Equipment |
3 to 30 years |
The residual value of an asset is the estimated amount that the Group would currently obtain from disposal of the asset less the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life. The assets’ residual values and useful lives are reviewed, and adjusted if appropriate, at each reporting date and when necessary.
An asset’s carrying amount is written down immediately to its recoverable amount if the asset’s carrying amount is greater than its estimated recoverable amount.
Gains and losses on disposals are determined as the difference between the income from the disposal and the asset’s carrying amount, and are recognised in profit or loss within other income/expenses.
3.13 Investment property
Investment property is property (land, buildings or a part of a building, or both) held to earn rentals or for capital appreciation (or both). Investment property is treated as long-term investments.
Investment property is carried at historical cost less accumulated depreciation and accumulated impairment losses, if any. Depreciation of buildings is calculated using the straight-line method over their useful lives generally ranging from 10 to 50 years, depending on the type of the building.
Subsequent expenditure is capitalised when it is probable that future economic benefits associated with the item will flow to the Group and the cost of the item can be measured reliably. All other repairs and maintenance are charged to profit or loss when they are incurred. If the Group starts using the investment property, it is reclassified to property, plant and equipment.
The Group discloses the fair value of investment property on the basis of periodical independent valuations by expert valuers.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
3.14 Intangible assets
Intangible assets may be acquired in exchange for a non-cash asset or assets, or a combination of cash and non-cash items, whereby the cost of such intangible asset is determined at fair value unless the exchange transaction lacks commercial substance or the fair value of items received or assets disposed of cannot be reliably measured, in which case the carrying value is determined as the carrying amount of the asset disposed of.
(i) Licences, brands, distribution rights and registration files
Product distribution rights and right over use of registration files generally have a definite useful life and are carried at cost less accumulated amortisation and accumulated impairment losses, if any. Amortisation is calculated using the straight-line method to allocate the cost of licences, distribution rights and registrations, and brands with definite useful lives over their useful lives estimated from 3 to 15 years.
Rights to acquired trademarks and know-how are carried at cost and have an indefinite useful life, since based on an analysis of all of the relevant factors at the reporting date, there is no foreseeable limit to the period of time over which the identified rights are expected to generate net cash inflows. Intangible assets with indefinite useful lives are tested annually for impairment and are stated at cost less accumulated impairment loss (note 3.15).
(ii) Computer software
Computer software licences are capitalised on the basis of the costs incurred to acquire and bring to use the specific software. These costs are amortised over their useful lives estimated at 5 years.
(iii) Internally-generated intangible assets - research and development expenditure
Expenditure on research activities is recognised as an expense in the period in which it is incurred. An internally-generated intangible asset arising from development (or from the development phase of an internal project) is recognised if, and only if, all of the following have been demonstrated:
§ the technical feasibility of completing the intangible asset so that it will be available for use or sale;
§ the intention to complete the intangible asset and use or sell it;
§ the ability to use or sell the intangible asset;
§ how the intangible asset will generate probable future economic benefits;
§ the availability of adequate technical, financial and other resources to complete the development and to use or sell the intangible asset; and
§ the ability to measure reliably the expenditure attributable to the intangible asset during its development.
The amount initially recognised for internally-generated intangible assets is the sum of the expenditure incurred from the date when the intangible asset first meets the recognition criteria listed above. Where no internally-generated intangible asset can be recognised, development expenditure is recognised in profit or loss in the period in which it is incurred.
Subsequent to initial recognition, internally-generated intangible assets are reported at cost less accumulated amortisation and accumulated impairment loss, on the same basis as intangible assets that are acquired separately.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
3.15 Impairment of non-financial assets
At each reporting date, the Group reviews the carrying amounts of its non-financial assets (apart from inventories and deferred taxes) to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss. Where it is not possible to estimate the recoverable amount of an individual asset, the Group estimates the recoverable amount of the cash-generating unit to which the asset belongs. Where a reasonable and consistent basis of allocation can be identified, corporate assets are also allocated to individual cash-generating units, or otherwise they are allocated to the smallest group of cash-generating units for which a reasonable and consistent allocation basis can be identified.
Intangible assets with indefinite useful lives and other intangible assets are tested for impairment annually, and whenever there is an indication that the asset may be impaired.
Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a post-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.
If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is expensed immediately. In situation when an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognized as income immediately.
3.16 Inventories
Inventories of raw materials and spare parts are stated at the lower of cost, determined using the weighted average cost method, and net realisable value. Net realisable value is the estimated selling price in the ordinary course of business, less applicable variable selling expenses.
The cost of work-in-progress and finished goods comprises raw materials, direct labour, other direct costs and related production overheads (based on normal operating capacity).
Merchandise is carried at the lower of purchase cost and selling price (less applicable taxes and rebates).
3.17 Trade receivables
i) Trade receivables
Trade receivables are recognised initially at cost which is equal to the fair value at the moment of recognition and subsequently measured at amortised cost using the effective interest method, if significant; if not, at nominal amount less an allowance for impairment.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
3.17 Trade receivables (continued)
ii) Bills of exchange
For the purpose of collecting its receivables, the Group receives security instruments.
Bills of exchange received from customers with respect to outstanding trade receivables may be discounted with factoring companies prior to their maturity. If a bill of exchange bears a recourse right, the factoring company takes over the receivable management, but does not assume the credit risk of non-collection of the receivable from the original (principal) debtor. Based on factoring company’s payments, the Group records collection of receivables from the original (principal) debtor and simultaneously records receivables for the discounted bill of exchange and liabilities for recourse right.
For bills of exchange collected from the principal debtor upon maturity, receivables from the principal debtor are closed following the collection of the bill of exchange.
3.18 Cash and cash equivalents
Cash and cash equivalents comprise cash in hand, deposits held at call with banks and other short-term highly liquid instruments with original maturities of three months or less. Bank overdrafts are included within current liabilities on the consolidated statement of financial position.
3.19 Share capital
Share capital consists of ordinary shares. Incremental costs directly attributable to the issue of new shares or options are shown in equity as a deduction, net of tax, from the proceeds of those transactions. Any excess of the fair value of the consideration received over the par value of the shares issued is presented in the notes as a share premium.
If the Group purchases its own equity share capital (treasury shares), the consideration paid, including any directly attributable incremental costs (net of income taxes) is deducted from equity attributable to the Company’s equity holders until the shares are cancelled, reissued or disposed of. Where such shares are subsequently sold or reissued, any consideration received, net of any directly attributable incremental transaction costs and the related income tax effects, is included in equity attributable to the Company’s equity holders.
3.20 Employee benefits
(i) Pension obligations and post-employment benefits
In the normal course of business through salary payment, the Group makes payments to mandatory pension funds operated by third parties on behalf of its employees as required by law. All contributions made to the mandatory pension funds are recorded as salary expense when incurred. The Group is not obliged to provide any other post-employment benefits with respect to these pension schemes.
(ii) Termination benefits
Termination benefits are payable when employment is terminated by the Group before the normal retirement date, or whenever an employee accepts voluntary redundancy in exchange for these benefits. The Group recognises termination benefits as expenses when it is demonstrably committed to either: terminating the employment of current employees according to a detailed formal plan without possibility of withdrawal; or providing termination benefits as a result of an offer made to encourage voluntary redundancy.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
3.20 Employee benefits (continued)
(iii) Regular retirement benefits
Retirement benefits falling due more than 12 months after the reporting date are discounted to their present value based on the calculation performed at each reporting date by an independent actuary, using assumptions regarding the number of staff likely to earn regular retirement benefits, estimated benefit cost and the discount rate which is determined as the average expected rate of return on investment in government and corporate bonds. Actuarial gains and losses arising from experience adjustments and changes in actuarial assumptions are recognised in other comprehensive income.
(iv) Long-term employee benefits
The Group recognises a liability for long-term employee benefits (jubilee awards) evenly over the period the benefit is earned based on actual years of service. The long-term employee benefit liability is determined annually by an independent actuary, using assumptions regarding the likely number of staff to whom the benefits will be payable, estimated benefit cost and the discount rate which is determined as the average expected rate of return on investment in corporate bonds. Actuarial gains and losses arising from experience adjustments and changes in actuarial assumptions are recognised in profit or loss.
(v) Short-term employee benefits
The Group recognises a provision for employee bonuses where contractually obliged or where there is a past practice that has created a constructive obligation.
(vi) Share-based compensation
The Group operates an equity-settled,
share-based compensation plan. The fair value of the
employee services received in exchange for the grant of the options is
recognised as an expense. The total amount to be expensed over the vesting
period is determined by reference to the fair value of the options granted,
excluding the impact of any non-market vesting conditions (for example,
profitability and sales growth targets). At each reporting date, the entity
revises its estimates of the number of options that are expected to become
exercisable. It recognises the impact of the revision to original estimates, if
any, in the consolidated statement of comprehensive income (profit or loss),
with a corresponding adjustment to equity during the remaining vesting period.
The proceeds received net of any directly attributable transaction costs are credited to share capital (nominal value of shares) and share premium (the difference between the nominal value of shares and the proceeds received) when the options are exercised.
3.21 Provisions
Provisions are recognized when the Group has a present obligation (legal or constructive) as a result of a past event and it is probable (i.e. more likely than not) that an outflow of resources will be required to settle the obligation, and a reliable estimate can be made of the amount of the obligation. Provisions are reviewed at each reporting date and adjusted to reflect the current best estimate. Where the effect of discounting is material, the amount of the provision is the present value of the expenditures expected to be required to settle the obligation, determined using the estimated risk free interest rate as the discount rate. Where discounting is used, the reversal of such discounting in each year is recognized as a financial expense and the carrying amount of the provision increases in each year to reflect the passage of time.
Provisions for restructuring costs are recognized when the Group has a detailed formal plan for the restructuring that has been communicated to parties concerned.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
3.22 Financial instruments
A. Financial assets
(i) Recognition and initial measurement
Trade receivables are initially recognised when they are originated. All other financial assets are initially recognised when the Group becomes a party to the contractual provisions of the instrument.
A financial asset (unless it is a trade receivable without a significant financing component) is initially measured at fair value plus, for an item not at fair value through profit or loss (FVTPL), transaction costs that are directly attributable to its acquisition or issue. A trade receivable without a significant financing component is initially measured at the transaction price.
(ii) Classification and subsequent measurement
On initial recognition, a financial asset is classified as measured at:
- amortised cost;
- fair value through other comprehensive income (FVOCI) – debt instruments;
- fair value through other comprehensive income (FVOCI) – equity instruments;
- or FVTPL (fair value through profit or loss).
Financial assets are not reclassified subsequent to their initial recognition unless the Group changes its business model for managing financial assets, in which case all affected financial assets are reclassified on the first day of the first reporting period following the change in the business model.
A financial asset is measured at amortised cost if it meets both of the following conditions and is not designated as at FVTPL:
- it is held within a business model whose objective is to hold assets to collect contractual cash flows; and
- its contractual terms give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding.
A debt instruments is measured at FVOCI if it meets both of the following conditions and is not designated as at FVTPL:
- it is held within a business model whose objective is achieved by both collecting contractual cash flows and selling financial assets; and
- its contractual terms give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding.
On initial recognition of an equity instruments that is not held for trading, the Group may irrevocably elect to present subsequent changes in the instrument’s fair value in OCI. This election is made on an instrument-by-instrument basis.
All financial assets not classified as measured at amortised cost or FVOCI as described above are measured at FVTPL. This includes all derivative financial assets. On initial recognition, the Group may irrevocably designate a financial asset that otherwise meets the requirements to be measured at amortised cost or at FVOCI as at FVTPL if doing so eliminates or significantly reduces an accounting mismatch that would otherwise arise.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
3.22 Financial instruments (continued)
A Financial assets (continued)
(ii) Classification and subsequent measurement (continued)
Business model assessment
The Group makes an assessment of the objective of the business model in which a financial asset is held at a portfolio level because this best reflects the way the business is managed and information is provided to management. The information considered includes:
- the stated policies and objectives for the portfolio and the operation of those policies in practice. These include whether management’s strategy focuses on earning contractual interest income, maintaining a particular interest rate profile, matching the duration of the financial assets to the duration of any related liabilities or expected cash outflows or realising cash flows through the sale of the assets;
- how the performance of the portfolio is evaluated and reported to the Group’s management;
- the risks that affect the performance of the business model (and the financial assets held within that business model) and how those risks are managed;
- how managers of the business are compensated – e.g. whether compensation is based on the fair value of the assets managed or the contractual cash flows collected; and
- the frequency, volume and timing of sales of financial assets in prior periods, the reasons for such sales and expectations about future sales activity.
Transfers of financial assets to third parties in transactions that do not qualify for derecognition are not considered sales for this purpose, consistent with the Group’s continuing recognition of the assets.
Trade receivables are held in the business model of holding for the purpose of collection.
Financial assets that are held for trading or are managed and whose performance is evaluated on a fair value basis are measured at FVTPL.
Assessment whether contractual cash flows are solely payments of principal and interest
For the purposes of this assessment, relevant for the purpose of classifying financial assets at amortised cost, ‘principal’ is defined as the fair value of the financial asset on initial recognition. ‘Interest’ is defined as consideration for the time value of money and for the credit risk associated with the principal amount outstanding during a particular period of time and for other basic lending risks and costs (e.g. liquidity risk and administrative costs), as well as a profit margin.
In assessing the main criterion, i.e. whether the contractual cash flows are solely payments of principal and interest, the Group considers the contractual terms of the instrument. This includes assessing whether the financial asset contains a contractual term that could change the timing or amount of contractual cash flows such that it would not meet this condition.
The structure of the Group’s financial assets is simple and primarily relates to trade receivables without a significant financial component, loans given and short-term deposits in banks at fixed interest rates, while forward contracts are of insignificant amount. This significantly reduces the complexity of the assessment whether the financial assets meet the criterion of ‘solely payments of principal and interest'.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
3.22 Financial instruments (continued)
A Financial assets (continued)
(ii) Classification and subsequent measurement (continued)
Subsequent measurement and gains and losses
The table below provides an overview of key provisions of the accounting policy used by the Group for subsequent measurement of financial assets and recognition of gains and losses on each class of financial assets:
|
These assets are subsequently measured at fair value. Net gains and losses, including any interest or dividend income, are recognised in profit or loss. |
|
|
Financial assets at amortised cost |
These assets are subsequently measured at amortised cost using the effective interest method. The amortised cost is reduced by impairment losses. Interest income, foreign exchange gains and losses and impairment are recognised in profit or loss. Any gain or loss on derecognition is recognised in profit or loss. |
|
Debt instruments at FVOCI |
These assets are subsequently measured at fair value. Interest income calculated using the effective interest method, foreign exchange gains and losses and impairment are recognised in profit or loss. Other net gains and losses are recognised in OCI. On derecognition, gains and losses accumulated in OCI are reclassified to profit or loss. |
|
Equity instruments at FVOCI |
These assets are subsequently measured at fair value. Dividends are recognised as income in profit or loss unless the dividend clearly represents a recovery of part of the cost of the instruments. Other net gains and losses are recognised in OCI and are never reclassified to profit or loss. |
(iii) Derecognition
The Group derecognises a financial asset when the contractual rights to the cash flows from the financial asset expire, or it transfers the rights to receive the contractual cash flows in a transaction in which substantially all of the risks and rewards of ownership of the financial asset are transferred or in which the Group neither transfers nor retains substantially all of the risks and rewards of ownership and it does not retain control of the financial asset.
The Group enters into transactions whereby it transfers assets recognised in its statement of financial position, but retains either all or substantially all of the risks and rewards of the transferred assets. In these cases, the transferred assets are not derecognised.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
3.22 Financial instruments (continued)
B. Financial liabilities
(i) Recognition and initial measurement
Debt securities are initially recognised when they are originated. All other financial liabilities are initially recognised when the Group becomes a party to the contractual provisions of the instrument.
A financial liability is initially measured at fair value plus, for an item not at FVTPL, transaction costs that are directly attributable to its acquisition or issue.
(ii) Classification and subsequent measurement
Financial liabilities are classified as measured at amortised cost or FVTPL. A financial liability is classified as at FVTPL if it is classified as held-for-trading, it is a derivative or it is designated as such on initial recognition. Financial liabilities at FVTPL are measured at fair value and net gains and losses, including any interest expense, are recognised in profit or loss. Other financial liabilities are subsequently measured at amortised cost using the effective interest method. Interest expense and foreign exchange gains and losses are recognised in profit or loss. Any gain or loss on derecognition is also recognised in profit or loss.
(iii) Derecognition
The Group derecognises a financial liability when its contractual obligations are discharged or cancelled, or expire. The Group also derecognises a financial liability when its terms are modified and the cash flows of the modified liability are substantially different, in which case a new financial liability based on the modified terms is recognised at fair value.
On derecognition of a financial liability, the difference between the carrying amount extinguished and the consideration paid (including any non-cash assets transferred or liabilities assumed) is recognised in profit or loss.
C. Offsetting
Financial assets and financial liabilities are offset and the net amount presented in the statement of financial position when, and only when, the Group currently has a legally enforceable right to set off the amounts and it intends either to settle them on a net basis or to realise the asset and settle the liability simultaneously.
D. Derivative financial instruments
The Group holds derivative financial instruments to hedge its foreign currency and interest rate risk exposures. Embedded derivatives are separated from the host contract and accounted for separately if the host contract is not a financial asset and certain criteria are met. Derivatives are initially measured at fair value. Subsequent to initial recognition, derivatives are measured at fair value, and changes therein are generally recognised in profit or loss.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
3.22 Financial instruments (continued)
E. Impairment of non-derivative financial assets
Recognition of impairment losses
The Group recognises loss allowances for expected credit loss (ECL)s on:
- financial assets measured at amortised cost;
- debt instruments measured at FVOCI; and
- contract assets.
The Group measures loss allowances at an amount equal to lifetime ECLs, except for the following, which are measured at 12-month ECLs:
- debt securities that are determined to have low credit risk at the reporting date; and
- other debt securities and bank balances for which credit risk (i.e. the risk of default occurring over the expected life of the financial instrument) has not increased significantly since initial recognition.
Loss allowances for trade receivables are always measured at an amount equal to lifetime ECLs.
When determining whether the credit risk of a financial asset has increased significantly since initial recognition and when estimating ECLs, the Group considers reasonable and supportable information that is relevant and available without undue cost or effort. This includes both quantitative and qualitative information and analysis, based on the Group’s historical experience and informed credit assessment and including forward-looking information.
The Group assumes that the credit risk on a financial asset has increased significantly if early warning indicators have been activated in accordance with the Group’s policy or contractual terms of the instrument.
The Group considers a financial asset to be fully or partially in default if:
- the borrower is unlikely to pay its credit obligations to the Group in full, without recourse by the Group to actions such as realising security (if any is held); or
- the financial asset is more than 360 days past due.
Lifetime ECLs are the ECLs that result from all possible default events over the expected life of a financial instrument.
12-month ECLs are the portion of ECLs that result from default events that are possible within the 12 months after the reporting date (or a shorter period if the expected life of the instrument is less than 12 months).
The maximum period considered when estimating ECLs is the maximum contractual period over which the Group is exposed to credit risk.
Measurement of ECLs
ECLs are estimate of credit losses. Credit losses are measured as the difference between the cash flows due to the Group in accordance with the contract and the cash flows that the Group expects to receive. Regular external trade receivables that are not past due and uncollected receivables past due up to 360 days from the maturity date are impaired using the percentage that reflects the expectations of the non-collection of trade receivables (ECL). The percentage of impairment is determined on the basis of the average of the previous three-year period (historical rate) separately for each of the Group’s companies, adjusted for the macroeconomic impact. The calculation of the historical rate is adjusted for extraordinary and specific circumstances, if required.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
3.22 Financial instruments (continued)
E Impairment of non-derivative financial assets (continued)
Credit-impaired financial assets
At each reporting date, the Group assesses whether financial assets carried at amortised cost and debt securities at FVOCI are credit-impaired. A financial asset is ‘credit-impaired’ when one or more events that have a detrimental impact on the estimated future cash flows of the financial asset have occurred.
Evidence that a financial asset is credit-impaired includes the following observable data:
- significant financial difficulty of the borrower or issuer;
- a breach of contract such as a significant delay of payment by the borrower;
- it is probable that the borrower will enter bankruptcy or other financial reorganisation; or
- the disappearance of an active market for a security because of financial difficulties.
Presentation of allowance for ECL in the statement of financial position.
Loss allowances for financial assets measured at amortised cost are deducted from the gross carrying amount of the assets. For debt securities at FVOCI, the loss allowance is charged to profit or loss and is recognised in OCI.
Write-off of financial assets
3.23 Reclassification of items in the Statement of Financial Position and the Statement of Cash Flows
In accordance with the EU Transparency Directive by which ESMA (European Securities and Markets Authority) introduces the obligation to implement ESEF (European single electronic format based on the XBRL format) for Issuers, the Group has reclassified items of the Statement of Financial Position and Cash Flow Statement with the aim of optimal use of valid taxonomy.
The effects of reclassification are as follows:
Statement of financial position
|
(in thousands of HRK) |
2020 before reclassification |
Reclassification |
2020 after reclassification |
|
Share capital |
1,706,048 |
(1,706,048) |
- |
|
Issued capital |
- |
1,566,401 |
1,566,401 |
|
Share premium |
- |
187,215 |
187,215 |
|
Treasury shares |
- |
(47,568) |
(47,568) |
|
Total |
1,706,048 |
- |
1,706,048 |
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
3.23 Reclassification of items in the Statement of Financial Position and the Statement of Cash Flows (continued)
Statement of financial position (continued)
|
(in thousands of HRK) |
2020 before reclassification |
Reclassification |
2020 after reclassification |
|
Non-current liabilities |
|||
|
Provisions |
78,474 |
(78,474) |
- |
|
Non-current provisions for employee benefits |
- |
52,024 |
52,024 |
|
Other non-current provisions |
- |
26,450 |
26,450 |
|
Total |
78,474 |
- |
78,474 |
|
(in thousands of HRK) |
2020 before reclassification |
Reclassification |
2020 after reclassification |
|
Current liabilities |
|||
|
Provisions |
32,171 |
(32,171) |
- |
|
Current provisions for employee benefits |
- |
32,030 |
32,030 |
|
Other current provisions |
- |
141 |
141 |
|
Total |
32,171 |
- |
32,171 |
Cash flow statement
|
(in thousands of HRK) |
2020 before reclassification |
Reclassification |
2020 after reclassification |
|
Profit for the year |
256,134 |
(256,134) |
- |
|
Income tax |
57,876 |
(57,876) |
- |
|
Profit before tax |
- |
314,010 |
314,010 |
|
Total |
314,010 |
- |
314,010 |
|
(in thousands of HRK) |
2020 before reclassification |
Reclassification |
2020 after reclassification |
|
Liquidation of subsidiary |
242 |
(242) |
- |
|
Reversal of impairment of other liabilities |
(5,299) |
5,299 |
- |
|
Impairment of trade receivables |
(189) |
189 |
- |
|
Impairment/(reversal of impairment) of trade and other liabilities |
- |
(5,246) |
(5,246) |
|
Total |
(5,246) |
- |
(5,246) |
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
3.23 Reclassification of items in the Statement of Financial Position and the Statement of Cash Flows (continued)
Cash flow statement (continued)
|
(in thousands of HRK) |
2020 before reclassification |
Reclassification |
2020 after reclassification |
|
Gain from sale of right-of-use assets |
(41) |
41 |
- |
|
Loss/(Gain) on disposal of property, plant, equipment and intangibles |
364 |
(364) |
- |
|
(Gain)/loss from sale and disposal of non-current assets |
- |
323 |
323 |
|
Total |
323 |
- |
323 |
|
(in thousands of HRK) |
2020 before reclassification |
Reclassification |
2020 after reclassification |
|
Repayment of borrowings |
(528,147) |
36,651 |
(491,496) |
|
Repayment of leases |
- |
(36,651) |
(36,651) |
|
Total |
(528,147) |
- |
(528,147) |
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 4 – NEW STANDARDS AND INTERPRETATIONS NOT YET ADOPTED
At the date of issue of these financial statements, the following standards, amendments and interpretations issued by the International Accounting Standards Board are not yet effective.
· Amendments to IFRS 3 Business Combinations; IAS 16 Property, Plant and Equipment; IAS 37 Provisions, Contingent Liabilities and Contingent Assets, all issued on 14 May 2020, (effective date for annual periods beginning on or after 1 January 2022).
· Amendments to Annual Improvements 2018-2020, issued on 14 May 2020 (effective date for annual periods beginning on or after 1 January 2022).
At the date of authorization of these financial statements the following standards, revisions and interpretations were in issue by the International Accounting Standards Board but not yet adopted by the EU. The endorsement might be expected in 2022:
· Amendments to IAS 1 Presentation of Financial Statements: Classification of Liabilities as Current or Non-current and Classification of Liabilities as Current or Non-current - Deferral of Effective Date, issued on 23 January 2020 and 15 July 2020 respectively (effective date for annual periods beginning on or after 1 January 2023).
· Amendments to IAS 1 Presentation of Financial Statements and IFRS Practice Statement 2: Disclosure of Accounting policies, issued on 12 February 2021 (effective date for annual periods beginning on or after 1 January 2023).
· Amendments to IAS 8 Accounting policies, Changes in Accounting Estimates and Errors: Definition of Accounting Estimates issued on 12 February 2021 (effective date for annual periods beginning on or after 1 January 2023).
· Amendments to IAS 12 Income Taxes: Deferred Tax related to Assets and Liabilities arising from a Single Transactions, issued on 7 May 2021 (effective date for annual periods beginning on or after 1 January 2023).
The Group does not expect the adoption of these standards and interpretations to have a material impact on the Group’s financial statements.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 5 – IMPACT OF NEW ACCOUNTING POLICIES
The accounting policies adopted are consistent with those of the previous financial year except for the following amended IFRSs which have been adopted by the Group as of 1 January 2021:
· Amendment to IFRS 16 Leases Covid 19-Related Rent Concessions, issued on 31 March 2020 (effective date for annual periods beginning on or after 1 April 2021).
· Amendments to IFRS 9, IAS 39, IFRS 7, IFRS 4 and IFRS 16 Interest Rate Benchmark Reform – Phase 2, issued on 27 August 2020 (effective date for annual periods beginning on or after 1 January 2021).
The adoption of these standards and interpretations did not have a significant impact on the Group’s financial statements.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 6 – KEY ACCOUNTING JUDGEMENTS AND ESTIMATES
The preparation of financial statements in conformity with Financial reporting standards as adopted by the European Union (EU IFRS) requires management to make judgments, estimates and assumptions that affect the application of policies and reported amounts of assets and liabilities, income and expenses. The estimates and associated assumptions are based on historical experience and various other factors that are believed to be reasonable under the circumstances, the results of which form the basis of making the judgments about carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimate is revised if the revision affects only that period or in the period of revision and future periods if the revision affects both current and future periods.
Judgments made by management in the application of EU IFRSs that have significant effect on the financial statements and estimates with a significant risk of material adjustments in the next year are discussed in more detail below.
(i) Deferred tax assets recognition
The deferred tax asset represents income taxes recoverable through future deductions from taxable profits and is recorded in the statement of financial position. Deferred income tax assets are recorded to the extent that realisation of the related tax benefit is probable. In determining future taxable profits and the amount of tax benefits that are probable in the future, management makes judgements and applies estimation based on previous years taxable profits and expectations of future income that are believed to be reasonable under the existing circumstances (see note 15).
(ii) Actuarial estimates used in determining obligations for employee benefits
The cost of defined benefits is determined using actuarial estimates. Actuarial estimates involve assumptions about discount rates, future salary increases and the mortality or fluctuation rates. Due to the long-term nature of those plans, these estimates contain an element of uncertainty (see note 35).
(iii) Consequences of certain legal actions
The Group is involved in a number of legal actions which have arisen from the regular course of operations. Management makes estimates of probable outcomes of the legal actions, and the provisions for the Group’s obligations arising from these legal actions are recognised on a consistent basis.
The Group recognises a provision in the total expected amount of outflows of economic benefits as a result of the court case, which is generally the claim amount plus penalty interest (if applicable), if it is more likely than not, based on the opinion of management after consultation with legal advisers, that the outcome of the court case will be unfavourable for the Group. The Group does not recognise provisions for court cases or the expected related legal costs and penalty interest (if applicable) in cases where management estimates that an unfavourable outcome of the court case is less likely than a favourable outcome for the Group.
Where indications exist of a possible settlement in relation to a particular court case, a provision is recognised, based on the best estimate of management made in consultation with its legal advisers, in the amount of the expected settlement less any existing amounts already provided for in relation to that particular court case.
Where the Group is a plaintiff in a particular court case, any economic benefits expected to flow to the Group as a result are recognised only when virtually certain which is generally as at the date of inflow of these economic benefits.
Provisions for the Group’s obligations arising from legal actions are recognised on a consistent basis and estimated on a case by case principle (see note 3.21 and 35).
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 6 – KEY ACCOUNTING JUDGEMENTS AND ESTIMATES (CONTINUED)
(iv) Recoverability of trade and other receivables
The recoverable amount of trade and other receivables is estimated at present value of future cash flows discounted at the market interest rate at the measurement date. Short-term receivables with no stated interest rate are measured by the amount of original invoice if the effect of discounting is not significant.
The Group regularly reviews the ageing structure of trade receivables and monitors the average collection period. In cases where debtors with extended payment periods are identified, the Group reduces the related credit limits and payment days for future transactions and, in cases where it deems it necessary, imposes restrictions on future transactions until the outstanding balance is repaid either entirely or in part. In cases where the Group identifies receivables toward debtors which have entered into pre-bankruptcy or bankruptcy proceedings, an impairment loss is immediately recognised in full.
By applying the percentage that reflects expectations on the non-collection of trade receivables (expected credit loss), the Group impairs undue regular external trade receivables and past due uncollected receivables up to 360 days from the maturity date.
In the process of regulating the collection of overdue debts, the Group actively negotiates with the respective debtors taking into account expectations of future business relations, significance of exposure to an individual debtor, possibilities of compensation, exercise of instruments of security (if any) or seizure of assets.
(v) Impairment testing for goodwill, brands and rights
The Group tests goodwill, brands and rights for impairment on an annual basis in accordance with accounting policy 3.14. For the purposes of impairment testing, goodwill, brands and rights with indefinite useful lives and brands and rights with finite useful lives have been allocated to cash generating units within reportable segments at their net carrying amount at the reporting date as follows:
|
Goodwill |
Brands |
Rights |
|||
|
Operating segment |
(in thousands of HRK)
|
||||
|
BP Culinary |
- |
8,140 |
- |
||
|
BP Baby food, sweets and snack |
- |
21,144 |
- |
||
|
BP Podravka food |
- |
439 |
- |
||
|
BP Žito and Lagris |
28,103 |
46,405 |
- |
||
|
BP Fish |
- |
18,800 |
- |
||
|
Pharmaceuticals |
- |
- |
55,542 |
||
|
Other - unallocated |
- |
- |
9,807 |
||
|
28,103 |
94,928 |
65,349 |
|||
The recoverable amount of cash generating units is determined based on value-in-use calculations or fair value. These calculations use cash flow projections from financial budgets approved by management and cover a period of five years.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 6 – KEY ACCOUNTING JUDGEMENTS AND ESTIMATES (CONTINUED)
(v) Impairment testing for goodwill, brands and rights (continued)
Goodwill
Goodwill relates entirely to goodwill arising on acquisition of the subsidiary Podravka Lagris a.s. The Group annually performs an impairment test in order to assess whether the recoverable amount of goodwill indicates potential impairment of its carrying amount. The calculation of the recoverable amount of goodwill is based on five-year plans for sales on the Czech market and business plans of the subsidiary developed by the Group bearing in mind its corporate selling and marketing strategy, relevant markets trends (such as estimated movements in gross domestic product, market share of relevant products and categories) and the analysis of its competitors. The sales plans also include potential risks of the realistic environment caused by the COVID-19 pandemic.
The calculation of the recoverable amount implies a terminal growth rate for cash flows after the projected five-year period amounting to 2.00% (2020: 2.50%). Cash flows created from such plans are discounted using the post-tax discount rate which reflects the risk of the underlying asset, and which has been defined for the purposes of the impairment test for goodwill as the weighted average cost of capital after tax for the Czech market and the food industry and amounts to 5.25% (2020: 4.65%).
As a result of the impairment testing of goodwill, the Group had no impairment losses relating to goodwill during 2021 and 2020.
The sensitivity analysis of presumptions indicates the need for the impairment of goodwill in case of an increase in the weighted average cost of capital rate by 1 basis point or a decrease in the terminal growth rate (assuming unchanged weighted average cost of capital) by 1 basis point.
Brands
Brands relate to acquired rights of use of logos, trademarks and brand names which the Group allocates to business segments in accordance with internal categorisation of products to which the specific brand relates, whereby the brand value is either allocated entirely to a specific segment or where applicable and where a brand relates to products and categories which relate to several segments, it is allocated based on the share of gross margin of the brand in each of the segments.
The Group annually performs impairment tests in order to assess whether the recoverable amount of brands indicates potential impairment of their carrying amount whereby the primary focus is on brands where the difference between the recoverable amount and the carrying amount indicates a significant sensitivity to changes in key variables used in impairment testing. The calculation of the recoverable amount of brands is based on five-year plans for sales of product and categories which comprise a certain brand and which the Group developed bearing in mind its corporate and marketing strategy, trends on relevant markets where the brands are sold (such as estimated movements in gross domestic product, market share of relevant products and categories) and the analysis of its competitors. The sales plans for products and categories comprising each brand also include potential risks of the realistic environment caused by the COVID-19 pandemic.
Cash flows created from such plans are discounted using the post-tax discount rate which reflects the risk of the underlying asset, and which has been defined for the purposes of the impairment test for brands as the weighted average cost of capital (WACC) for the primary market the brand is sold on and the food industry.
For the purpose of recoverable amount of brands whose dominant market is the Adria region, as at 31 December 2021 the Group applied an income approach – the method of non-payment of royalties.
The basis of the method of non-payment of royalties is that the value of intangible assets equals the amount that the owner would pay for the licence over the assets if it had not been owned, i.e. the value equals post-tax discounted expenses saved if royalties, i.e. the compensation for the use of trademarks, are not paid.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 6 – KEY ACCOUNTING JUDGEMENTS AND ESTIMATES (CONTINUED)
(v) Impairment testing for goodwill, brands and rights (continued)
Brands (continued)
When calculating the recoverable amount of brands whose dominant market is the Adria region (a total of 5 brands), rates equal to the weighted average cost of capital after tax (WACC) per individual market and the food industry were used, ranging from 3.34% to 7.09% (2020: ranging from 4.71% to 9.61%), while the applied terminal growth rate for all brands is 2.00% (2020: ranging from 2.30% to 3.65%). The recoverable amount of the most significant brands resulting from the discounted cash flow method is as follows:
|
Book value |
Recoverable amount |
|||
|
2021 |
2020 |
2021 |
2020 |
|
|
Brands |
(in thousands of HRK) |
|||
|
Brand 1 |
6,299 |
6,299 |
21,886 |
13,868 |
|
Brand 2 |
15,500 |
15,500 |
81,954 |
67,974 |
|
Brand 3 |
21,144 |
21,144 |
76,831 |
44,855 |
|
Brand 4 |
439 |
439 |
2,490 |
1,363 |
|
Brand 5 |
3,300 |
3,300 |
8,412 |
6,092 |
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 6 – KEY ACCOUNTING JUDGEMENTS AND ESTIMATES (CONTINUED)
(v) Impairment testing for goodwill, brands and rights (continued)
Brands (continued)
|
Brand |
Significant inputs |
Value |
Sensitivity of the input to fair value |
|
|
Method of non-payment of royalties |
Brand 1
|
Weighted average cost of capital |
2021: 4.02% 2020: 5.56% |
Increase of weighted average cost of capital by 413 basis points (2020: 278) with unchanged terminal growth rate would result in an decrease of fair value in amount of HRK 55 thousand (2020: HRK 3 thousand)
|
|
Terminal growth rate |
2021: 2.00% 2020: 2.49% |
Decrease of terminal growth rate with unchanged weighted average cost of capital by 515 basis points (2020: 342)would result in an decrease of fair value in amount of HRK 32 thousand (2020: HRK 2 thousand)
|
||
|
Method of non-payment of royalties |
Brand 2 |
Weighted average cost of capital |
2021: 6.19% 2020: 7.96% |
Increase of weighted average cost of capital by 1,981 basis points (2020: 1,794)with unchanged terminal growth rate would result in an decrease of fair value in amount of HRK 27 thousand (2020: HRK 6 thousand)
|
|
Terminal growth rate |
2021: 2.00% 2020: 3.16% |
Decrease of terminal growth rate with unchanged weighted average cost of capital by 8,100 basis points (2020: 6,015)would result in an decrease of fair value in amount of HRK 25 thousand (2020: HRK 4 thousand)
|
||
|
Method of non-payment of royalties |
Brand 3 |
Weighted average cost of capital |
2021: 3.66% 2020: 5.20% |
Increase of weighted average cost of capital by 454 basis points (2020: 318)with unchanged terminal growth rate would result in an decrease of fair value in amount of HRK 30 thousand (2020: HRK 14 thousand)
|
|
Terminal growth rate |
2021: 2.00% 2020: 2.46% |
Decrease of terminal growth rate with unchanged weighted average cost of capital by 571 basis points (2020: 394)would result in an decrease of fair value in amount of HRK 27 thousand (2020: HRK 32 thousand)
|
||
|
Method of non-payment of royalties |
Brand 4 |
Weighted average cost of capital |
2021: 3.34% 2020: 4.71% |
Increase of weighted average cost of capital by 666 basis points (2020: 535)with unchanged terminal growth rate would result in an decrease of fair value in amount of HRK 7 thousand (2020: HRK 3 thousand)
|
|
Terminal growth rate |
2021: 2.00% 2020: 2.30% |
Decrease of terminal growth rate with unchanged weighted average cost of capital by 950 basis points (2020: 715)would result in an decrease of fair value in amount of HRK 18 thousand (2020: HRK 2 thousand)
|
||
|
Method of non-payment of royalties |
Brand 5
|
Weighted average cost of capital |
2021: 7.09% 2020: 9.61% |
Increase of weighted average cost of capital by 841 basis points (2020: 538)with unchanged terminal growth rate would result in an decrease of fair value in amount of HRK 10 thousand (2020: HRK 5 thousand)
|
|
Terminal growth rate |
2021: 2.00% 2020: 3.65% |
Decrease of terminal growth rate with unchanged weighted average cost of capital by 1,460 basis points (2020: 815)would result in an decrease of fair value in amount of HRK 26 thousand (2020: HRK 4 thousand)
|
During 2021, the Group recognised brands impairment costs in the amount of HRK 671 thousand (2020: HRK 0 thousand).
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 6 – KEY ACCOUNTING JUDGEMENTS AND ESTIMATES (CONTINUED)
(v) Impairment testing for goodwill, brands and rights (continued)
Brands (continued)
When calculating the recoverable amount of brands whose dominant market is the Slovenian market (a total of 20 brands), rates equal to the weighted average cost of capital after tax (WACC) per individual market and the food industry were used, ranging from 3.34% to 5.22% (2020: ranging from 4.79% to 7.63%), while the applied terminal growth rate ranges from 1.69% to 2.00% (2020: ranging from 1.90% to 2.86%).
The recoverable amount of most significant brands resulting from the discounted cash flow method is as follows:
|
Book value |
Recoverable amount |
|||
|
2021 |
2020 |
2021 |
2020 |
|
|
Brands |
(in thousands of HRK) |
|||
|
Brand 1 |
12,872 |
12,906 |
90,546 |
62,615 |
|
Brand 2 |
3,899 |
3,909 |
38,676 |
20,235 |
|
Brand 3 |
2,992 |
3,000 |
22,333 |
12,622 |
|
Brand 4 |
908 |
910 |
5,459 |
3,323 |
|
Brand 5 |
654 |
656 |
1,494 |
2,271 |
|
Brand 6 |
689 |
690 |
7,365 |
3,715 |
|
Brand 7 |
285 |
286 |
2,870 |
1,394 |
|
Brand 8 |
249 |
249 |
1,697 |
2,887 |
|
Brand 9 |
3,162 |
3,170 |
18,236 |
9,154 |
|
Brand 10 |
1,907 |
1,912 |
14,457 |
7,387 |
|
Brand 11 |
282 |
283 |
1,976 |
791 |
|
Brand 12 |
2,419 |
2,425 |
13,887 |
7,891 |
|
Brand 13 |
1,795 |
1,800 |
18,032 |
8,942 |
|
Brand 14 |
1,591 |
1,596 |
8,137 |
4,494 |
|
Brand 15 |
730 |
732 |
2,471 |
2,011 |
|
Brand 16 |
185 |
185 |
2,133 |
1,216 |
|
Brand 17 |
2,187 |
2,193 |
16,794 |
10,022 |
|
Brand 18 |
2,510 |
2,588 |
7,597 |
5,355 |
|
Brand 19 |
746 |
748 |
4,604 |
2,391 |
|
Brand 20 |
3,656 |
3,665 |
44,360 |
20,972 |
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 6 – KEY ACCOUNTING JUDGEMENTS AND ESTIMATES (CONTINUED)
(v) Impairment testing for goodwill, brands and rights (continued)
Brands (continued)
|
Valuation technique |
Brand |
Significant inputs |
Value |
Sensitivity of the input to fair value |
|
Method of non-payment of royalties |
Brand 1
|
Weighted average cost of capital |
2021: 4.20% 2020: 5.40% |
Increase of weighted average cost of capital by 1,563 basis points (2020: 1,391) with unchanged terminal growth rate would result in an decrease of fair value in amount of HRK 9 thousand (2020: HRK 4 thousand)
|
|
Terminal growth rate |
2021: 1.70% 2020: 1.90% |
Decrease of terminal growth rate with unchanged weighted average cost of capital by 3,421 basis points (2020: 3,073)would result in an decrease of fair value in amount of HRK 7 thousand (2020: HRK 3 thousand)
|
||
|
Method of non-payment of royalties |
Brand 2 |
Weighted average cost of capital |
2021: 3.40% 2020: 4.80% |
Increase of weighted average cost of capital by 1,294 basis points (2020: 1,138)with unchanged terminal growth rate would result in an decrease of fair value in amount of HRK 13 thousand (2020: HRK 2 thousand)
|
|
Terminal growth rate |
2021: 2.00% 2020: 2.30% |
Decrease of terminal growth rate with unchanged weighted average cost of capital by 2,480 basis points (2020: 2,085)would result in an decrease of fair value in amount of HRK 12 thousand (2020: HRK 4 thousand)
|
||
|
Method of non-payment of royalties |
Brand 3 |
Weighted average cost of capital |
2021: 3.30% 2020: 4.80% |
Increase of weighted average cost of capital by 916 basis points (2020: 852)with unchanged terminal growth rate would result in an decrease of fair value in amount of HRK 20 thousand (2020: HRK 3 thousand)
|
|
Terminal growth rate |
2021: 2.00% 2020: 2.30% |
Decrease of terminal growth rate with unchanged weighted average cost of capital by 1,410 basis points (2020: 1,332)would result in an decrease of fair value in amount of HRK 14 thousand (2020: HRK 3 thousand)
|
||
|
Method of non-payment of royalties |
Brand 4 |
Weighted average cost of capital |
2021: 4.40% 2020: 6.20% |
Increase of weighted average cost of capital by 1,310 basis points (2020: 1,028)with unchanged terminal growth rate would result in an decrease of fair value in amount of HRK 8 thousand (2020: HRK 3 thousand)
|
|
Terminal growth rate |
2021: 2.00% 2020: 2.60% |
Decrease of terminal growth rate with unchanged weighted average cost of capital by 2,700 basis points (2020: 1,850)would result in an decrease of fair value in amount of HRK 12 thousand (2020: HRK 4 thousand)
|
||
|
Method of non-payment of royalties |
Brand 5
|
Weighted average cost of capital |
2021: 5.50% 2020: 5.30% |
Increase of weighted average cost of capital by 496 basis points (2020: 870)with unchanged terminal growth rate would result in an decrease of fair value in amount of HRK 2 thousand (2020: HRK 3 thousand)
|
|
Terminal growth rate |
2021: 1.80% 2020: 2.00% |
Decrease of terminal growth rate with unchanged weighted average cost of capital by 739 basis points (2020: 1,420)would result in an decrease of fair value in amount of HRK 24 thousand (2020: HRK 3 thousand)
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 6 – KEY ACCOUNTING JUDGEMENTS AND ESTIMATES (CONTINUED)
(v) Impairment testing for goodwill, brands and rights (continued)
Brands (continued)
|
Valuation technique |
Brand |
Significant inputs |
Value |
Sensitivity of the input to fair value |
|
Method of non-payment of royalties |
Brand 6
|
Weighted average cost of capital |
2021: 3.30% 2020: 4.80% |
Increase of weighted average cost of capital by 1,366 basis points (2020: 1,160) with unchanged terminal growth rate would result in an decrease of fair value in amount of HRK 7 thousand (2020: HRK 3 thousand)
|
|
Terminal growth rate |
2021: 2.00% 2020: 2.30% |
Decrease of terminal growth rate with unchanged weighted average cost of capital by 2,780 basis points (2020: 2,150)would result in an decrease of fair value in amount of HRK 14 thousand (2020: HRK 4 thousand)
|
||
|
Method of non-payment of royalties |
Brand 7 |
Weighted average cost of capital |
2021: 3.30% 2020: 4.80% |
Increase of weighted average cost of capital by 1,366 basis points (2020: 1,040)with unchanged terminal growth rate would result in an decrease of fair value in amount of HRK 14 thousand (2020: HRK 3 thousand)
|
|
Terminal growth rate |
2021: 2.00% 2020: 2.30% |
Decrease of terminal growth rate with unchanged weighted average cost of capital by 2,700 basis points (2020: 1,780)would result in an decrease of fair value in amount of HRK 12 thousand (2020: HRK 2 thousand)
|
||
|
Method of non-payment of royalties |
Brand 8 |
Weighted average cost of capital |
2021: 3.30% 2020: 4.80% |
Increase of weighted average cost of capital by 822 basis points (2020: 2,680)with unchanged terminal growth rate would result in an decrease of fair value in amount of HRK 15 thousand (2020: HRK 3 thousand)
|
|
Terminal growth rate |
2021: 2.00% 2020: 2.30% |
Decrease of terminal growth rate with unchanged weighted average cost of capital by 1,160 basis points (2020: 27,200)would result in an decrease of fair value in amount of HRK 10 thousand (2020: HRK 1 thousand)
|
||
|
Method of non-payment of royalties |
Brand 9 |
Weighted average cost of capital |
2021: 3.30% 2020: 4.80% |
Increase of weighted average cost of capital by 666 basis points (2020: 486)with unchanged terminal growth rate would result in an decrease of fair value in amount of HRK 35 thousand (2020: HRK 2 thousand)
|
|
Terminal growth rate |
2021: 2.00% 2020: 2.30% |
Decrease of terminal growth rate with unchanged weighted average cost of capital by 900 basis points (2020: 639)would result in an decrease of fair value in amount of HRK 15 thousand (2020: HRK 3 thousand)
|
||
|
Method of non-payment of royalties |
Brand 10
|
Weighted average cost of capital |
2021: 4.70% 2020: 6.80% |
Increase of weighted average cost of capital by 1,876 basis points (2020: 1,212)with unchanged terminal growth rate would result in an decrease of fair value in amount of HRK 19 thousand (2020: HRK 3 thousand)
|
|
Terminal growth rate |
2021: 2.00% 2020: 2.70% |
Decrease of terminal growth rate with unchanged weighted average cost of capital by 5,750 basis points (2020: 2,435)would result in an decrease of fair value in amount of HRK 8 thousand (2020: HRK 3 thousand)
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 6 – KEY ACCOUNTING JUDGEMENTS AND ESTIMATES (CONTINUED)
(v) Impairment testing for goodwill, brands and rights (continued)
Brands (continued)
|
Valuation technique |
Brand |
Significant inputs |
Value |
Sensitivity of the input to fair value |
|
Method of non-payment of royalties |
Brand 11
|
Weighted average cost of capital |
2021: 3.40% 2020: 4.90% |
Increase of weighted average cost of capital by 10 basis points (2020: 10) with unchanged terminal growth rate would result in an decrease of fair value in amount of HRK 125 thousand (2020: HRK 29 thousand)
|
|
Terminal growth rate |
2021: 2.00% 2020: 2.40% |
Decrease of terminal growth rate with unchanged weighted average cost of capital by 5 basis points (2020: 10)would result in an decrease of fair value in amount of HRK 64 thousand (2020: HRK 27 thousand)
|
||
|
Method of non-payment of royalties |
Brand 12 |
Weighted average cost of capital |
2021: 4.70% 2020: 6.90% |
Increase of weighted average cost of capital by 1,407 basis points (2020: 1,001)with unchanged terminal growth rate would result in an decrease of fair value in amount of HRK 41 thousand (2020: HRK 3 thousand)
|
|
Terminal growth rate |
2021: 2.00% 2020: 2.80% |
Decrease of terminal growth rate with unchanged weighted average cost of capital by 3,000 basis points (2020: 1,802)would result in an decrease of fair value in amount of HRK 12 thousand (2020: HRK 3 thousand)
|
||
|
Method of non-payment of royalties |
Brand 13 |
Weighted average cost of capital |
2021: 3.40% 2020: 4.80% |
Increase of weighted average cost of capital by 1,336 basis points (2020: 1,052)with unchanged terminal growth rate would result in an decrease of fair value in amount of HRK 16 thousand (2020: HRK 3 thousand)
|
|
Terminal growth rate |
2021: 2.00% 2020: 2.30% |
Decrease of terminal growth rate with unchanged weighted average cost of capital by 2,650 basis points (2020: 1,820)would result in an decrease of fair value in amount of HRK 24 thousand (2020: HRK 2 thousand)
|
||
|
Method of non-payment of royalties |
Brand 14 |
Weighted average cost of capital |
2021: 4.50% 2020: 6.30% |
Increase of weighted average cost of capital by 1,104 basis points (2020: 710)with unchanged terminal growth rate would result in an decrease of fair value in amount of HRK 32 thousand (2020: HRK 2 thousand)
|
|
Terminal growth rate |
2021: 2.00% 2020: 2.60% |
Decrease of terminal growth rate with unchanged weighted average cost of capital by 1,939 basis points (2020: 1,080)would result in an decrease of fair value in amount of HRK 18 thousand (2020: HRK 2 thousand)
|
||
|
Method of non-payment of royalties |
Brand 15
|
Weighted average cost of capital |
2021: 4.80% 2020: 5.90% |
Increase of weighted average cost of capital by 684 basis points (2020: 635)with unchanged terminal growth rate would result in an decrease of fair value in amount of HRK 14 thousand (2020: HRK 3 thousand)
|
|
Terminal growth rate |
2021: 1.90% 2020: 2.20% |
Decrease of terminal growth rate with unchanged weighted average cost of capital by 993 basis points (2020: 920)would result in an decrease of fair value in amount of HRK 16 thousand (2020: HRK 3 thousand)
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 6 – KEY ACCOUNTING JUDGEMENTS AND ESTIMATES (CONTINUED)
(v) Impairment testing for goodwill, brands and rights (continued)
Brands (continued)
|
Valuation technique |
Brand |
Significant inputs |
Value |
Sensitivity of the input to fair value |
|
Method of non-payment of royalties |
Brand 16
|
Weighted average cost of capital |
2021: 3.70% 2020: 5.20% |
Increase of weighted average cost of capital by 2,134 basis points (2020: 1,770) with unchanged terminal growth rate would result in an decrease of fair value in amount of HRK 14 thousand (2020: HRK 3 thousand)
|
|
Terminal growth rate |
2021: 2.00% 2020: 2.40% |
Decrease of terminal growth rate with unchanged weighted average cost of capital by 7,700 basis points (2020: 5,250)would result in an decrease of fair value in amount of HRK 7 thousand (2020: HRK 2 thousand)
|
||
|
Method of non-payment of royalties |
Brand 17 |
Weighted average cost of capital |
2021: 3.40% 2020: 4.80% |
Increase of weighted average cost of capital by 963 basis points (2020: 946)with unchanged terminal growth rate would result in an decrease of fair value in amount of HRK 5 thousand (2020: HRK 2 thousand)
|
|
Terminal growth rate |
2021: 2.00% 2020: 2.30% |
Decrease of terminal growth rate with unchanged weighted average cost of capital by 1,550 basis points (2020: 1,553)would result in an decrease of fair value in amount of HRK 27 thousand (2020: HRK 3 thousand)
|
||
|
Method of non-payment of royalties |
Brand 18 |
Weighted average cost of capital |
2021: 5.20% 2020: 7.60% |
Increase of weighted average cost of capital by 658 basis points (2020: 542)with unchanged terminal growth rate would result in an decrease of fair value in amount of HRK 23 thousand (2020: HRK 4 thousand)
|
|
Terminal growth rate |
2021: 2.00% 2020: 2.90% |
Decrease of terminal growth rate with unchanged weighted average cost of capital by 950 basis points (2020: 785)would result in an decrease of fair value in amount of HRK 18 thousand (2020: HRK 3 thousand)
|
||
|
Method of non-payment of royalties |
Brand 19 |
Weighted average cost of capital |
2021: 3.30% 2020: 4.80% |
Increase of weighted average cost of capital by 765 basis points (2020: 580)with unchanged terminal growth rate would result in an decrease of fair value in amount of HRK 27 thousand (2020: HRK 3 thousand)
|
|
Terminal growth rate |
2021: 2.00% 2020: 2.30% |
Decrease of terminal growth rate with unchanged weighted average cost of capital by 1,050 basis points (2020: 795)would result in an decrease of fair value in amount of HRK 8 thousand (2020: HRK 2 thousand)
|
||
|
Method of non-payment of royalties |
Brand 20
|
Weighted average cost of capital |
2021: 3.30% 2020: 4.80% |
Increase of weighted average cost of capital by 1,646 basis points (2020: 1,278)with unchanged terminal growth rate would result in an decrease of fair value in amount of HRK 20 thousand (2020: HRK 3 thousand)
|
|
Terminal growth rate |
2021: 2.00% 2020: 2.30% |
Decrease of terminal growth rate with unchanged weighted average cost of capital by 4,080 basis points (2020: 2,558)would result in an decrease of fair value in amount of HRK 6 thousand (2020: HRK 2 thousand)
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 6 – KEY ACCOUNTING JUDGEMENTS AND ESTIMATES (CONTINUED)
(v) Impairment testing for goodwill, brands and rights (continued)
Rights
Rights relate to registration files (pharmaceutical segment), distribution rights relating either to a specific segment or to several segments combined and acquired rights for operating pharmacies (pharmaceutical segment). Registration files and distribution rights have finite useful lives over which they are amortised and impaired in the event circumstances arise which indicate a need for impairment in excess of the regular amortisation charge. Pharmaceutical rights relate to acquired rights to perform pharmaceutical activities that are fully allocated to the segment “Pharmaceuticals”. In accordance with local legislation such rights do not expire (the Group does not expect regulatory changes in this respect).
The Group annually performs impairment tests in order to assess whether the recoverable amount of pharmaceutical rights indicates potential impairment of their carrying amount. Rights with an unlimited useful lives are allocated for the purpose of impairment testing to cash-generating units within the business segments and their net carrying value at the reporting date is HRK 40,025 thousand (2020: HRK 40,025 thousand).
The recoverable value of cash-generating units is determined by calculations of value in use based on projections of discounted cash flows on the basis of financial plans approved by the Management Board, which cover a five-year period from the reporting date.
Key assumptions on which projections of future discounted cash flows are based include an average revenue growth rate in the five-year period of 2%, and normalization of the currently reduced consumption of drugs, caused by the COVID-19 pandemic.
In cash flows after the five-year period, a terminal growth rate of 2 % was used, and the present value of net future cash flows was calculated using discount rates based on the average weighted cost of capital of 5.89% after taxation (for assets that generate the majority of income on the Croatian market) (2020: 7.69% after taxation).
During 2021, the Group recognised rights impairment in the amount of HRK 7,003 thousand (2020: reversal of rights impairment in the amount HRK 4,000 thousand).
During 2021, the Group did not have impairment cost on pharmacy rights (2020: the Group reversed previously recognized impairment of pharmacy rights in the amount of HRK 8,200 thousand for one pharmacy unit, while for another pharmacy unit it recognized an impairment in the amount of HRK 4,200 thousand).
Following the impairment test, the Group further compared similar transactions in the domestic market which also indicate that the fair value of pharmacy rights is higher than the carrying amount. Management views the cash-generating unit as a single pharmacy unit in a particular geographical area.
None of the pharmacy units but one show sensitivity to key assumptions.
Sensitivity analysis for the pharmacy unit with a carrying value of HRK 4,606 thousand at the reporting date (2020: HRK 4,606 thousand) indicates that with the terminal growth rate of 0% (with unchanged weighted average cost of capital) there would be a need for impairment in the amount to HRK 270 thousand. The sensitivity analysis also shows that with an increase in the weighted average cost of capital by 150 basis points (to 7.39%), with unchanged terminal growth rate from key assumptions, the value of the impairment would be HRK 233 thousand
.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 6 – KEY ACCOUNTING JUDGEMENTS AND ESTIMATES (CONTINUED)
(vi) Impairment test for property, plant and equipment, investment property and assets held for sale
The Group annually performs analysis of impairment indicators for property, plant and equipment in order to assess whether the recoverable amount indicates potential impairment of their carrying amount. In 2021, the Group recognised impairment of property and plant in the amount of HRK 766 thousand (2020: HRK 0 thousand). During 2021, the Group did not recognise any impairment of equipment (2020: HRK 132 thousand).
For property, plant and equipment held for sale, upon classification of such assets as held for sale the Group estimates their recoverable amount based on an independent expert valuer’s estimate of the fair value of these assets less costs to sell and records these assets at the lower of their carrying amount and the recoverable amount. Generally, the Group considers with significant confidence that the recoverable amount of such assets will be realized through sale or disposal in the short term and in cases where there has been a delay in disposal due to circumstances which do not require reclassification of such assets into property, plant and equipment, the Group considers whether there have been significant changes in the circumstances and expectations related to the disposal process which would require re-assessment of their fair value. If a significant change in circumstances has not occurred, but the asset relates to property which is intended to be used until disposal, the Group approximates the possible impairment that could arise from the date of classification of such assets as held for sale up to the reporting date at the level of depreciation that would have been recognised had those assets not been classified as held for sale.
During 2021, the COVID-19 pandemic did not have an impact on the going concern of the Podravka Group’s operations.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 7 – DETERMINATION OF FAIR VALUES
The Group has an established control framework with respect to fair value measurement which assumes the overall responsibility of the Management Board and finance department in relation to the monitoring of all significant fair value measurements, consultation with external experts and the responsibility to report, with respect the above, to those charged with corporate governance.
Fair values are measured using information collected from third parties in which case the Board and the finance department assess whether the evidence collected from third parties support the conclusion that such valuations meet the requirements of IFRSs, including the level in the fair value hierarchy where such valuations should be classified.
All significant issues related to fair values estimates are reported to the Supervisory Board and the Audit Committee.
Fair values are categorised into different levels in a fair value hierarchy based on the inputs used in the valuation techniques as follows:
- Level 1 - quoted prices (unadjusted) in active markets for identical assets or liabilities.
- Level 2 - inputs other than quoted prices included in level 1, that are observable for the asset or liability either directly (i.e. as prices) or indirectly (i.e. derived from prices).
- Level 3 - input variables for assets or liabilities that are not based on observable market data (unobservable inputs).
The fair value of financial instruments traded in active markets is based on quoted market prices at the balance sheet date. A market is regarded as active if quoted prices are readily and regularly available from an exchange, dealer, broker, industry group, or regulatory agency, and those prices represent actual and regularly occurring market transactions on an arm’s length basis.
The fair value of financial instruments that are not traded in an active market (for example, over-the-counter derivatives) is determined by using valuation techniques. These valuation techniques maximise the use of observable market data where it is available and rely as little as possible on entity specific estimates. If all significant inputs required to fair value an instrument are observable, the instrument is included in level 2.
If one or more significant inputs are not based on observable market data, the fair value estimate is included in level 3.
In preparing these financial statements, the Group has made the following significant fair value estimates, as further explained in detail in the following notes:
· note 23: Non-current financial assets
· note 26: Financial assets at fair value through profit or loss
· note 28: Non-current assets held for sale
· note 33: Financial liabilities at fair value through profit or loss
· note 39: Share-based payments
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 8 – SALES REVENUE
Sales revenue
|
2021 |
2020 |
||||
|
(in thousands of HRK) |
|||||
|
Revenue from sale of products and merchandise |
4,604,342 |
4,473,547 |
|||
|
Revenue from services |
27,177 |
29,670 |
|||
|
4,631,519 |
4,503,217 |
||||
For management purposes, the Group is organised in business units based on the similarity in the nature of individual product groups and has identified reportable segments in accordance with quantitative thresholds for segment reporting. The reportable segments of the Group are as follows:
- BP Culinary
- BP Baby food, sweets and snacks
- BP Podravka Food
- BP Žito and Lagris
Žito and related companies
Other companies
- BP Meat products, meat solutions and savoury spreads
- BP Fish
- Pharmaceuticals
- Other sales
The reportable segments are part of the internal financial reporting to the Management Board which was identified as the chief operating decision maker. The Management Board reviews the internal reports regularly and assesses the segment performance, and uses those reports in making operating decisions.
Segment revenues and results
Set out below is an analysis of the Group’s revenue and results by its reportable segments, presented in accordance with IFRS 8 Operating segments and a reconciliation of segment profits to profit or loss before tax as presented in the consolidated statement of comprehensive income. The revenue presented below relates to third-party sales. Inter-segment revenues are eliminated on consolidation.
|
(in thousands of HRK) |
Segment revenues |
Segment expenses |
Segment depreciation |
Segment profits/(loss) |
|
|
2021 |
2021 |
2021 |
2021 |
||
|
BP Culinary |
1,046,963 |
757,285 |
24,854 |
264,824 |
|
|
BP Baby food, sweets and snack |
473,393 |
388,956 |
25,042 |
59,395 |
|
|
BP Podravka food |
440,280 |
428,722 |
24,929 |
(13,371) |
|
|
BP Žito and Lagris |
902,864 |
884,700 |
36,985 |
(18,821) |
|
|
Žito and related companies |
729,798 |
703,528 |
32,389 |
(6,119) |
|
|
Other companies |
173,066 |
181,172 |
4,596 |
(12,702) |
|
|
BP Meat products, solutions and spreads |
304,040 |
297,156 |
13,522 |
(6,638) |
|
|
BP Fish |
212,375 |
208,300 |
7,455 |
(3,380) |
|
|
Pharmaceutical |
1,030,254 |
832,714 |
64,659 |
132,881 |
|
|
Other sales |
221,350 |
218,666 |
5,126 |
(2,441) |
|
|
4,631,519 |
4,016,499 |
202,572 |
412,449 |
||
|
Finance income (note 13) |
1,782 |
||||
|
Other income (note 9) |
34,983 |
||||
|
Central administration costs |
(73,604) |
||||
|
Other expenses (note 10) |
(8,529) |
||||
|
Finance expenses (note 14) |
(7,801) |
||||
|
Profit before tax |
359,280 |
||||
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 8 – SALES REVENUE (CONTINUED)
Segment revenues and results (continued)
|
(in thousands of HRK) |
Segment revenues |
Segment expenses |
Segment depreciation |
Segment profits/(loss) |
|
|
2020 |
2020 |
2020 |
2020 |
||
|
BP Culinary |
1,003,114 |
720,962 |
25,390 |
256,762 |
|
|
BP Baby food, sweets and snack |
460,803 |
369,597 |
23,947 |
67,259 |
|
|
BP Podravka food |
403,115 |
391,101 |
25,482 |
(13,468) |
|
|
BP Žito and Lagris |
926,213 |
887,710 |
39,261 |
(758) |
|
|
Žito and related companies |
752,381 |
711,476 |
35,659 |
5,246 |
|
|
Other companies |
173,832 |
176,234 |
3,602 |
(6,004) |
|
|
BP Meat products, solutions and spreads |
305,443 |
300,103 |
13,067 |
(7,727) |
|
|
BP Fish |
220,994 |
212,624 |
7,101 |
1,269 |
|
|
Pharmaceutical |
976,195 |
783,746 |
62,885 |
129,564 |
|
|
Other sales |
207,340 |
203,066 |
4,691 |
(417) |
|
|
4,503,217 |
3,868,909 |
201,824 |
432,484 |
||
|
Finance income (note 13) |
542 |
||||
|
Other income (note 9) |
23,247 |
||||
|
Central administration costs |
(78,984) |
||||
|
Other expenses (note 10) |
(44,401) |
||||
|
Finance expenses (note 14) |
(18,878) |
||||
|
Profit before tax |
314,010 |
||||
Balance sheet by segments
|
31.12.2021 |
31.12.2020 |
||||||
|
(in thousands of HRK) |
Total |
Pharmaceuticals |
Nutrition Segments |
Total |
Pharmaceuticals |
Nutrition Segments |
|
|
ASSETS |
|||||||
|
Total non-current assets |
2,885,741 |
955,882 |
1,929,859 |
2,904,357 |
1,009,440 |
1,894,917 |
|
|
Total current assets |
2,023,211 |
629,985 |
1,393,226 |
2,036,291 |
643,445 |
1,392,846 |
|
|
Total assets |
4,908,952 |
1,585,867 |
3,323,085 |
4,940,648 |
1,652,885 |
3,287,763 |
|
|
LIABILITIES |
|||||||
|
Equity |
3,630,977 |
1,177,600 |
2,453,377 |
3,372,050 |
1,099,478 |
2,272,572 |
|
|
Minority interest |
63,289 |
63,106 |
183 |
54,932 |
54,540 |
392 |
|
|
Total non-current liabilities |
346,028 |
138,931 |
207,097 |
506,473 |
206,828 |
299,645 |
|
|
Total current liabilities |
868,658 |
206,230 |
662,428 |
1,007,193 |
292,039 |
715,154 |
|
|
Total equity and liabilities |
4,908,952 |
1,585,867 |
3,323,085 |
4,940,648 |
1,652,885 |
3,287,763 |
|
Group does not follow detailed breakdown of balance sheet by segment but only by the two main segments on consolidated level.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 8 – SALES REVENUE (CONTINUED)
Segment revenues and results (continued)
BP Culinary comprises the following product groups: seasonings, soups, ready-to-cook meals and bouillons, food mixes and monospices.
BP Baby food, sweets and snacks comprises the following product groups: Lino world, sweets, drinks and snacks.
BP Podravka Food comprises the following product groups: condiments, tomato, sauces, fruit, vegetables and Podravka flour.
BP Žito and Lagris comprises the following product groups: core food, bakery and mill products, tea, confectionery and cereals for adults.
BP Meat products, meat solutions and savoury spreads comprises the following product groups: canned meat, sausages, food solution and other meat.
BP Fish comprises fish products.
The Pharmaceutical segment comprises the following: ethical drugs (medically prescribed drugs), non-prescription program (drugs for which no medical prescription is required), nutraceuticals and trade goods and services. Pharmaceuticals segment is regulated by the Croatian Institute for Health Insurance, which provides prescription drug prices and by the relevant regulatory authorities in connection with the registration of medicines in the Croatian market. Foreign markets in this segment have similar regulation characteristics.
The Other segment comprises the following product groups: merchandise and food services.
Business programmes (BP) comprise own brands, B2B, private labels and service production.
The accounting policies of the reportable segments are the same as the Group’s accounting policies described in note 3. Segment profit represents the profit earned by each segment without allocation of central administration costs, other income, other expenses, finance expenses, and income tax expense.
Geographical information
The Group operates in five principal geographical areas by which it reports third-party sales:
|
(in thousands of HRK) |
2021 |
2020 |
|
|
Region Adria |
3,218,531 |
3,111,544 |
|
|
Region Central Europe |
553,824 |
558,399 |
|
|
Region Western Europe and overseas countries |
512,448 |
504,964 |
|
|
Region Eastern Europe |
326,599 |
313,318 |
|
|
Region New markets |
20,117 |
14,992 |
|
|
4,631,519 |
4,503,217 |
||
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 8 – SALES REVENUE (CONTINUED)
Information about major customers
Third-party sales in Croatia account for 32% (2020: 31%) of the total revenue from external customers, whereas the remaining 68% (2020: 69%) represent foreign sales. Top 20 customers participate with 32% (2020: 33%) in the value of external sales in total income.
Sales to major customers owned or controlled by the same third party group represent approximately 10% of the Group’s total revenue in 2021 (2020: approximately 11% of the total revenue). Below is a more detailed overview of countries by geographical area:
|
Region Adria |
International markets |
|||||
|
|
Western Europe and Overseas |
Central Europe |
Eastern Europe |
New markets |
||
|
Southeast Europe |
Western Europe |
Overseas |
|
|
|
|
|
Croatia |
Germany |
USA |
Poland |
Russian Federation |
Irak |
Burkina Faso |
|
Slovenia |
Austria |
Canada |
Czech Republic |
Ukraine |
United Arab Emirates |
China |
|
Bosnia and Herzegovina |
Switzerland |
Australia |
Slovakia |
Kazakhstan |
Kuwait |
Japan |
|
North Macedonia |
France |
New Zealand |
Hungary |
Estonia |
Katar |
South Korea |
|
Serbia |
Great Britain |
|
Romania |
Lithuania |
Oman |
Singapore |
|
Montenegro |
Italy |
|
|
Latvia |
Saudi Arabia |
Hong Kong |
|
Kosovo |
Denmark |
|
|
Moldova |
Turkey |
Taiwan |
|
Bulgaria |
Sweden |
|
|
Belarus |
Jordan |
Israel |
|
Albania |
Nederlands |
|
|
Armenia |
Lebanon |
Mongolia |
|
Greece |
Belgium |
|
|
Kyrgystan |
Egypt |
Maldivies |
|
|
Ireland |
|
|
Uzbekistan |
Libya |
Bolivia |
|
|
Spain |
|
|
Georgia |
Kenya |
Chile |
|
|
Portugal |
|
|
|
DR Congo |
|
|
|
Malta |
|
|
|
Liberia |
|
NOTE 9 – OTHER INCOME
|
2021 |
2020 |
||||
|
(in thousands of HRK) |
|||||
|
Interest and foreign exchange differences on trade receivables and payables |
14,701 |
- |
|||
|
Grant income |
8,781 |
8,589 |
|||
|
Gain on disposal of assets held for sale |
5,272 |
1,320 |
|||
|
Reversal of impairment of other receivables |
407 |
5,299 |
|||
|
Gain on disposal of
property, plant, equipment |
303 |
- |
|||
|
Gains on write-off right-of-use assets |
64 |
41 |
|||
|
Reversal of impairment of intangible assets |
- |
4,000 |
|||
|
Other income |
5,455 |
3,998 |
|||
|
34,983 |
23,247 |
||||
In 2021, the Group generated income from interest and foreign exchange gains on trade receivables and trade payables in the amount of HRK 14,701 thousand (2020: expense of HRK 43,511 thousand).
Grant income mainly refers to non-repayable state grants for the employment of disabled persons.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 10 – OTHER EXPENSES
|
2021 |
2020 |
||||
|
(in thousands of HRK) |
|||||
|
Impairment loss on property, plant, equipment and intangibles |
8,440 |
132 |
|||
|
Interest expense relating to trade payables and other |
89 |
152 |
|||
|
Interest and foreign exchange differences on trade receivables and payables |
- |
43,511 |
|||
|
Loss on disposal of property, plant, equipment and intangibles |
- |
364 |
|||
|
Subsidiary liquidation |
- |
242 |
|||
|
8,529 |
44,401 |
||||
NOTE 11 – EXPENSES BY NATURE
|
2021 |
2020 |
||||
|
(in thousands of HRK) |
|||||
|
Raw materials supplies, energy and cost of goods sold including change in inventory |
2,323,721 |
2,216,360 |
|||
|
Staff costs (note 12) |
1,082,505 |
1,066,377 |
|||
|
Services (i) |
227,727 |
230,747 |
|||
|
Depreciation and amortisation (ii) |
218,166 |
218,225 |
|||
|
Advertising and promotion |
195,192 |
199,977 |
|||
|
Transport |
114,374 |
108,115 |
|||
|
Taxes and contributions independent of operating results |
25,649 |
25,600 |
|||
|
Entertainment |
23,578 |
17,846 |
|||
|
Rental expense |
16,661 |
16,421 |
|||
|
Insurance premiums |
12,927 |
14,875 |
|||
|
Cost of disposal of packaging, administrative fees, etc |
11,703 |
11,328 |
|||
|
Litigation expenses |
10,764 |
941 |
|||
|
Telecommunications |
10,326 |
10,241 |
|||
|
Daily allowances and other business travel expenses |
8,973 |
7,801 |
|||
|
Bank charges |
5,522 |
5,451 |
|||
|
Impairment of trade receivables (note 25) |
940 |
(189) |
|||
|
Other |
3,946 |
(399) |
|||
|
Total cost of goods sold, selling and distribution costs, marketing costs and general and administrative costs |
4,292,674 |
4,149,717 |
|||
(i) Costs of services include audit fees. Fees for the audit of the Group’s financial statements amounted to HRK 3,064 thousand (2020: HRK 2,572 thousand and HRK 173 thousand of one-off costs of the audit of previous years). Fees for the assurance engagements performed to the Group amounted to HRK 206 thousand (2020: HRK 226 thousand). During 2021, the Group did not receive any non-audit services from the auditor.
(ii) Depreciation and amortisation include HRK 1,828 thousand of government grants for co-financing of assets (2020: HRK 1,847 thousand).
The Group reports gross profit as revenue from the sale of products less operating expenses as shown in the specification above with the net effect of other income (Note 9) and other expenses (Note 10).
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 11 – EXPENSES BY NATURE (CONTINUED)
The following tables present expenses by nature contained in cost of goods sold:
|
2021 |
2020 |
||||
|
(in thousands of HRK) |
|||||
|
Raw material and supplies |
1,648,898 |
1,590,383 |
|||
|
Cost of goods sold |
627,355 |
579,727 |
|||
|
Staff costs |
462,696 |
456,971 |
|||
|
Depreciation and amortisation |
124,459 |
124,368 |
|||
|
Production services |
58,409 |
61,186 |
|||
|
Taxes and contributions independent of operating results |
11,261 |
12,141 |
|||
|
Other expenses (transport, rent, education, etc) |
20,303 |
19,026 |
|||
|
Cost of goods sold |
2,953,381 |
2,843,802 |
|||
The Group reports gross profit as revenue from the sale of products less cost of goods sold as shown in the specification above.
Depreciation and amortisation allocated to each function is as follows:
|
2021 |
2020 |
||
|
(in thousands of HRK) |
|||
|
Cost of goods sold |
124,459 |
124,368 |
|
|
Selling, logistics and distribution costs |
46,200 |
45,884 |
|
|
General and administrative expenses |
36,230 |
36,672 |
|
|
Marketing expenses |
11,277 |
11,301 |
|
|
218,166 |
218,225 |
||
Staff costs allocated to each function is as follows:
|
2021 |
2020 |
||
|
(in thousands of HRK) |
|||
|
Cost of goods sold |
462,696 |
456,972 |
|
|
Selling, logistics and distribution costs |
301,224 |
292,812 |
|
|
General and administrative expenses |
211,397 |
207,363 |
|
|
Marketing expenses |
107,188 |
109,230 |
|
|
1,082,505 |
1,066,377 |
||
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 12 – STAFF COSTS
|
2021 |
2020 |
||||
|
(in thousands of HRK) |
|||||
|
Salaries |
928,804 |
915,299 |
|||
|
Transport |
25,418 |
25,236 |
|||
|
Share options (note 39) |
9,512 |
11,120 |
|||
|
Termination benefits |
6,565 |
6,660 |
|||
|
Other cost of employees |
112,206 |
108,062 |
|||
|
1,082,505 |
1,066,377 |
||||
As at 31 December 2021, the number of staff employed by the Group was 6,557 (2020: 6,650). The average number of employees of the Group during 2021 is 6,663 employees (2020: 6,721 employees).
In 2021, termination and retirement benefits of HRK 6,565 thousand were paid to 114 employees (2020: termination and retirement benefits of HRK 6,660 thousand were paid to 91 employees).
Other employee costs relate mainly to meal expenses in the amount of HRK 24,522 thousand (2020: HRK 30,255 thousand). Other significant items within other cost of employees are Christmas, Easter and other non-taxable employee benefits in the amount of HRK 27,245 thousand (2020: HRK 26,455 thousand), and holiday pay in the amount of HRK 22,915 thousand (2020: HRK 22,425 thousand).
NOTE 13 – FINANCE INCOME
|
2021 |
2020 |
||||
|
(in thousands of HRK) |
|||||
|
Net foreign exchange gains on borrowings |
1,154 |
- |
|||
|
Interest on term deposits |
360 |
208 |
|||
|
Other interests |
252 |
2 |
|||
|
Dividend income |
12 |
- |
|||
|
Remeasurement of financial
instruments at fair value |
4 |
332 |
|||
|
1,782 |
542 |
||||
NOTE 14 – FINANCE EXPENSES
|
2021 |
2020 |
||||
|
(in thousands of HRK) |
|||||
|
Interest expense and similar charges |
7,784 |
14,772 |
|||
|
Unrealised losses per forward |
17 |
- |
|||
|
Net foreign exchange loss on borrowings |
- |
4,106 |
|||
|
7,801 |
18,878 |
||||
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
Income tax expense consists of:
|
2021 |
2020 |
||||
|
(in thousands of HRK) |
|||||
|
Current income tax |
51,256 |
50,503 |
|||
|
Deferred tax (income)/expense |
(9,798) |
7,373 |
|||
|
41,458 |
57,876 |
||||
Effective tax rate reconciliation
A reconciliation of tax expense per the statement of comprehensive income and taxation at the statutory rate is detailed in the table below:
|
2021 |
2020 |
||||
|
(in thousands of HRK) |
|||||
|
Profit before taxation |
359,280 |
314,010 |
|||
|
Income tax at 18% |
64,670 |
56,522 |
|||
|
Non-taxable income |
(2) |
(830) |
|||
|
Non-deductible expenses |
7,070 |
6,951 |
|||
|
Tax incentives (research and development, education and other) |
(2,985) |
(2,542) |
|||
|
Recognition of previously unrecognized temporary differences and tax losses as deferred tax assets |
(24,433) |
- |
|||
|
Temporary differences and
tax losses not recognised |
1,973 |
2,271 |
|||
|
Utilisation of tax losses previously not
recognised |
(12) |
(758) |
|||
|
Effect of different tax rates |
(5,308) |
(4,055) |
|||
|
Tax for the previous year |
9 |
23 |
|||
|
Tax paid abroad |
476 |
294 |
|||
|
Income tax |
41,458 |
57,876 |
|||
|
Effective tax rate |
12% |
18% |
|||
Investment tax credit
In March 2015, pursuant to the Investment Promotion and Development of Investment Climate Act, the subsidiary Belupo d.d. became eligible to receive incentive measures. The Ministry of Economy approved the tax incentive measures, as a subsidy for qualifying costs of new employment linked to the investment project and an incentive for capital expenditure related to the investment project, in the form of an investment tax credit in the amount of HRK 163,717 thousand for which the subsidiary will be able to reduce its future income tax liabilities and/or receive cash reimbursements as an incentive for employment related to the investment project.
The subsidiary has the right to use the investment tax credit in the next 10 years from the date of approval by the relevant authorities. The execution of the investment project is subject to supervision by the relevant institutions and the subsidiary is not permitted to reduce the number of new jobs (related to the terms of the incentive measures) in addition to other conditions, throughout the period of the incentive measures, but no less than 5 years. If the conditions of the tax incentive are not met, the subsidiary would have to retroactively pay income tax inclusive of any penalty interest.
Based on the assessment of the recoverability of the tax incentive made by the management of the subsidiary and the Group, in financial statements for 2015, the subsidiary and Group initially recognised the entire amount of approved tax incentives as a deferred tax asset and an income tax benefit. In future years, the deferred tax asset will be utilised in accordance with the utilization of the tax incentive, i.e. in accordance with and subject to the availability of tax obligations against which the credits can be offset and/or amounts of cash reimbursements the subsidiary receives as incentives for new employment as part of the investment project. In 2021, deferred tax asset of HRK 24,158 thousand was used from this basis.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 15 – INCOME TAX (CONTINUED)
Unused tax losses
In accordance with tax regulations, as at 31 December 2021 the Group has unused tax losses in the amount of HRK 87,095 thousand (2020: HRK 79,255 thousand) which consist of tax losses in Slovenia (in the amount of HRK 3,006 thousand), Tanzania (in the amount of HRK 35,866 thousand), Poland (in the amount of HRK 5,962 thousand), Germany (in the amount of HRK 8,260 thousand), the Czech Republic (in the amount of HRK 6,294 thousand), Bulgaria (in the amount of HRK 1,001 thousand) and Croatia (in the amount of HRK 26,705 thousand).
Unused tax losses carried forward were recognized as deferred tax assets in the amount of HRK 5,258 thousand. In the financial statements, the Group did not recognize deferred tax assets for the remaining tax losses since it is not probable that the tax losses will be utilized by the companies they relate to. Unused tax losses (gross) at the reporting date were as follows:
|
2021 |
2020 |
||
|
(in thousands of HRK) |
|||
|
Tax losses expiring at 31 December 2021 |
- |
3,303 |
|
|
Tax losses expiring at 31 December 2022 |
4,251 |
4,474 |
|
|
Tax losses expiring at 31 December 2023 |
1,189 |
1,251 |
|
|
Tax losses expiring at 31 December 2024 |
4,903 |
4,408 |
|
|
Tax losses expiring at 31 December 2025 |
8,418 |
8,372 |
|
|
Tax losses expiring at 31 December 2026 |
20,200 |
- |
|
|
Tax losses with no expiration date |
48,134 |
57,447 |
|
|
87,095 |
79,255 |
||
Deferred tax assets arise from the following:
|
2021 |
Opening balance |
Recognised in profit or loss |
Recognised directly in equity |
Foreign exchange differences |
Closing balance |
|
(in thousands of HRK) |
|||||
|
Basis: |
|||||
|
Intangible assets |
3,873 |
9 |
- |
- |
3,882 |
|
Property, plant and equipment |
7,111 |
(60) |
- |
1 |
7,052 |
|
Financial assets |
25,014 |
25,649 |
- |
- |
50,663 |
|
Provisions |
16,102 |
5,118 |
177 |
30 |
21,427 |
|
Share-based payments |
2,135 |
861 |
(257) |
- |
2,739 |
|
Inventories |
12,939 |
(138) |
- |
- |
12,801 |
|
Investment tax credit |
70,294 |
(24,967) |
- |
- |
45,327 |
|
Unutilised tax losses carried forward |
2,891 |
2,321 |
- |
46 |
5,258 |
|
Receivables |
1,052 |
(100) |
- |
- |
952 |
|
Deferred tax assets |
141,411 |
8,693 |
(80) |
77 |
150,101 |
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 15 – INCOME TAX (CONTINUED)
Deferred tax assets (continued)
|
2020 |
Opening balance |
Recognised in profit or loss |
Recognised directly in equity |
Foreign exchange differences |
Closing balance |
|
(in thousands of HRK) |
|||||
|
Basis: |
|||||
|
Intangible assets |
4,541 |
(668) |
- |
- |
3,873 |
|
Property, plant and equipment |
7,303 |
(195) |
- |
3 |
7,111 |
|
Financial assets |
24,705 |
309 |
- |
- |
25,014 |
|
Provisions |
12,548 |
3,228 |
321 |
5 |
16,102 |
|
Share-based payments |
1,263 |
872 |
- |
- |
2,135 |
|
Inventories |
11,185 |
1,743 |
- |
11 |
12,939 |
|
Investment tax credit |
83,774 |
(13,480) |
- |
- |
70,294 |
|
Unutilised tax losses carried forward |
2,744 |
474 |
- |
(327) |
2,891 |
|
Receivables |
1,002 |
50 |
- |
- |
1,052 |
|
Deferred tax assets |
149,065 |
(7,667) |
321 |
(308) |
141,411 |
Based on the revaluation of tax recoverability, the Group recognised deferred tax assets based on loss on financial assets in the amount of HRK 25,027 thousand, and wrote off deferred tax assets on the basis of incentives in the amount of HRK 667 thousand.
Deferred tax liability
Deferred tax liabilities arise from the following:
|
2021 |
Opening balance |
Recognised in profit or loss |
Foreign exchange differences |
Closing balance |
|
(in thousands of HRK) |
||||
|
Basis: |
||||
|
Intangible assets |
(11,335) |
1,172 |
(10) |
(10,173) |
|
Property, plant and equipment |
(27,699) |
(67) |
(45) |
(27,811) |
|
(39,034) |
1,105 |
(55) |
(37,984) |
|
|
2020 |
Opening balance |
Recognised in profit or loss |
Foreign exchange differences |
Closing balance |
|
(in thousands of HRK) |
||||
|
Basis: |
||||
|
Intangible assets |
(11,393) |
58 |
- |
(11,335) |
|
Property, plant and equipment |
(27,690) |
236 |
(245) |
(27,699) |
|
(39,083) |
294 |
(245) |
(39,034) |
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 16 – EARNINGS/ (LOSS) PER SHARE
Basic earnings per share
Basic earnings per share are determined by dividing the Group’s net earnings or losses with the weighted average number of ordinary shares in issue during the year, excluding the weighted average number of ordinary shares purchased by the Group and held as treasury shares.
Diluted earnings per share
Diluted earnings per share were calculated as the basic earnings per share, including the impact of the number of share options granted to employees, of which 116,800 were not exercised (2020: 40,500 options). The price of all unexercised share options is lower than the share market price as at 31 December 2021. The value of diluted earnings per share is the lower of the basic earnings per share obtained and the diluted earnings per share obtained.
Basic and diluted weighted average number of shares is as follows:
|
2021 |
2020 |
|||||
|
Ordinary shares as at 1 January |
7,120,003 |
7,120,003 |
||||
|
Effect of treasury shares |
(105,916) |
(127,916) |
||||
|
Weighted average number of shares at 31 December (basic) |
7,014,087 |
6,992,087 |
||||
|
Effect of share based payments |
116,800 |
40,500 |
||||
|
Weighted average number of shares at 31 December (diluted) |
7,130,887 |
7,032,587 |
||||
Basic and diluted earnings per share for the Group as a whole was as follows:
|
2021 |
2020 |
|||||
|
Basic earnings per share |
||||||
|
Profit for the year attributable to the owners of parent company (in thousands of HRK ) |
309,221 |
248,934 |
||||
|
Basic earnings per share |
44.1 |
35.6 |
||||
|
Diluted earnings per share |
||||||
|
Profit for the year attributable to the owners of parent company (in thousands of HRK ) |
309,221 |
248,934 |
||||
|
Diluted earnings per share |
43.4 |
35.4 |
||||
NOTE 17 – GOODWILL
|
(in thousands of HRK) |
|||||
|
2021 |
2020 |
||||
|
Cost |
|||||
|
At 1 January |
67,304 |
67,304 |
|||
|
At 31 December |
67,304 |
67,304 |
|||
|
Accumulated impairment losses |
|||||
|
At 1 January |
40,485 |
40,054 |
|||
|
Effect of foreign exchange differences |
(1,284) |
431 |
|||
|
At 31 December |
39,201 |
40,485 |
|||
|
Carrying amount at 31 December |
28,103 |
26,819 |
|||
During 2021 and 2020 there was no impairment of goodwill. A more detailed description of the approach and methods used in impairment testing is provided in note 6(v).
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 18 – INTANGIBLE ASSETS
|
(in thousands of HRK) |
Software and licences |
Rights, registration files, know how |
Brands |
Intangible assets in progress |
Total |
|
Cost |
|||||
|
At 1 January 2020 |
260,507 |
249,127 |
202,305 |
39,375 |
751,314 |
|
Effect of foreign exchange differences |
(123) |
225 |
277 |
10 |
389 |
|
Additions |
143 |
- |
- |
29,998 |
30,141 |
|
Transfers |
17,297 |
6,546 |
- |
(23,843) |
- |
|
Disposals and write-off's |
(417) |
(1,031) |
- |
(1,099) |
(2,547) |
|
Transfer from tangible fixed assets |
- |
- |
- |
99 |
99 |
|
At 31 December 2020 |
277,407 |
254,867 |
202,582 |
44,540 |
779,396 |
|
Accumulated amortisation and impairments |
|||||
|
At 1 January 2020 |
(221,746) |
(178,032) |
(106,977) |
- |
(506,755) |
|
Effect of foreign exchange differences |
74 |
(85) |
168 |
- |
157 |
|
Disposals and write-off's |
327 |
849 |
- |
- |
1,176 |
|
Amortisation |
(16,912) |
(7,907) |
- |
- |
(24,819) |
|
Reversal of impairment of pharmacy rights net |
- |
4,000 |
- |
- |
4,000 |
|
At 31 December 2020 |
(238,257) |
(181,175) |
(106,809) |
- |
(526,241) |
|
Carrying amount as at 31 December 2020 |
39,150 |
73,692 |
95,773 |
44,540 |
253,155 |
|
Cost |
|||||
|
At 1 January 2021 |
277,407 |
254,867 |
202,582 |
44,540 |
779,396 |
|
Effect of foreign exchange differences |
(4) |
(50) |
329 |
(5) |
270 |
|
Additions |
387 |
- |
- |
26,052 |
26,439 |
|
Transfers |
23,960 |
5,894 |
- |
(29,854) |
- |
|
Disposals and write-off's |
(147) |
(1,782) |
- |
(51) |
(1,980) |
|
Transfer to tangible fixed assets |
- |
- |
- |
917 |
917 |
|
Impairment of assets |
- |
(5,961) |
(71) |
(336) |
(6,368) |
|
At 31 December 2021 |
301,603 |
252,968 |
202,840 |
41,263 |
798,674 |
|
Accumulated amortisation and impairments |
|||||
|
At 1 January 2021 |
(238,257) |
(181,175) |
(106,809) |
- |
(526,241) |
|
Effect of foreign exchange differences |
(49) |
25 |
(503) |
- |
(527) |
|
Disposals and write-off's |
143 |
1,713 |
- |
- |
1,856 |
|
Amortisation |
(15,745) |
(7,476) |
- |
- |
(23,221) |
|
Impairment of assets |
- |
(706) |
(600) |
- |
(1,306) |
|
At 31 December 2021 |
(253,908) |
(187,619) |
(107,912) |
- |
(549,439) |
|
Carrying amount as at 31 December 2021 |
47,695 |
65,349 |
94,928 |
41,263 |
249,235 |
Of the total amount of accumulated amortisation and impairment losses, HRK 28,224 thousand relates to accumulated impairment losses (2020: HRK 20,550 thousand).
The total intangible assets with indefinite useful lives as at 31 December 2021 amount to HRK 160,277 thousand and relate to brands and other rights.
During 2021, the Group recognised brand impairment costs in the amount of HRK 671 thousand (2020: HRK 0 thousand). Also, during 2021, the Group recognised rights impairment in the amount of HRK 7,003 thousand (2020: reversal of rights impairment in the amount HRK 4,000 thousand).
Intangible assets under construction relate to capitalised development expenses and purchased registration files for which health regulatory approval has not yet been received.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 19 – PROPERTY, PLANT AND EQUIPMENT
|
(in thousands of HRK) |
Land and buildings |
Equipment |
Assets under construction |
Total |
|
|
Cost |
|||||
|
At 1 January 2020 |
2,881,419 |
2,472,825 |
78,721 |
5,432,965 |
|
|
Effect of foreign exchange differences |
4,758 |
2,403 |
57 |
7,218 |
|
|
Additions |
- |
1,958 |
160,452 |
162,410 |
|
|
Transfers |
26,834 |
116,063 |
(142,897) |
- |
|
|
Disposals and write-off's |
(1,518) |
(51,783) |
(681) |
(53,982) |
|
|
Transfer to intangible assets (i) |
- |
- |
(99) |
(99) |
|
|
Transfer to investment property (iii) |
- |
- |
(533) |
(533) |
|
|
Impairment of assets |
- |
- |
(132) |
(132) |
|
|
At 31 December 2020 |
2,911,493 |
2,541,466 |
94,888 |
5,547,847 |
|
|
Accumulated depreciation and impairments |
|||||
|
At 1 January 2020 |
(1,677,442) |
(1,542,217) |
(327) |
(3,219,986) |
|
|
Effect of foreign exchange differences |
(236) |
(835) |
- |
(1,071) |
|
|
Disposals and write-off's |
833 |
50,957 |
- |
51,790 |
|
|
Depreciation charge for the year |
(57,033) |
(99,270) |
- |
(156,303) |
|
|
At 31 December 2020 |
(1,733,878) |
(1,591,365) |
(327) |
(3,325,570) |
|
|
Carrying amount as at 31 Dec 2020 |
1,177,615 |
950,101 |
94,561 |
2,222,277 |
|
|
Cost |
|||||
|
At 1 January 2021 |
2,911,493 |
2,541,466 |
94,888 |
5,547,847 |
|
|
Effect of foreign exchange differences |
(1,898) |
(151) |
812 |
(1,237) |
|
|
Additions |
338 |
1,321 |
142,833 |
144,492 |
|
|
Transfers |
20,748 |
117,253 |
(138,001) |
- |
|
|
Disposals and write-off's |
(517) |
(48,588) |
(126) |
(49,231) |
|
|
Transfer to intangible assets (i) |
- |
- |
(917) |
(917) |
|
|
Transfer to assets held for sale (ii) |
- |
- |
(843) |
(843) |
|
|
At 31 December 2021 |
2,930,164 |
2,611,301 |
98,646 |
5,640,111 |
|
|
Accumulated depreciation and impairments |
|||||
|
At 1 January 2021 |
(1,733,878) |
(1,591,365) |
(327) |
(3,325,570) |
|
|
Effect of foreign exchange differences |
1,389 |
(307) |
- |
1,082 |
|
|
Disposals and write-off's |
241 |
47,696 |
- |
47,937 |
|
|
Depreciation charge for the year |
(54,888) |
(101,453) |
- |
(156,341) |
|
|
Impairment of non-current assets |
(766) |
- |
- |
(766) |
|
|
At 31 December 2021 |
(1,787,902) |
(1,645,429) |
(327) |
(3,433,658) |
|
|
Carrying amount as at 31 Dec 2021 |
1,142,262 |
965,872 |
98,319 |
2,206,453 |
During 2021, the Group impaired land and buildings in the amount of HRK 766 thousand (2020: impairment of equipment in the amount of HRK 132 thousand).
(i) During 2021, the Group transferred property, plant and equipment to intangible assets in the amount of HRK 917 thousand (2020: HRK 99 thousand).
(ii) During 2021, the Group transferred property, plant and equipment to assets held for sale in the amount of HRK 843 thousand (2020: HRK 0 thousand).
(iii) During 2020, the Group transferred property, plant and equipment to investment property in the amount of HRK 533 thousand.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 19 – PROPERTY, PLANT AND EQUIPMENT (CONTINUED)
Assets under construction mainly relate to investments in modernisation of production capacities and extension of the product range.
During 2021, the Group had no investments related to interest expense capitalisation in property and equipment.
Mortgaged assets
Buildings, land and equipment of the Group with a net carrying amount of HRK 327,985 thousand (2020: HRK 712,307 thousand) are pledged as collateral against the Group’s borrowings.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 20 – LEASES
Movements in right-of-use assets:
|
(in thousands of HRK) |
Land |
Buildings |
Total land and buildings |
Equipment |
Total |
|
Cost |
|||||
|
As at 1 January 2020 |
12,814 |
59,971 |
72,785 |
63,402 |
136,187 |
|
Exchange rate effect |
- |
132 |
132 |
54 |
186 |
|
Additions |
(846) |
7,638 |
6,792 |
35,104 |
41,896 |
|
Disposals and write-off's |
(25) |
(3,472) |
(3,497) |
(13,039) |
(16,536) |
|
Balance at 31 December 2020 |
11,943 |
64,269 |
76,212 |
85,521 |
161,733 |
|
Accumulated depreciation |
|||||
|
As at 1 January 2020 |
325 |
13,690 |
14,015 |
22,004 |
36,019 |
|
Exchange rate effect |
- |
15 |
15 |
(21) |
(6) |
|
Depreciation charge for the year |
291 |
14,786 |
15,077 |
22,117 |
37,194 |
|
Disposals and write-off's |
(25) |
(2,260) |
(2,285) |
(9,507) |
(11,792) |
|
Balance at 31 December 2020 |
591 |
26,231 |
26,822 |
34,593 |
61,415 |
|
As at 31 December 2020 |
11,352 |
38,038 |
49,390 |
50,928 |
100,318 |
|
Cost |
|||||
|
As at 1 January 2021 |
11,943 |
64,269 |
76,212 |
85,521 |
161,733 |
|
Exchange rate effect |
- |
(30) |
(30) |
(101) |
(131) |
|
Increase/(Decrease) |
(317) |
7,951 |
7,634 |
29,461 |
37,095 |
|
Disposals and write-off's |
(20) |
(5,901) |
(5,921) |
(16,973) |
(22,894) |
|
Balance at 31 December 2021 |
11,606 |
66,289 |
77,895 |
97,908 |
175,803 |
|
Accumulated depreciation |
|||||
|
As at 1 January 2021 |
591 |
26,231 |
26,822 |
34,593 |
61,415 |
|
Exchange rate effect |
1 |
(123) |
(122) |
(56) |
(178) |
|
Depreciation charge for the year |
273 |
14,861 |
15,134 |
23,587 |
38,721 |
|
Disposals and write-off's |
(19) |
(2,990) |
(3,009) |
(14,380) |
(17,389) |
|
Balance at 31 December 2021 |
846 |
37,979 |
38,825 |
43,744 |
82,569 |
|
As at 31 December 2021 |
10,760 |
28,310 |
39,070 |
54,164 |
93,234 |
Movements in lease liabilities for right-of-use assets:
|
2021 |
2020 |
|||||
|
(in thousands of HRK) |
||||||
|
As at 1 January |
101,964 |
101,828 |
||||
|
Interest expense |
2,537 |
2,595 |
||||
|
Increase of lease liabilities during the year (net) |
31,590 |
37,152 |
||||
|
Lease liabilities payments |
(41,374) |
(39,246) |
||||
|
Exchange rate difference |
455 |
(365) |
||||
|
As at 31 December |
95,172 |
101,964 |
||||
|
Current portion of long term liability for right-of-use assets |
32,403 |
33,322 |
||||
|
Long term liability for right-of-use assets |
62,769 |
68,642 |
||||
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
|
|
|
|
|
|
NOTE 20 – LEASES (CONTINUED)
Amounts recognised in the statement of comprehensive income:
|
2021 |
2020 |
||||
|
(in thousands of HRK) |
|||||
|
Depreciation charge for the year |
38,721 |
37,194 |
|||
|
Expenses related to short-term leases and leases of low-value assets etc. |
25,119 |
26,392 |
|||
|
Interest expense |
2,537 |
2,595 |
|||
|
Total amount recognised in the statement of comprehensive income |
66,377 |
66,181 |
|||
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 21 – INVESTMENT PROPERTY
|
(in thousands of HRK) |
Total |
||||
|
Cost |
|||||
|
As at 1 January 2020 |
147,737 |
||||
|
Exchange rate effect |
129 |
||||
|
Transfer from property, plant and equipment |
533 |
||||
|
Balance at 31 December 2020 |
148,399 |
||||
|
Accumulated depreciation |
|||||
|
As at 1 January 2020 |
(29,497) |
||||
|
Exchange rate effect |
(24) |
||||
|
Depreciation charge for the year |
(1,792) |
||||
|
Balance at 31 December 2020 |
(31,313) |
||||
|
Net book value at 31 December 2020 |
117,086 |
||||
|
Cost |
|||||
|
As at 1 January 2021 |
148,399 |
||||
|
Exchange rate effect |
17 |
||||
|
Balance at 31 December 2021 |
148,416 |
||||
|
Accumulated depreciation |
|||||
|
As at 1 January 2021 |
(31,313) |
||||
|
Exchange rate effect |
14 |
||||
|
Depreciation charge for the year |
(1,711) |
||||
|
Balance at 31 December 2021 |
(33,010) |
||||
|
Net book value at 31 December 2021 |
115,406 |
||||
In 2021, the Group did not reclassify any portion of property, plant and equipment to investment property (2020: HRK 533 thousand).
Operating expenses amount to HRK 1,863 thousand (2020: HRK 2,059 thousand), while rental income from the property amounts to HRK 2,904 thousand (2020: HRK 2,967 thousand).
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 22 – SUBSIDIARIES
Group consists of the Company and the following subsidiaries in which the Company has an ownership and control:
|
Name of subsidiary |
Country |
2021 |
2020 |
Principal activity |
|
Belupo d.d., Koprivnica |
Croatia |
100.00% |
100.00% |
Production and distribution of pharmaceuticals |
|
Belupo dooel, Skopje* |
North Macedonia |
100.00% |
100.00% |
Sale and distribution of pharmaceuticals |
|
Belupo s.r.o. Bratislava* |
Slovakia |
100.00% |
100.00% |
Sale and distribution of pharmaceuticals |
|
Belupo d.o.o. Ljubljana* |
Slovenia |
100.00% |
100.00% |
Sale and distribution of pharmaceuticals |
|
Ljekarne Deltis Pharm, Koprivnica* |
Croatia |
100.00% |
100.00% |
Sale and distribution of pharmaceuticals |
|
Farmavita d.o.o. Sarajevo, Vogošća* |
Bosnia and Herzegovina |
65.00% |
65.00% |
Sale and distribution of pharmaceuticals |
|
Mirna d.d., Rovinj |
Croatia |
99.44% |
99.23% |
Fish processing and production |
|
Podravka-Lagris a.s., Dolni Lhota u Luhačovic |
Czech Rep. |
100.00% |
100.00% |
Rice production and sale |
|
Podravka-Polska Sp.z o.o., Warszawa |
Poland |
100.00% |
100.00% |
Seasonings sale and distribution |
|
Podravka-International Kft, Budapest |
Hungary |
100.00% |
100.00% |
Sale and distribution of food and beverages |
|
Podravka d.o.o., Belgrade |
Serbia |
100.00% |
100.00% |
Sale and distribution of food and beverages |
|
Podravka-Int. Deutschland –“Konar” GmbH |
Germany |
100.00% |
100.00% |
Sale and distribution of food and beverages |
|
Podravka-International s.r.o., Zvolen** |
Slovakia |
100.00% |
100.00% |
Sale and distribution of food and beverages |
|
Podravka d.o.o., Podgorica |
Montenegro |
100.00% |
100.00% |
Sale and distribution of food and beverages |
|
Podravka-International Pty Ltd, Silverwater |
Australia |
100.00% |
100.00% |
Sale and distribution of food and beverages |
|
Podravka EOOD, Sofia ***** |
Bulgaria |
100.00% |
100.00% |
Sale and distribution of food and beverages |
|
Podravka-International s.r.l., Bucharest |
Romania |
100.00% |
100.00% |
Sale and distribution of food and beverages |
|
Podravka DOOEL, Petrovec |
North Macedonia |
100.00% |
100.00% |
Sale and distribution of food and beverages |
|
Podravka d.o.o., Sarajevo |
Bosnia and Herzegovina |
100.00% |
100.00% |
Sale and distribution of food and beverages |
|
Podravka USA Inc., New York****** |
USA |
100.00% |
100.00% |
Sale and distribution of food and beverages |
|
Podravka d.o.o., Moskva |
Russia |
100.00% |
100.00% |
Sale and distribution of food and beverages |
|
Foodpro Limited, Dar es Salaam*** |
Tanzania |
100.00% |
100.00% |
Production and distribution of food |
|
Podravka Gulf Fze, Jebel Ali, Dubai |
UAE |
100.00% |
100.00% |
Sale and distribution |
|
Žito d.o.o., Ljubljana |
Slovenia |
100.00% |
100.00% |
Production and distribution of food |
|
Intes Storitve d.o.o., Maribor***** |
Slovenia |
100.00% |
100.00% |
Production and distribution of food |
|
Šumi bonboni d.o.o., Ljubljana***** |
Slovenia |
100.00% |
100.00% |
Production and distribution of food |
|
Žito maloprodaja d.o.o., Ljubljana***** |
Slovenia |
100.00% |
100.00% |
Sale of food and beverages |
|
Podravka d.o.o., Ljubljana***** |
Slovenia |
100.00% |
100.00% |
Sale and distribution of food and beverages |
* The Group holds these ownership interests indirectly through its subsidiary Belupo d.d.
**25% of ownership interest is held indirectly through the subsidiary Podravka-Lagris a.s., Dolni Lhota u Luhačovic
***15% of ownership interest is held indirectly through the subsidiary Podravka-Int. Deutschland – “Konar“ GmbH
*** During 2020, the name of the subsidiary Vegeta Podravka Limited, Tanzania was changed to Foodpro Limited, Dar es Salaam
****In 2020, the company Podravka International USA Inc., Wilmington was closed and the new company Podravka USA Inc., New York was established
***** The Group holds these ownership interests indirectly through its subsidiary Žito d.o.o.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 23 – NON-CURRENT FINANCIAL ASSETS
|
|
2021 |
2020 |
|||
|
(in thousands of HRK) |
|||||
|
Financial instruments |
54,133 |
54,133 |
|||
|
Impairment of financial instruments |
(17,736) |
(17,736) |
|||
|
Equity instruments |
5,388 |
5,379 |
|||
|
Other receivables and deposits |
1,420 |
1,510 |
|||
|
Loans receivable |
4 |
5 |
|||
|
43,209 |
43,291 |
||||
Equity instruments mainly relate to investments in unquoted equity instruments.
NOTE 24 – INVENTORIES
|
2021 |
2020 |
||||
|
(in thousands of HRK) |
|||||
|
Raw materials and supplies |
348,265 |
350,229 |
|||
|
Work in progress |
34,109 |
39,538 |
|||
|
Finished goods |
412,142 |
436,252 |
|||
|
Merchandise |
139,194 |
154,418 |
|||
|
933,710 |
980,437 |
||||
In 2021, the Group recognised impairment loss with respect to inventories in the amount of HRK 1,404 thousand (2020: HRK 9,533 thousand of impairment loss). The movement in inventory impairment provision is included in the statement of comprehensive income in line item ‘Cost of goods sold’.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 25 – TRADE AND OTHER RECEIVABLES
Movements in the impairment allowance for trade receivables are as follows:
|
2021 |
2020 |
||||
|
(in thousands of HRK) |
|||||
|
At 1 January |
190,566 |
198,036 |
|||
|
Increase |
3,554 |
2,815 |
|||
|
Amounts collected |
(2,612) |
(3,004) |
|||
|
Written off as uncollectable |
(12,783) |
(7,281) |
|||
|
At 31 December |
178,725 |
190,566 |
|||
Impairment losses on trade receivables and subsequent collections are included in 'Selling and distribution expenses'.
Ageing analysis of trade receivables which have not been impaired:
|
2021 |
2020 |
||||
|
(in thousands of HRK) |
|||||
|
Non due |
806,095 |
719,819 |
|||
|
0-90 days |
146,634 |
181,420 |
|||
|
91-180 days |
12,195 |
15,484 |
|||
|
181-360 days |
3,692 |
6,068 |
|||
|
968,616 |
922,791 |
||||
Major customers
Trade receivables from major customers owned or controlled by the same third party from regular business as at 31 December 2021 amount to HRK 145,310 thousand (2020: HRK 122,805 thousand).
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 26 – FINANCIAL ASSETS AT FAIR VALUE THROUGH PROFIT OR LOSS
|
2021 |
2020 |
||||
|
(in thousands of HRK) |
|||||
|
Forward contracts |
- |
106 |
|||
|
- |
106 |
||||
During 2021, the Group used forward contracts entered into with commercial banks with the primary intention of managing the fluctuations of foreign currencies with respect to the purchase and sale of foreign currencies. As at 31 December 2021, the forward contracts did not have positive fair value (2020: HRK 106 thousand).
The nominal value of currency forwards, according to the exchange rate contracted in the forward contracts, as at 31 December 2021 amounted to HRK 2,738 thousand with the contracts maturing in the period from 20 January 2022 and 21 March 2022 (2020: HRK 8,826 thousand with maturities between 11 January 2021 and 8 June 2021).
Gains and losses recognized as changes in the market value of the currency forward contracts are recorded in the statement of comprehensive income within ‘financial income/financial expenses, net’.
Fair value measurement
The fair value of forward exchange contracts is based on the quotation of the exchange rate. In accordance with the used input variables, evaluation is categorized in the fair value hierarchy as level 2 (see note 7).
NOTE 27 – CASH AND CASH EQUIVALENTS
|
2021 |
2020 |
||||
|
(in thousands of HRK) |
|||||
|
Cash with banks |
32,951 |
51,378 |
|||
|
Cash in hand |
355 |
478 |
|||
|
33,306 |
51,856 |
||||
Cash with banks relates to transaction accounts at commercial banks that carry an average interest rate ranging from 0.00% to 0.15%.
The Group has certain transactions in foreign currencies and cash on bank accounts mainly in BAM (HRK 7,138 thousand), EUR (HRK 6,368 thousand), USD (HRK 5,672 thousand), HRK (HRK 2,594 thousand), HUF (HRK 2,394 thousand) and PLN (HRK 2,112 thousand), while in other currencies it holds HRK 7,028 thousand.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 28 – NON-CURRENT ASSETS HELD FOR SALE
|
2021 |
2020 |
||||
|
(in thousands of HRK) |
|||||
|
Land and buildings |
20,741 |
26,133 |
|||
|
Equipment |
2,942 |
2,740 |
|||
|
23,683 |
28,873 |
||||
In 2021, the Group sold a portion of non-current assets held for sale with the carrying value of HRK 6,261 thousand and realised gain on sale in the amount of HRK 5,272 thousand.
Of the total amount of land and buildings held for sale, HRK 11,531 thousand relates to land and buildings in Poland, HRK 1,239 thousand to land and buildings in Tanzania, HRK 2,206 thousand to land and buildings in Croatia, HRK 843 thousand to land and buildings on the market of Bosnia and Herzegovina, and HRK 4,922 thousand on the market of Slovenia.
Fair value measurement
Land and property held for sale in the amount of HRK 23,683 thousand are measured at fair value less costs of sell due to the fact that this value is lower than the net carrying value prior to classification as held for sale. The Group has made an estimation of fair value on classification date and regularly checks if estimation needs to be revised.
Fair value measurement according to inputs used in evaluation is classified as level 3 (see note 7). The following table summarizes the valuation methods and techniques as well as significant inputs used in measuring the fair value at the classification date:
|
Valuation methods and techniques |
Significant unobservable inputs |
|
Property For buildings and land, cost and comparative methods are used. Equipment For equipment, the cost method is used. |
Among other factors, the estimated discount rate considers the underlying quality of the property and its location on similar locations for a comparative type of property. |
Equipment held for sale
The amount of HRK 2,942 thousand as at 31 December 2021 relates to equipment in the production plant in Tanzania (2020: HRK 2,740 thousand).
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 29– SHARE CAPITAL
|
Number of shares |
Ordinary shares |
Share premium |
Treasury shares |
Total |
||
|
(in pcs) |
(in thousands of HRK) |
|||||
|
|
||||||
|
At 1 January 2020 |
6,992,087 |
1,566,401 |
179,803 |
(47,568) |
1,698,636 |
|
|
Exercise of options (i) |
- |
- |
(3,708) |
- |
(3,708) |
|
|
Fair value of share based payments (i) |
- |
- |
11,120 |
- |
11,120 |
|
|
At 31 December 2020 |
6,992,087 |
1,566,401 |
187,215 |
(47,568) |
1,706,048 |
|
|
|
||||||
|
At 1 January 2021 |
6,992,087 |
1,566,401 |
187,215 |
(47,568) |
1,706,048 |
|
|
Exercise of options (i) |
22,000 |
- |
(1,986) |
8,181 |
6,195 |
|
|
Fair value of share based payments (i) |
- |
- |
6,260 |
- |
6,260 |
|
|
At 31 December 2021 |
7,014,087 |
1,566,401 |
191,489 |
(39,387) |
1,718,503 |
|
As at 31 December 2021, the Company’s share capital amounted to HRK 1,566,401 thousand, distributed among 7,120,003 shares out of which 105,916 relates to treasury shares (2020: HRK 1,566,401 thousand, distributed among 7,120,003 shares out of which 127,916 relates to treasury shares). Nominal value of one share amounts to HRK 220.00. All issued shares are fully paid in.
(i) Share based payments
During 2021, the Company did not purchase any treasury shares (2020: 0 treasury shares).
The shareholder structure as at the reporting date was as follows:
|
2021 |
2020 |
|||
|
Structure of ownership |
Number of shares |
% of ownership |
Number of shares |
% of ownership |
|
PBZ CO OMF - Category B |
1,097,644 |
15.42 |
1,097,644 |
15.42 |
|
AZ OMF category B |
917,563 |
12.89 |
917,563 |
12.89 |
|
CERP - Croatian Pension Insurance Institute |
727,703 |
10.22 |
727,703 |
10.22 |
|
Erste Plavi OMF category B |
638,248 |
8.96 |
724,373 |
10.17 |
|
Raiffeisen OMF category B |
625,298 |
8.78 |
625,298 |
8.78 |
|
CERP - Republic of Croatia |
452,792 |
6.36 |
415,564 |
5.84 |
|
Kapitalni fond d.d. |
406,842 |
5.71 |
406,842 |
5.71 |
|
MESNA INDUSTRIJA BRAĆA PIVAC D.O.O. |
226,578 |
3.18 |
30,288 |
0.43 |
|
HPB - Republic of Croatia |
167,281 |
2.35 |
167,281 |
2.35 |
|
Treasury account |
105,916 |
1.49 |
127,916 |
1.80 |
|
Other shareholders |
1,754,138 |
24.64 |
1,879,531 |
26.39 |
|
Total |
7,120,003 |
100.00 |
7,120,003 |
100.00 |
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 30 – RESERVES
|
(in thousands of HRK) |
Reserves for treasury shares |
Legal reserves |
Reserves for reinvested profit |
Statutory reserves |
Other reserves |
Total |
|
At 1 January 2020 |
147,604 |
66,358 |
189,738 |
64,046 |
385,834 |
853,580 |
|
Allocation of profits (note 31) |
- |
10,238 |
- |
3,505 |
78,312 |
92,055 |
|
Foreign exchange rate differences |
- |
- |
- |
- |
8,141 |
8,141 |
|
Actuarial losses (net of tax) |
- |
- |
- |
- |
(2,602) |
(2,602) |
|
At 31 December 2020 |
147,604 |
76,596 |
189,738 |
67,551 |
469,685 |
951,174 |
|
At 1 January 2021 |
147,604 |
76,596 |
189,738 |
67,551 |
469,685 |
951,174 |
|
Allocation of profits (note 31) |
- |
9,712 |
- |
2,621 |
127,215 |
139,548 |
|
Foreign exchange rate differences |
- |
- |
- |
- |
502 |
502 |
|
The effect of acquiring additional minority interest |
- |
- |
- |
- |
33 |
33 |
|
Actuarial losses (net of tax) |
- |
- |
- |
- |
(969) |
(969) |
|
At 31 December 2021 |
147,604 |
86,308 |
189,738 |
70,172 |
596,466 |
1,090,288 |
The legal reserve is required under Croatian law according under which the Company is committed to build up legal reserves to a minimum of 5% of the profit for the year until the total reserve reaches 5% of the share capital. Both legal reserves and reserves for treasury shares, as well as reserves for reinvested profits, are non-distributable. Other reserves mainly relate to (non-distributable) reserves required by the Company’s Articles of Association and foreign exchange translation reserves related to subsidiaries abroad.
(i) Transfers within capital and reserves
In 2021, the General Assembly reached a decision to allocate the Company’s profit from 2020 in the amount of HRK 193,832 thousand as follows: the amount of HRK 9,692 thousand to legal reserves, the amount of HRK 120,060 thousand to other reserves and the amount of HRK 63,127 thousand for the declared dividend (HRK 9.00 per share), while the remaining amount of HRK 953 thousand is retained in unallocated profit.
In addition, in 2021, in accordance with the decisions of their General Assemblies, subsidiaries allocated the profit as follows: the amount of HRK 2,621 thousand to statutory reserves, the amount of HRK 20 thousand to legal reserves and HRK 7,155 thousand to other reserves.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 31 – RETAINED EARNINGS
Movement in retained earnings is presented as follows:
|
2021 |
2020 |
|||
|
(in thousands of HRK) |
||||
|
At 1 January |
714,828 |
620,878 |
||
|
- transfer to legal and other reserves |
(139,548) |
(92,055) |
||
|
- dividend declared |
(63,127) |
(62,929) |
||
|
- exercise of options |
812 |
- |
||
|
- profit for the year |
309,221 |
248,934 |
||
|
At 31 December |
822,186 |
714,828 |
||
At 29 June 2021, the General Assembly reached a decision on dividend distribution in amount of HRK 63,127 thousand, HRK 9.00 per share (2020: HRK 62,929 thousand, HRK 9.00 per share).
NOTE 32 – NON-CONTROLLING INTERESTS
Podravka Group has non-controlling interests arising from acquisitions of 65% of ownership interest in subsidiary Farmavita d.o.o. Sarajevo and 99.44% in the related company Mirna d.d. (2020: 99.23%). Summary financial information for the company Farmavita d.o.o., Sarajevo as at 31 December 2021 (excluding consolidation eliminations) and for the company Mirna d.d. are as follows:
|
31 December 2021 |
Mirna d.d. |
Farmavita |
|||
|
(in thousands of HRK) |
|||||
|
Non-controlling interest |
0.6% |
35.0% |
|||
|
Statement of financial position |
|||||
|
Non-current assets |
71,775 |
74,995 |
|||
|
Current assets |
47,792 |
148,118 |
|||
|
Current liabilities |
(127,096) |
(51,125) |
|||
|
Non-current liabilities |
(20,429) |
(9,995) |
|||
|
Net assets |
(27,958) |
161,993 |
|||
|
Statement of comprehensive income for the period |
|||||
|
Sales revenue |
74,961 |
254,598 |
|||
|
(Loss)/Profit after tax |
(18,296) |
25,934 |
|||
|
Other comprehensive income |
10 |
(138) |
|||
|
Total comprehensive income for the period |
(18,286) |
25,796 |
|||
|
Statement of cash flows |
|||||
|
Net increase in cash and cash equivalents |
11 |
(7,693) |
|||
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 32 – NON-CONTROLLING INTERESTS (CONTINUED)
The movement in non-controlling interest was as follows:
|
2021 |
2020 |
||
|
(in thousands of HRK) |
|||
|
Balance at 1 January |
54,932 |
46,334 |
|
|
Subsidiary liquidation |
- |
911 |
|
|
Effect of acquiring non-controlling interests |
(107) |
- |
|
|
Foreign exchange differences |
(137) |
487 |
|
|
Share in current year profit |
8,601 |
7,200 |
|
|
Balance at 31 December |
63,289 |
54,932 |
|
|
Relating to: |
|||
|
Mirna d.d. |
183 |
392 |
|
|
Farmavita d.o.o. |
63,106 |
54,540 |
|
NOTE 33 - FINANCIAL LIABILITIES AT FAIR VALUE THROUGH PROFIT OR LOSS
|
2021 |
2020 |
||||
|
(in thousands of HRK) |
|||||
|
Forwards |
|
|
35 |
66 |
|
|
|
|
35 |
66 |
||
The negative fair value of forward exchange contracts as at 31 December 2021 amounted to HRK 35 thousand (2020: HRK 66 thousand).
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 34 – BORROWINGS
|
2021 |
2020 |
||||
|
|
(in thousands of HRK) |
||||
|
Non-current borrowings |
|||||
|
Banks in Croatia |
129,631 |
201,441 |
|||
|
Banks abroad |
9,588 |
99,602 |
|||
|
Finance lease |
521 |
151 |
|||
|
139,740 |
301,194 |
||||
|
Current borrowings |
|||||
|
Banks in Croatia |
205,700 |
235,891 |
|||
|
Banks abroad |
52,886 |
145,862 |
|||
|
Finance lease |
298 |
224 |
|||
|
258,884 |
381,977 |
||||
|
Total borrowings |
398,624 |
683,171 |
|||
In 2016, Podravka d.d., Belupo d.d. and Žito d.o.o. agreed a syndicated loan with EBRD and business banks in the total amount of EUR 123 million. For refinancing the existing borrowings, the companies used a total of EUR 98,850 thousand. During 2021, Podravka d.d., Belupo d.d. and Žito d.o.o. refinanced the remaining syndicated loan amount by commercial bank borrowings.
As part of the above mentioned loan, the Group is obligated to comply with the following debt covenants:
a) Interest coverage ratio (ICR). The parameter is calculated as the ratio of consolidated EBITDA and consolidated interest expense and bank fee for the year.
b) Debt coverage ratio (DCR). The parameter is calculated as the ratio of consolidated net debt and consolidated EBITDA.
c) Equity ratio (ER). The parameter is calculated as the ratio of consolidated share capital and reserves and consolidated total assets.
Bank borrowings in the amount of HRK 120,588 thousand (2020: HRK 379,272 thousand) are secured by mortgages over the Group’s land and buildings and movables with a net carrying value of HRK 327,985 thousand (Note 19).
The lease liabilities of the Group are as follows:
|
Minimum lease payments |
Finance cost |
Present value |
||||
|
2021 |
2020 |
2021 |
2020 |
2021 |
2020 |
|
|
(in thousands of HRK) |
||||||
|
Up to 1 year |
318 |
236 |
(20) |
(12) |
298 |
224 |
|
Between 1 and 5 years |
532 |
158 |
(11) |
(6) |
521 |
151 |
|
Total |
850 |
394 |
(31) |
(18) |
819 |
375 |
|
Included in the consolidated financial statements within: |
||||||
|
Current borrowings |
298 |
224 |
||||
|
Non-current borrowings |
521 |
151 |
||||
|
819 |
375 |
|||||
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 34 – BORROWINGS (CONTINUED)
The maturity of non-current borrowings is as follows:
|
2021 |
2020 |
||||
|
(in thousands of HRK) |
|||||
|
Between 1 and 2 years |
99,451 |
217,940 |
|||
|
Between 2 and 5 years |
40,289 |
83,254 |
|||
|
139,740 |
301,194 |
||||
Fixed and variable interest rates by major currencies are as follows:
|
2021 |
2020 |
|||||
|
HRK |
EUR |
Other |
HRK |
EUR |
Other |
|
|
Non-current borrowings |
||||||
|
Banks in Croatia |
||||||
|
variable interest rate |
0.57% |
- |
- |
0.57% |
- |
- |
|
fixed interest rate |
0.70% |
0.35% |
- |
0.75% |
- |
- |
|
Banks abroad |
||||||
|
variable interest rate |
- |
3.00% |
- |
- |
0.94% |
- |
|
fixed interest rate |
- |
0.35% |
5.00% |
- |
- |
4.79% |
|
Financial leases |
||||||
|
variable interest rate |
- |
4.80% |
- |
- |
- |
4.80% |
|
fixed interest rate |
- |
- |
3.89% |
- |
- |
- |
|
Current borrowings |
||||||
|
Banks |
||||||
|
variable interest rate |
- |
0.63% |
4.48% |
0.51% |
- |
0.99% |
|
fixed interest rate |
0.51% |
- |
- |
0.67% |
- |
- |
An overview of borrowings by fixed and variable interest rates is as follows:
|
2021 |
2020 |
|||||
|
fixed |
variable |
fixed |
variable |
|||
|
(in thousands of HRK) |
||||||
|
Non-current borrowings |
99,022 |
40,718 |
147,903 |
153,291 |
||
|
Current borrowings |
202,509 |
56,375 |
174,957 |
207,020 |
||
|
301,531 |
97,093 |
322,860 |
360,311 |
|||
The average weighted cost of debt on the Group’s interest-bearing liabilities as at 31 December 2021 was 0.93% (31 December 2020: 0.84%).
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 34 – BORROWINGS (CONTINUED)
The carrying amounts and fair values of the Group’s long-term borrowings are as follows:
|
Carrying value |
Fair value |
|||||
|
2021 |
2020 |
2021 |
2020 |
|||
|
(in thousands of HRK) |
||||||
|
Non-current borrowings |
||||||
|
Banks in Croatia |
129,631 |
201,441 |
129,045 |
200,133 |
||
|
Banks abroad |
9,588 |
99,602 |
9,582 |
99,867 |
||
|
Finance leases |
521 |
151 |
534 |
151 |
||
|
139,740 |
301,194 |
139,161 |
300,151 |
|||
The carrying amounts of the Group’s borrowings are denominated in the following currencies:
|
2021 |
2020 |
|||||
|
(in thousands of HRK) |
||||||
|
Croatian kuna |
186,490 |
437,332 |
||||
|
EUR |
173,349 |
217,699 |
||||
|
Other currencies |
38,785 |
28,140 |
||||
|
398,624 |
683,171 |
|||||
The Group has the following undrawn bank borrowing facilities:
|
2021 |
2020 |
|||||
|
(in thousands of HRK) |
||||||
|
Available for withdrawal |
420,785 |
408,715 |
||||
|
420,785 |
408,715 |
|||||
These comprise unused short-term revolving facilities, guarantees and letters of credit which the Group has available with several commercial banks.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 34 – BORROWINGS (CONTINUED)
Reconciliation of movements in liabilities with cash flows from financing activities:
|
(in thousands of HRK) |
Loans |
Lease liabilities |
Share capital |
Other reserves |
Retained earnings |
Non-controlling interests |
Total |
|
|
At 1 January 2021 |
683,171 |
101,964 |
1,706,048 |
469,685 |
714,828 |
54,932 |
3,730,628 |
|
|
Cash transactions: |
||||||||
|
Loans received |
226,847 |
- |
- |
- |
- |
- |
226,847 |
|
|
Loans repayments |
(512,326) |
- |
- |
- |
- |
- |
(512,326) |
|
|
Repayment of lease liabilities |
- |
(38,837) |
(38,837) |
|||||
|
Sale of treasury shares |
- |
- |
7,983 |
- |
- |
- |
7,983 |
|
|
Additional acquisition of non-controlling interest |
- |
- |
- |
33 |
- |
(107) |
(74) |
|
|
Dividend paid |
- |
- |
- |
- |
(62,782) |
- |
(62,782) |
|
|
Total cash transactions |
(285,479) |
(38,837) |
7,983 |
33 |
(62,782) |
(107) |
(379,189) |
|
|
Non-cash transactions: |
||||||||
|
Effect of change in exchange rates |
183 |
519 |
- |
502 |
- |
(137) |
1,067 |
|
|
Actuarial gains (net of deferred tax) |
- |
- |
- |
(969) |
- |
- |
(969) |
|
|
Transfer from retained earnings (note 31) |
- |
- |
- |
127,215 |
(139,548) |
- |
(12,333) |
|
|
Other non-cash transactions |
749 |
37,095 |
- |
- |
812 |
- |
38,656 |
|
|
Gain from right-of-use assets write-off |
- |
(5,569) |
- |
- |
- |
(5,569) |
||
|
Total other changes related to equity |
- |
- |
4,472 |
- |
308,876 |
8,601 |
321,949 |
|
|
At 31 December 2021 |
398,624 |
95,172 |
1,718,503 |
596,466 |
822,186 |
63,289 |
3,694,240 |
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 35 – PROVISIONS
|
(in thousands of HRK) |
Jubilee awards |
Unused holiday accruals |
Retirement benefits |
Termination benefits and bonuses |
Legal cases |
Total |
|
As at 31 December 2020 |
||||||
|
Non-current |
16,467 |
- |
35,556 |
- |
26,451 |
78,474 |
|
Current |
2,191 |
14,596 |
- |
15,243 |
141 |
32,171 |
|
At 1 January 2021 |
18,658 |
14,596 |
35,556 |
15,243 |
26,592 |
110,645 |
|
Increase of provisions |
2,392 |
11,294 |
4,014 |
23,435 |
11,031 |
52,166 |
|
Utilised during the year |
(2,958) |
(9,456) |
(2,680) |
(15,049) |
(1,977) |
(32,120) |
|
At 31 December 2021 |
18,092 |
16,434 |
36,890 |
23,629 |
35,646 |
130,691 |
|
|
|
|
||||
|
Non-current |
15,935 |
- |
36,890 |
- |
34,265 |
87,090 |
|
Current |
2,157 |
16,434 |
- |
23,629 |
1,381 |
43,601 |
|
18,092 |
16,434 |
36,890 |
23,629 |
35,646 |
130,691 |
(i) Legal cases
Legal provisions relate to a number of legal proceedings initiated against the Group which stem from regular commercial activities and court cases including former employees. The expenses relating to the provisions are included in the consolidated statement of comprehensive income within Other income or Administrative expenses. Based on the expert opinion of legal counsels, the Group’s Management believes that the outcome of these legal proceedings will not give rise to any significant losses beyond the amounts provided as at 31 December 2021.
(ii) Termination benefits and bonuses
As at 31 December 2021, the Group recognised HRK 21,414 thousand of provisions for bonuses to key management (2020: HRK 15,243 thousand) and HRK 2,021 thousand of provisions for short-term termination benefits relating to redundancy (2020: HRK 0 thousand).
(iii) Jubilee awards and regular retirement benefits
According to the Collective Labour Agreement signed by the Group companies, the Group has an obligation to pay jubilee awards, retirement and other benefits to its employees. No other post-retirement benefits are provided. The present values of these obligations, the related current service cost and past service cost were measured using the projected credit unit method.
The actuarial estimates have been derived on the basis of the following key assumptions:
|
2021 |
2020 |
|||
|
Discount rate |
0.40% - 3.00% |
0.50% - 3.17% |
||
|
Fluctuation rate |
4.40% - 12.80% |
4.60% - 12.50% |
||
|
Average expected remaining working lives (in years) |
22 |
21 |
||
The management believes that the Croatian corporate bond market is a deep market.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 35 – PROVISIONS (CONTINUED)
Changes in the present value of the defined benefit obligation during the period:
|
2021 |
2020 |
||||
|
(in thousands of HRK) |
Jubilee awards |
Retirement |
Jubilee awards |
Retirement |
|
|
|
|||||
|
At 1 January |
18,658 |
35,556 |
18,648 |
31,759 |
|
|
Past service cost |
83 |
99 |
195 |
405 |
|
|
Current service cost |
1,272 |
2,560 |
1,088 |
1,611 |
|
|
Interest expense |
102 |
112 |
70 |
51 |
|
|
Actuarial (gains) / losses |
935 |
1,243 |
1,522 |
3,324 |
|
|
Benefits paid |
(2,958) |
(2,680) |
(2,865) |
(1,594) |
|
|
At 31 December |
18,092 |
36,890 |
18,658 |
|
35,556 |
NOTE 36 – OTHER NON-CURRENT LIABILITIES
|
2021 |
2020 |
||
|
(in thousands of HRK) |
|||
|
Deferred income on government incentives |
18,445 |
18,755 |
|
|
Other non-current liabilities |
- |
374 |
|
|
18,445 |
19,129 |
||
Deferred income on government grants relates to non-monetary government grant to subsidiary in Slovenia and it is based on the amount of contributions for the employment of disabled persons.
In accordance with the relevant regulations, the aforementioned contributions are not paid into the government budget and it can be used for the acquisition of qualifying non-current tangible assets during three years’ period. The amount of unpaid contributions is then recognized as government grant and transferred to profit or loss on a systematic basis over the useful life of the related assets. If the grant is not used for the acquisition of non-current assets within the prescribed period, unpaid contributions become payable.
The amount of deferred income on government grants that is expected to be transferred to profit or loss in the period of up to one year on a basis of depreciation of qualifying assets, or the amount of unpaid contributions, which will not qualify as a government grant and will become payable within one year, is recognized as a current liability in trade and other payables.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 37 – TRADE AND OTHER PAYABLES
|
2021 |
2020 |
||||
|
(in thousands of HRK) |
|||||
|
Trade payables |
307,650 |
338,402 |
|||
|
Other payables |
223,666 |
216,508 |
|||
|
531,316 |
554,910 |
||||
At 31 December 2021 and 31 December 2020, the carrying amounts of trade and other payables approximate their fair values due to the short-term nature of those liabilities.
Other liabilities include the following:
|
2021 |
2020 |
|
|
(in thousands of HRK) |
||
|
Accrued expenses |
91,420 |
87,113 |
|
Salaries and other benefits to employees |
81,069 |
77,904 |
|
Deferred income |
29,404 |
29,825 |
|
Taxes, contributions and value added tax |
7,248 |
7,334 |
|
Advances received |
4,402 |
1,520 |
|
Dividends payable |
2,930 |
2,585 |
|
Packaging waste disposal fee payable |
700 |
784 |
|
Accrued interest |
543 |
836 |
|
Other payables |
5,950 |
8,607 |
|
223,666 |
216,508 |
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 38 – RISK MANAGEMENT
Categories of financial instruments are as follows:
|
2021 |
2020 |
||||
|
(in thousands of HRK) |
|||||
|
Financial assets at amortised cost |
|||||
|
Long-term loans (note 23) |
4 |
5 |
|||
|
Long-term deposits (note 23) |
1,420 |
1,510 |
|||
|
Short-term loans (note 25) |
7 |
8 |
|||
|
Trade receivables (including bills of exchange) (note 25) |
968,616 |
922,791 |
|||
|
Cash and cash equivalents (note 27) |
33,306 |
51,856 |
|||
|
1,003,353 |
976,170 |
||||
|
Financial assets through other comprehensive income |
|||||
|
Equity instruments |
5,388 |
5,379 |
|||
|
Financial assets at fair value through profit or loss |
|||||
|
Financial instruments |
36,397 |
36,397 |
|||
|
Forward contracts (note 26) |
- |
106 |
|||
|
36,397 |
36,503 |
||||
|
Total financial assets |
1,045,138 |
1,018,052 |
|||
|
Financial liabilities at amortised cost |
|||||
|
Finance lease liabilities (note 34) |
819 |
375 |
|||
|
Borrowings (note 34) |
397,805 |
682,796 |
|||
|
Lease liabilities (note 20) |
95,172 |
101,964 |
|||
|
Trade and interest payables (note 37) |
308,193 |
339,238 |
|||
|
801,989 |
1,124,373 |
||||
|
Financial liabilities at fair value through profit or loss |
|||||
|
Forward contract (note 33) |
35 |
66 |
|||
|
35 |
66 |
||||
|
Total financial liabilities |
802,024 |
1,124,439 |
|||
Fair value of financial instruments
The fair values of financial assets and financial liabilities are determined as follows:
· the fair value of financial assets and financial liabilities with standard terms and conditions and traded on active liquid markets is determined with reference to quoted market prices;
· the fair value of other financial assets and other financial liabilities is determined in accordance with generally accepted pricing models based on discounted cash flow analysis using prices from observable current market transactions and dealer quotes for similar instruments.
Financial instruments held to maturity in the normal course of operations are carried at the lower of cost and the net amount less the portion repaid. Fair value is determined as the amount at which a financial instrument can be exchanged between willing and knowledgeable parties in an arm’s-length transaction, except in the event of forced sale or liquidation.
At the reporting date, the carrying amounts of cash and cash equivalents, short-term deposits and short-term borrowings approximate their market value due to the short-term nature of those assets and liabilities and due to the fact that a majority of these assets and liabilities are at variable interest rates approximating market interest rates.
Financial assets arising from currency forward contracts are measured at fair value as explained in note 26.
The Podravka Group considers that the carrying amount of investments in unquoted and quoted equity instruments with no active market approximates their fair value due to the fact that the respective instruments were acquired at a price willingly agreed by knowledgeable and unrelated parties.
The carrying amounts of finance lease liabilities and borrowings and lease liabilities approximate their fair values as these liabilities bear variable interest rates or fixed interest rate approximating market interest rates.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 38 – RISK MANAGEMENT (CONTINUED)
Financial risk management
In its operations, the Podravka Group is exposed to various financial risks, especially the currency, interest rate and price risks, and in addition to these financial risks, significant risks include credit risk and liquidity risk. Managing the currency, interest rate and credit risks is performed by the Treasury sector and the finance departments of individual companies, together with active management of excess liquidity investment and active management of financial assets and liabilities.
An integral part of the overall Enterprise Risk Management (ERM) project is the reporting procedure for the purpose of managing financial risks. The purpose of this procedure is to ensure that the Management is informed about critical events that may jeopardize profitability or cause a significant loss of cash, while these critical events are still in the early stages. This allows for timely decision-making on specific business activities for the purpose of managing critical events.
Capital risk management
The gearing ratio at the reporting date was as follows:
|
2021 |
2020 |
||||
|
(in thousands of HRK) |
|||||
|
Debt (non-current and current borrowings including forwards) |
398,659 |
683,237 |
|||
|
Cash and cash equivalents |
(33,306) |
(51,856) |
|||
|
Net debt |
365,353 |
631,381 |
|||
|
Equity |
3,694,266 |
3,426,982 |
|||
|
Net debt to equity ratio |
10% |
18% |
|||
Debt is defined as long- and short-term borrowings. Equity includes all capital and reserves. Besides monitoring the ratio of net debt to equity, the Company’s Treasury together with financial departments in subsidiaries, also monitors the net debt ratio and operating profit before depreciation and amortization (EBITDA).
Credit risk management
Credit risk refers to the risk that counterparty will default on its contractual obligations resulting in a possible financial loss to the Podravka Group. The Company adopted an “Collection of due receivables process” and applies it in operations with customers, based on which it takes security instruments, wherever possible, for the purpose of hedging possible financial risks and loss as a consequence of default. In addition, during 2021, the Podravka Group insured collection of receivables for a group of foreign markets. The Company insured receivables in the markets of the Republic of Croatia, Turkey, Qatar, Belarus, Ukraine, United Arab Emirates, Saudi Arabia, Oman, Kuwait, Egypt, Japan and Kenya. For a certain group of markets, Podravka’s related companies also insure receivables from external customers. In 2021, Belupo d.d., Podravka Moscow, Podravka Lagris, Podravka Poland and the Žito Group insured their receivables with insurers.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 38 – RISK MANAGEMENT (CONTINUED)
Financial risk management (continued)
Credit risk management (continued)
The Podravka Group enters into business only with counterparties with good credit ratings, securing, when needed, receivables for the purpose of decreasing the risk of financial loss as a consequence of default. The Podravka Group exposure based on receivables, and the credit ratings of its counterparties are continuously monitored.
The Group’s exposure to major customers
The control of the Group’s exposure to major customers is carried out through regular monitoring of receivables and certain measures to control the collection and delivery of goods, as well as the acquisition of adequate collection security instruments.
The Group accepts new customers and continues cooperation with existing customers with payment delays subject to meeting the Group’s credit risk parameters. Receivables are analysed on a weekly basis and necessary measures are taken with respect to their collection.
Risk mitigation instruments are defined based on the financial performance ratios for individual customers, using internet services where the required information is available (financial statements, credit ratings). The company’s exposure and credit rating are continuously monitored through credit limits set by the company and insurer, which are continuously controlled and adjusted if appropriate.
During 2021, the Podravka Group did not have significant damage claims related to the insurance of receivable collection.
Liquidity risk management
The Podravka Group manages liquidity risk by maintaining optimum amounts of cash on accounts, in addition to adequate sources of financing from credit lines available, for the purpose of the efficient management of short- and long-term funding and liquidity requirements.
The process of continuous monitoring of cash flows at the Podravka Group level, matching the maturity profiles of trade receivables and payables to customers and suppliers, banks and other financial institutions, enables timely ensuring optimum liquidity level required for Podravka Group’s operating purposes.
Planning cash flows is performed at the level of each company in the Podravka Group, where the companies follow the guidelines set by Podravka Treasury, aimed at settling all liabilities and adjusting other contractual relationships.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 38 – RISK MANAGEMENT (CONTINUED)
Financial risk management (continued)
Liquidity risk management (continued)
Liquidity risk analysis
Tables below show contracted maturity of financial liabilities and financial assets of the Podravka Group stated in the consolidated statement of financial position at the end of each reporting period.
The tables have been drawn up based on the undiscounted cash flows based on contracted terms at reporting date and include cash flows from both interest and principal.
The liquidity risk analysis below shows no potential deficit of short-term liquidity for the Group.
|
as at 31 December 2021 |
Net book value |
Contracted cashflow |
Up to one year |
1 - 5 years |
over 5 years |
|
(in thousands of HRK) |
|||||
|
Non-interest bearing liabilities: |
|||||
|
Forward contracts |
35 |
35 |
35 |
- |
- |
|
Trade and interest payables |
308,193 |
308,193 |
307,553 |
640 |
- |
|
308,228 |
308,228 |
307,588 |
640 |
- |
|
|
Interest bearing liabilities |
|||||
|
Finance lease liabilities |
819 |
877 |
327 |
550 |
- |
|
Borrowings |
397,805 |
399,960 |
246,487 |
153,473 |
- |
|
Lease liabilities |
95,172 |
106,882 |
35,466 |
54,540 |
16,876 |
|
493,796 |
507,719 |
282,280 |
208,563 |
16,876 |
|
|
802,024 |
815,947 |
589,868 |
209,203 |
16,876 |
|
|
Non-interest bearing assets: |
|||||
|
Trade receivables |
968,616 |
968,616 |
967,486 |
1,130 |
- |
|
Financial instruments |
41,785 |
41,785 |
- |
41,785 |
- |
|
Cash and cash equivalents |
33,306 |
33,306 |
33,306 |
- |
- |
|
1,043,707 |
1,043,707 |
1,000,792 |
42,915 |
- |
|
|
Interest bearing assets: |
|||||
|
Long-term loans |
11 |
11 |
7 |
4 |
- |
|
Long-term deposits |
1,420 |
1,424 |
928 |
496 |
- |
|
1,431 |
1,435 |
935 |
500 |
- |
|
|
1,045,138 |
1,045,142 |
1,001,727 |
43,415 |
- |
|
|
Net liquidity position |
243,114 |
229,195 |
411,859 |
(165,788) |
(16,876) |
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 38 – RISK MANAGEMENT (CONTINUED)
Financial risk management (continued)
Liquidity risk management (continued)
Liquidity risk analysis (continued)
|
as at 31 December 2020 |
Net book value |
Contracted cashflow |
Up to one year |
1 - 5 |
over 5 years |
|
(in thousands of HRK) |
|||||
|
Non-interest bearing liabilities: |
|||||
|
Forward contracts |
66 |
66 |
66 |
- |
- |
|
Trade and interest payables |
339,238 |
339,238 |
337,571 |
1,667 |
- |
|
339,304 |
339,304 |
337,637 |
1,667 |
- |
|
|
Interest bearing liabilities |
|||||
|
Finance lease liabilities |
375 |
393 |
248 |
145 |
- |
|
Borrowings |
682,796 |
690,023 |
386,456 |
303,567 |
- |
|
Lease liabilities |
101,964 |
112,242 |
35,148 |
57,743 |
19,351 |
|
785,135 |
802,658 |
421,852 |
361,455 |
19,351 |
|
|
1,124,439 |
1,141,962 |
759,489 |
363,122 |
19,351 |
|
|
Non-interest bearing assets: |
|||||
|
Trade receivables (including bills of exchange) |
922,791 |
922,791 |
922,791 |
- |
- |
|
Financial instruments |
41,776 |
41,776 |
- |
41,776 |
- |
|
Forward contracts |
106 |
106 |
106 |
- |
- |
|
Cash and cash equivalents |
51,856 |
51,856 |
51,856 |
- |
- |
|
1,016,529 |
1,016,529 |
974,753 |
41,776 |
- |
|
|
Interest bearing assets: |
|||||
|
Long-term loans |
13 |
13 |
13 |
- |
- |
|
Long-term deposits |
1,510 |
1,510 |
882 |
628 |
- |
|
1,523 |
1,523 |
895 |
628 |
- |
|
|
1,018,052 |
1,018,052 |
975,648 |
42,404 |
- |
|
|
Net liquidity position |
(106,387) |
(123,910) |
216,159 |
(320,718) |
(19,351) |
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 38 – RISK MANAGEMENT (CONTINUED)
Financial risk management (continued)
Market risks
(i) Interest rate risk management
The Podravka Group continuously monitors interest rate changes and projections so that it can respond in a timely manner if necessary. Given that the Podravka Group has contracted most of its borrowings at a fixed interest rate, the Podravka Group is not significantly exposed to interest rate risk.
Exposure to changes in interest rates on loans in accordance with the agreed dates of changes in interest rates is as follows:
|
(in thousands of HRK) |
2021 |
2020 |
|||
|
|
|
|
|||
|
EURIBOR based bank loans |
3,643 |
217,698 |
|||
|
EURIBOR based finance lease |
561 |
375 |
|||
|
TZMF bill of exchange based loans* |
60,013 |
125,318 |
|||
|
PRIBOR based bank loans** |
32,875 |
16,922 |
|||
|
|
97,092 |
360,313 |
* Treasury bills of the Ministry of Finance
** Prague Interbank Offer Rate
Interest rate sensitivity analysis
The sensitivity analysis below is determined based on the exposure to changes in contractual interest rates at the reporting date. For floating rate liabilities, the analysis is prepared by calculating the effect of a reasonably possible increase in interest rates on floating rate debt on the expected contractual cash flows of such debt compared to those calculated using the interest rates applicable at the current reporting period end date.
The estimated effect of an increase in interest rates of 50 basis points on the Podravka Group’s result before tax for the reporting periods is as follows:
|
as at 31 December 2021 |
Contractual cash flows |
up to 1 year |
from 1 to 2 years |
from 2 to 5 years |
|
|
|
(in thousands of HRK) |
||||
|
At current interest rates |
99,172 |
58,207 |
20,787 |
20,178 |
|
|
At current interest rates + 50 basis points |
99,803 |
58,636 |
20,939 |
20,228 |
|
|
Effect of increase of interest rate by 50 bp |
(631) |
(429) |
(152) |
(50) |
|
|
as at 31 December 2020 |
Contractual cash flows |
up to 1 year |
from 1 to 2 years |
from 2 to 5 years |
|
|
(in thousands of HRK) |
|||||
|
|
|||||
|
At current interest rates |
363,424 |
209,178 |
114,009 |
40,237 |
|
|
At current interest rates + 50 basis points |
365,435 |
210,505 |
114,493 |
40,437 |
|
|
Effect of increase of interest rate by 50 bp |
(2,011) |
(1,327) |
(484) |
(200) |
|
At the reporting date the Group’s exposure to interest rate risk is not deemed to be significant.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 38 – RISK MANAGEMENT (CONTINUED)
Financial risk management (continued)
Market risks (continued)
(ii) Price risk
The success of business of Podravka Group is dependent on adequate sources of raw materials, as well as their prices on the market, the efficiency of the production process and distribution of products to its customers.
The cost of raw materials can play a significant role in the cost of finished products the Podravka Group produces, therefore, it is subject to fluctuations of market prices of agricultural, food and pharmaceutical raw materials, whose impact cannot always be mitigated through the sale price for the buyer.
Protective customs and trade mechanisms in the EU protecting EU producers represent a risk in terms of increased customs duties (antidumping) for certain raw materials from third countries.
Also, frequent disruptions on the global market caused by environmental and geopolitical factors and a consolidation in the sector of primary production of raw materials, as well as global disruptions in the supply chain caused by the COVID-19 pandemic, might result in higher purchase prices in the future.
Risks of raw material procurement and product delivery
The Podravka Group realises the procurement on the domestic and foreign markets, while the majority of turnover with foreign suppliers relates to suppliers from EU member states.
Among procurement function risks, the risk of availability of goods on market is one of the most significant, due to its possible impact on the Podravka Group’s operations.
Over the last years, this risk is more prominent due to more frequent adverse weather conditions caused by climate change on the global level (long droughts, floods, etc.). The consequence are lower yields of some agricultural plants often coupled with their lower quality, which leads to the deficit of these raw materials in the free market (fresh and dried vegetables), even for several consecutive seasons. More frequent livestock diseases (African swine fever) cause global disruptions on the meat market, while political or social unrest in certain countries, state interventions on market (hazelnut, cocoa) or speculation with key agricultural and food products (wheat, sugar) are a constant threat in the global business environment. The global pandemic of the COVID-19 virus has further increased the supply risk, which is primarily manifested in the availability of the necessary materials due to the functioning of the entire supply chain in difficult circumstances.
Operating in such conditions, the procurement function of the Podravka Group minimizes these impacts through managing the strategic procurement categories and key suppliers, consolidation of purchasing volumes with the aim to strengthen market positions and ensure availability of raw materials for the production in required volumes, of satisfying quality and on time. Also, by continuously monitoring new technological solutions and introducing replacement raw materials where possible, the Podravka Group actively works on the mitigation and/or elimination of the risk of procurement of raw materials and availability of products.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 38 – RISK MANAGEMENT (CONTINUED)
Financial risk management (continued)
Market risks (continued)
(ii) Price risk (continued)
Risks of price fluctuations of basic raw materials
The market of agricultural and food products, as the most significant source of raw materials for the Group, is among the most sensitive markets of the modern world. Therefore, the volatility of prices of agricultural and food raw materials is a significant element in the Group’s business environment, especially in conditions of prominent disruptions on the global and local markets. One of the reasons lies in the already mentioned risks of availability of goods due to environmental, geopolitical and social factors and speculations with key agricultural and food products, especially those in the wheat and sugar sectors. Exceptional price volatility is particularly relevant in the commodity market segment (hazelnut, sugar, spices, cocoa, powdered milk, energy sources, etc.), which was significant during the last year on the one hand due to disruptions in the supply chain, and on the other, due to increased demand in the market of China.
Protective customs and trade mechanisms in the EU that, on one hand, protect EU producers, on the other hand pose a risk in terms of increased customs duties (antidumping) for certain raw materials from third countries.
In the part of pharmaceutical raw materials there has also been a rise in prices due to significant changes in the input raw material market. Due to the rise in ecological awareness and closure of factories in China that could not survive under the new conditions, there was a lack of primary raw materials which ultimately resulted in an increase in the prices of chemical syntheses.
The global pandemic of the COVID-19 virus has further increased on the one hand the supply risk, which is primarily manifested in the availability of the necessary materials due to the functioning of the entire supply chain in difficult circumstances, but also the risk of price changes.
To minimise these impacts, the Podravka Group’s procurement function continuously monitors movements in prices and market trends, conducts joint tenders for certain strategic procurement categories, uses new procurement techniques (e-procurement, internet auctions) to increase the efficiency of the sourcing process and reduce the cost of procurement. Timely contracting, allocating a portion of risk to our suppliers, optimisation of material specifications and introduction of replacement raw materials, as well as active implementation of the Commodity Risk Management with strengthening of cost-driver analysis and technical analyses of all relevant inputs are only some of the measures taken by the Podravka Group for the purpose of best estimates of price movements and the minimisation of market price volatility risk.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 38 – RISK MANAGEMENT (CONTINUED)
Financial risk management (continued)
Market risks (continued)
(iii) Currency risk
The carrying amounts of the Podravka Group’s financial assets and financial liabilities denominated in foreign currencies at the reporting date are as follows.
|
Liabilities |
Assets |
|||
|
2021 |
2020 |
2021 |
2020 |
|
|
(in thousands of HRK) |
(in thousands of HRK) |
|||
|
European Union (EUR) |
451,481 |
493,350 |
256,615 |
227,427 |
|
Czech (CZK) |
48,374 |
33,361 |
19,851 |
15,874 |
|
Bosnia and Herzegovina (BAM) |
35,833 |
38,499 |
144,961 |
146,334 |
|
Poland (PLN) |
27,610 |
24,008 |
39,466 |
42,167 |
|
Russia (RUB) |
12,230 |
9,108 |
155,150 |
143,252 |
|
Other currencies |
26,897 |
22,651 |
109,546 |
114,573 |
|
602,425 |
620,977 |
725,589 |
689,627 |
|
Foreign currency sensitivity analysis
The Podravka Group performs certain transactions in foreign currencies and is therefore exposed to risks of changes in exchange rates, with the highest exposure during 2021 to changes in the exchange rate of the Croatian kuna against EUR, CZK, BAM, PLN and RUB.
During 2021, the Podravka Group contracted derivative financial instruments to hedge currency risk, aimed at hedging the planned exchange rate for 2021. Using Bloomberg terminal, macroeconomic projections are regularly being monitored and fx forward transactions are contracted based on projections, in line with the “Layer hedging” model.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 38 – RISK MANAGEMENT (CONTINUED)
Financial risk management (continued)
Market risks (continued)
(iii) Currency risk (continued)
Foreign currency sensitivity analysis (continued)
Currency risks arise from operation of subsidiary companies in foreign markets and the purchase of food raw materials in the international market which is largely in EUR and USD. Similarly, the Podravka Group is partially financed through borrowings denominated in EUR.
During 2021, the Podravka Group performed the balance sheet currency structure analysis and continued to apply the model of managing transaction currency risk called “Layer hedging”. This model is applied to the following currencies: USD, AUD, CAD, RUB, CZK, HUF and PLN. The integral parts of the model include the identification of risk sources and exposure measurement process of contracting derivative financial instruments for hedging purposes and the control and reporting system.
Additionally, within the model exposure limit parameters were set which are triggers for contracting prescribed hedging levels. This way, the currency risk is largely transferred from related parties to the Company that adjusts these cash inflows with outflows (natural hedging), thus reducing the overall exposure to currency risk, and also creating the opportunity to contract derivative financial instruments on the remaining amount of net cash flow at the central level.
During 2021, Podravka d.d. concluded fx forward contracts for managing currency risk of the following foreign currencies: AUD, CAD, RUB, HUF and PLN. Due to the exchange rate regime implemented by the Croatian National Bank, derivative financial instruments were not contracted for the exposure of the exchange rate of Croatian kuna towards the EUR. Belupo d.d., a company in the Podravka Group, realises a significant portion of its revenue in the Russian market and is therefore exposed to changes of the RUB exchange rate. Podravka International Kft., Budapest realizes part of its outflows in euros due to the settlement of its obligations in the specified currency. During 2021, a subsidiary entered into fx forward transactions for EUR HUF rate aimed at hedging the EUR exchange rate change.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 38 – RISK MANAGEMENT (CONTINUED)
Financial risk management (continued)
Market risks (continued)
(iii) Currency risk (continued)
Foreign currency sensitivity analysis (continued)
The currency risk analysis is based on the official middle exchange rates for the currencies analysed above as per the Croatian National Bank, which were as follows, except for the Russian ruble for which the ECB exchange rate is used:
|
31.12.2021 |
31.12.2020 |
||
|
EUR |
7.5172 |
7.5369 |
|
|
CZK |
0.3011 |
0.2880 |
|
|
BAM |
3.8435 |
3.8536 |
|
|
PLN |
1.6356 |
1.6663 |
|
|
RUB |
0.0886 |
0.0820 |
The following table details the Podravka Group’s sensitivity to a 10% increase and decrease in Croatian kuna against the relevant foreign currencies where the Podravka Group has significant exposure (EUR, CZK, BAM and PLN) while the sensitivity to RUB change was calculated with a exchange rate change of 30%. The sensitivity analysis includes only outstanding cash items in foreign currency and their translation at the end of the period based on the percentage change in currency exchange rates. The sensitivity analysis includes monetary assets and monetary liabilities in foreign currencies. A negative number below indicates a decrease in profit where Croatian kuna changes against the relevant currency for the percentage specified above. For an inversely proportional change of Croatian kuna against the relevant currency, there would be an equal and opposite impact on the profit.
|
EUR exposure |
CZK exposure |
||||
|
2021 |
2020 |
2021 |
2020 |
||
|
(in thousands of HRK) |
(in thousands of HRK) |
||||
|
Increase/(decrease) of net result +10% |
(19,487) |
(26,592) |
(2,852) |
(1,749) |
|
|
Increase/(decrease) of net result -10% |
19,487 |
26,592 |
2,852 |
1,749 |
|
|
BAM exposure |
PLN exposure |
||||
|
2021 |
2020 |
2021 |
2020 |
||
|
(in thousands of HRK) |
(in thousands of HRK) |
||||
|
Increase/(decrease) of net result +10% |
10,913 |
10,784 |
1,186 |
1,816 |
|
|
Increase/(decrease) of net result -10% |
(10,913) |
(10,784) |
(1,186) |
(1,816) |
|
|
RUB exposure |
|||||
|
2021 |
2020 |
||||
|
(in thousands of HRK) |
|||||
|
Increase/(decrease) of net result +30% |
42,876 |
40,243 |
|||
|
Increase/(decrease) of net result -30% |
(42,876) |
(40,243) |
|||
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 38 – RISK MANAGEMENT (CONTINUED)
Financial risk management (continued)
Market risks (continued)
(iv) Sales function based risks
The Podravka Group generates 32% (2020: 31%) of its revenue on the Croatian market, whereas 68% (2020: 69%) of the sales are generated on international markets.
The Podravka Group determines the selling prices and rebates in accordance with the macroeconomic conditions prevailing in each of the markets, which is at the same time the maximum sales function based risk.
As for operations on the Croatian market, the Podravka Group expects increased risks associated with maintaining market position. To lessen this effect, the Podravka Group aims to further strengthen its competitiveness by increasing productivity, modernising its technology and strengthening its product brands.
The Podravka Group is making efforts through optimization of existing pricing policies and price levels for existing markets in the EU/CEE to secure a basis for the continuing successful long-term growth and avoid decrease in profit margins.
Business risks management
Industry risks
In the food industry, market trends as well as consumer habits change in a very short period of time. Due to this risk, the Group seeks to constantly improve the processes and meet market conditions. In the food industry, where the focus is on products and brands, the Group complies with legislative, health and manufacturing regulations. Clear legal regulation creates most of the production and sales processes within the Group and is subject to change, depending on the bodies adopting it. One of the major risks associated with the food industry is consumer health. All production processes are subject to international standards. By implementing better internal processes, the Group seeks to eliminate the majority of potential threats. The use of EU funds seeks to improve all business processes in the company and improve business at all levels in accordance with the guidelines and focuses of EU business.
At the time of the corona crisis, the food industry proved to be important in overcoming crisis situations. Disruptions in global supply chains pose a challenge to food producers, who have to contend with shortages of certain raw materials and difficult production conditions. Timely production planning and taking into account all unforeseen circumstances reduces the risk of production unreadiness to respond to extraordinary demands. The shortage of skilled labour due to the pandemic can greatly jeopardize production processes and their smooth and timely operation. Preventive measures to prevent the spread of virus infection in production facilities are of immense importance for the production.
The impact of the corona crisis on China and India, the world’s two largest exporters of pharmaceutical products with the cheapest production, has disrupted supply chains for drugs and other medical equipment around the world due to limited production, distribution and trade, as well as short-term shortages of certain products. It is necessary to provide in time the raw materials and materials necessary for the production of medicines in order to reduce the risk and maintain a sufficient supply of medicines to the local population.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 38 – RISK MANAGEMENT (CONTINUED)
Business risks management (continued)
Competition risk
The Group sells products both on the Croatian and international markets, and is exposed to numerous competitors in all product categories. Innovations, adjustments of the product price, quality and packaging are key changes that the Group is paying attention to in order to be different from competition.
In addition, the reputation of the brand, or the Group, is intangible value that differentiates it from the competition and creates the advantage. The fact that the Group is focused on securing the highest level of quality of its products contributes to the reputation that depends on many own products on the market on a daily basis.
Monitoring of consumer habits and preferences that are subject to constant changes, and adjustments to them, are one of a series of activities that the Group undertakes to maintain and increase the existing market positions and margins. An important element in the struggle with major international competitors is the difference between the financial resources needed for the overall promotion and sales of products, and it is often the key factor in reaching out to a new consumer.
Risks of IT system disruptions
The Group intensely uses IT systems that enable it to efficiently manage the Group, communicate with customers and suppliers, and collect all the information that management can rely on in making decisions.
Given the high degree of automation of business processes through the use of IT systems, the Group takes the necessary measures to minimise IT system disruptions due to problems with IT equipment, the space in which it is located, viruses and unauthorised external breaches into the systems.
As each IT system disruption causes significant problems in operating systems and financial losses, the Group has implemented IT system recovery procedures through the construction of an auxiliary IT room that assumes the function of the main IT system room in case of a problem. In the normal operating mode, both IT system rooms work in the active-active mode.
The Group regularly conducts internal and external penetration tests (conducted by external independent security experts) to minimise the risk of using system vulnerabilities for the spread of viruses and the risk of unwanted external breaches into the IT systems.
Also, following the implementation of advance security monitoring systems, monitored on a daily basis, the risk of external breaches into the Podravka Group’s IT systems is additionally reduced and minimised.
Podravka d.d. has implemented the ISO 27001 standard aimed at additionally strengthening security procedures and raising awareness of IT security among the Podravka Group’s employees.
Human resource risk management
Business ethics and excellence, commitment to achieving goals and to work, extra effort and commitment, and daily commitment, growth and development are the basis of the Group’s success and the characteristics of its employees.
Respect and trust, as well as teamwork based on dialogue and transparency in work, are encouraged and supported and form a solid foundation for continuous progress.
Through a series of proactive measures, the Group creates an environment where employees are engaged and loyal. The Group recognizes and rewards individuals who achieve excellent results, show exceptional effort and encourage innovation and efficiency.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 38 – RISK MANAGEMENT (CONTINUED)
Business risks management (continued)
Human resource risk management (continued)
In 2021, the Group identified the main risks related to human capital:
• Timely recruitment and retention of skilled labour for the needs of Production
• Unfavourable age structure of employees and retirement in the coming years
A new Human Resources Strategy has been defined, with some of the main pillars being Workforce transformation and renewal, and Professional development and new career options.
The Group addresses these risks and will focus on specific initiatives/activities aimed at minimizing the main risks:
1. Intensifying cooperation with educational institutions
2. Employment of young workers
3. Programs for trainees and new employees
4. Supply of workforce from new pools
5. Programs that encourage intergenerational and multicultural cooperation and understanding
6. Employer image management
In addition, the Group uses a number of other proactive measures and controls to keep these risks, as much as possible, at a satisfactory level.
Climate related risk
Group operates through two main business segments, Food and Pharmaceuticals. Both business activities are not eligible according to the EU Taxonomy Climate Delegated Act, meaning both business activities doesn't have significant negative effect on climate as production processes don't emit large amounts of Greenhouse Gases). Environment protection is one of Group's priorities and is implemented throughout the principles of sustainable development and clean production. All of the activities have to be aligned with national legal framework regarding environment protection as well as regulations of the country in which the Group operates. In case of non-existing of own legal framework, international standards apply.
Group is obliged to rational use of best sources of energy and raw material, waste management and constant prevention of negative influence on the environment, for production and for its products and services. According to Environment Protection Policy, Group takes actions in its own environment as well, where finding integral solutions for Greenhouse Gas emission reduction is one of the goals set in the Policy.
CO2 is the only Greenhouse Gas emitted as a result of production process, while there is no other Greenhouse Gasses emission. Throughout logistic and distribution part of the business (vehicle fleet) CO2 is emitted as well as very small amounts of CH4 and N2O, which is visible in the difference between total CO2 and total GHG. Investments in vehicle fleet and purchase of new EURO VI norm vehicles resulted in 2,89% decrease in CO2 emission in 2021 in respect to comparative period.
Use of renewable energy sources is increasingly represented in the production process (wood chips boiler room and photovoltaic power plant on Kalnik factory), while trough planed capital expenditures (new photovoltaic power plant in Danica factory area), the portion of use of renewable energy on the Group level will further increase.
Investments into energy efficiency upgrade of real estates and machinery result in reduction in use of energy sources and further decrease of CO2 emission and related negative effect on climate.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 39 – SHARE-BASED PAYMENT TRANSACTIONS
Employee share options
Options for the purchase of Podravka d.d. shares were granted to key management of the Group. The exercise price of the granted option equals the weighted average share price of Podravka d.d. shares as per the Zagreb Stock Exchange in the year the option is granted. Options are acquired separately for each business year. Share purchase options may be exercised after the expiration of at least two and at most five years from the year to which the share purchase option applies. In case of termination of employment, the acquired options can be exercised within 3 years from the date of termination of employment.
The following share-based payment options were effective as at 31 December 2021:
|
Date of issue |
Number of options |
Vesting terms |
Contracted vesting period |
|
|
Options granted to key management of the Group |
|
|
||
|
As at 12 December 2017 |
2,000 |
Service during the contracted vesting period |
31.12.2022. |
|
|
As at 17 March 2017 |
2,000 |
Service during the contracted vesting period |
31.12.2022. |
|
|
As at 17 May 2017 |
5,000 |
Service during the contracted vesting period |
31.12.2022. |
|
|
As at 17 May 2017 |
7,000 |
Service during the contracted vesting period |
06.01.2024. |
|
|
As at 21 July 2017 |
5,000 |
Service during the contracted vesting period |
31.12.2022. |
|
|
As at 01 May 2018 |
2,000 |
Service during the contracted vesting period |
31.12.2022. |
|
|
As at 30 June 2017 |
5,000 |
Service during the contracted vesting period |
31.12.2022. |
|
|
As at 31 December 2017 |
4,000 |
Service during the contracted vesting period |
04.10.2023. |
|
|
As at 31 July 2018 |
28,500 |
Service during the contracted vesting period |
31.12.2023. |
|
|
As at 31 July 2018 |
10,000 |
Service during the contracted vesting period |
06.01.2024. |
|
|
As at 23 July 2018 |
7,500 |
Service during the contracted vesting period |
31.12.2023. |
|
|
As at 13 December 2019 |
2,000 |
Service during the contracted vesting period |
31.12.2023. |
|
|
As at 4 October 2018 |
5,000 |
Service during the contracted vesting period |
04.10.2023. |
|
|
As at 10 December 2019 |
22,500 |
Service during the contracted vesting period |
31.12.2024. |
|
|
As at 28 May 2019 |
7,500 |
Service during the contracted vesting period |
31.12.2024. |
|
|
As at 10 December 2019 |
10,000 |
Service during the contracted vesting period |
06.01.2024. |
|
|
As at 30 July 2019 |
5,000 |
Service during the contracted vesting period |
04.10.2023. |
|
|
As at 30 July 2019 |
4,000 |
Service during the contracted vesting period |
31.12.2024. |
|
|
As at 13 December 2019 |
9,500 |
Service during the contracted vesting period |
31.12.2024. |
|
|
As at 10 December 2020 |
7,500 |
Service during the contracted vesting period |
31.12.2025. |
|
|
As at 19 September 2020 |
3,500 |
Service during the contracted vesting period |
04.10.2023. |
|
|
As at 19 September 2020 |
2,000 |
Service during the contracted vesting period |
31.12.2025. |
|
|
As at 29 September 2020 |
22,500 |
Service during the contracted vesting period |
31.12.2025. |
|
|
As at 29 September 2020 |
10,000 |
Service during the contracted vesting period |
06.01.2024. |
|
|
As at 2 December 2020 |
13,200 |
Service during the contracted vesting period |
31.12.2025. |
|
|
As at 2 December 2020 |
3,300 |
Service during the contracted vesting period |
31.03.2024. |
|
|
As at 30 April 2021 |
32,500 |
Service during the contracted vesting period |
31.12.2026. |
|
|
As at 10 December 2021 |
7,500 |
Service during the contracted vesting period |
31.12.2026. |
|
|
As at 13 September 2021 |
7,000 |
Service during the contracted vesting period |
31.12.2026. |
|
|
Total share options |
252,500 |
|
|
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 39 – SHARE-BASED PAYMENT TRANSACTIONS (CONTINUED)
Employee share options (continued)
Fair value measurement
The fair value of the employee share options is measured using the Black-Scholes formula. Measurement inputs include the share price on the measurement date, the exercise price of the instrument, expected volatility (based on an evaluation of the historical volatility of the share price, particularly over the historical period commensurate with the expected term), expected term of the instruments (based on historical experience and general option holder behaviour), expected dividends, and the risk-free interest rate (based on government bonds). In accordance with the input variables used, the fair value estimate of the option is categorised in the fair value hierarchy as level 1. Service and non-market performance conditions are not taken into account in determining fair value.
Input variables for calculation of fair value:
|
Share option programme for key management |
2021 |
2020 |
||
|
Fair value at grant date (weighted average) |
126 |
113 |
||
|
Share price at grant date (weighted average) |
457 |
415 |
||
|
Exercise price (weighted average) |
417 |
410 |
||
|
Expected volatility (weighted average) |
21% |
18% |
||
|
Expected life (weighted average in years) |
2.7 |
2.2 |
||
|
Risk-free interest rate (based on government bonds) |
5.09% |
3.78% |
||
|
Expense recognised in profit or loss |
2021 |
2020 |
||
|
(in thousands of HRK) |
||||
|
Equity-settled share-based payment transactions |
6,260 |
11,120 |
||
The exercise price of share options for key management is in the range HRK 317 to HRK 589.
Movement in number of share options and respective exercise prices in HRK is as follows:
|
2021 |
2020 |
|||
|
Number of options |
Weighted average exercise price |
Number of options |
Weighted average exercise price |
|
|
Outstanding at 1 January |
231,500 |
410 |
189,217 |
364 |
|
Exercised |
(26,000) |
356 |
(19,717) |
325 |
|
Granted |
47,000 |
632 |
62,000 |
485 |
|
Outstanding at 31 December |
252,500 |
417 |
231,500 |
410 |
|
Unused at 31 Dec |
116,800 |
333 |
40,500 |
355 |
As at 31 December 2021, there are 252,500 of outstanding options (2020: 231,500 options). In 2021, 26,000 options were exercised (2020: 19,717 options).
The weighted average exercise price of outstanding options at the end of 2021 is HRK 417 (2020: HRK 410). The price of all unexercised share options is lower than the share market price as at 31 December 2021. The weighted average remaining validity of options is 2.7 years at year end (2020: 2.2 years).
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 40 – RELATED PARTY TRANSACTIONS
Transactions between the Company and its subsidiaries, which are its related parties, are eliminated through consolidation and are not presented in this note.
Payments to members of the Supervisory Board, Management Board and directors
|
2021 |
2020 |
||||
|
(in thousands of HRK) |
|||||
|
Payments of members of the Management Board and directors |
|||||
|
Salaries, bonuses and other benefits paid |
47,007 |
47,645 |
|||
|
Share-based payments reimbursement |
4,012 |
- |
|||
|
51,019 |
47,645 |
||||
Management of the Group which consists of the Management Board and directors has 64 persons (2020: 65 persons).
During 2021, options were exercised by the active members of the Management Board and directors in the amount of HRK 4,012 thousand (2020: HRK 0 thousand). For details see note 39.
During 2021, a total of HRK 2,568 thousand was paid at Group level as compensation to members of the Supervisory Board (2020: HRK 2,521 thousand).
NOTE 41 – CONTINGENT LIABILITIES
|
2021 |
2020 |
||||
|
(in thousands of HRK) |
|||||
|
Guarantees and warranties given |
30,478 |
28,433 |
|||
|
30,478 |
28,433 |
||||
Guarantees and warranties mainly relate to the potential liability of Podravka d.d. on the basis of customs guarantees, guarantees for transit procedures and guarantees for regular repayment of advances, contingencies of the Belupo Group on the basis of performance guarantees and payment guarantees to the Croatian Ministry of Economy, Entrepreneurship and Crafts. Guarantees and warranties in part also relate to contingencies for performance guarantees of the Žito Group.
With respect to guarantees and warranties granted, contingent liabilities have not been recognised in the consolidated statement of financial position as at 31 December as the Management Board estimated that, as at 31 December 2021 and 2020, it is not probable that they will result in liabilities for the Group.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
NOTE 42 – COMMITMENTS
In 2021, the purchase costs of tangible fixed assets contracted with suppliers amounted to HRK 154,000 thousand (2020: HRK 37,163 thousand), which are not yet realised or recognised in the consolidated statement of financial position.
The future payments under operating leases in 2021 relate to the usage of IT equipment, other operating leases and mobile devices, as follows:
|
2021 |
2020 |
||
|
(in thousands of HRK) |
|||
|
Up to 1 year |
11,306 |
8,112 |
|
|
From 1 to 5 years |
14,773 |
14,167 |
|
|
26,079 |
22,279 |
||
NOTE 43 – EVENTS AFTER THE REPORTING DATE
At the meeting of the Podravka d.d. Supervisory Board held on 4 February 2022, the decision was made on the appointment of the President and members of the Management Board of Podravka d.d.
The Management Board of Podravka d.d. appointments:
1. Martina Dalić – President of the Management Board of Podravka d.d.
2. Davor Doko – member of the Management Board of Podravka d.d.
3. Ivan Ostojić – member of the Management Board of Podravka d.d.
4. Ljiljana Šapina – member of the Management Board of Podravka d.d.
5. Milan Tadić – member of the Management Board of Podravka d.d.
The mandate of the appointed President and members of the Management Board of Podravka d.d. started on 24 February 2022 and lasts until 23 February 2027, except for the appointed member of the Management Board Ivan Ostojić, whose term of office starts on 1 July 2022 and lasts until the expiration of the term of the entire Management Board.
Also, on 4 February 2022, in accordance with Articles 260a and 261 of the Companies Act, the company received the resignation of a member of the Company’s Supervisory Board, Ivan Ostojić, which enters into force on 30 June 2022.
On 10 February 2022, at the meeting of the Supervisory Board of Belupo d.d. a decision was made on the appointment of a member of the Management Board of Belupo d.d., and Marko Đerek was appointed a member of the Management Board of Belupo d.d. The mandate of the member of the Management Board of Belupo d.d. started on 24 February 2022 and lasts until the expiration of the term of office of the entire Management Board of Belupo d.d., 3 May 2022.